# EDGAR Filing Document

**Accession Number:** 0001039828
**File Stem:** 0001039828-25-000034
**Filing Date:** 2025-11
**Character Count:** 277722
**Document Hash:** 17ff7ab0ddd89cb3c35c35f2afc8df40
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001039828-25-000034.hdr.sgml**: 20251113

**ACCESSION NUMBER**: 0001039828-25-000034

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 141

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251113

**DATE AS OF CHANGE**: 20251113

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** American National Group Inc.
- **CENTRAL INDEX KEY:** 0001039828
- **STANDARD INDUSTRIAL CLASSIFICATION:** LIFE INSURANCE [6311]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 421447959
- **STATE OF INCORPORATION:** IA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-31911
- **FILM NUMBER:** 251479607

**BUSINESS ADDRESS:**
- **STREET 1:** 6000 WESTOWN PARKWAY
- **CITY:** WEST DEMOINES
- **STATE:** IA
- **ZIP:** 50266
- **BUSINESS PHONE:** 5152210002

**MAIL ADDRESS:**
- **STREET 1:** 6000 WESTOWN PARKWAY
- **CITY:** WEST DES MOINES
- **STATE:** IA
- **ZIP:** 50266

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AMERICAN EQUITY INVESTMENT LIFE HOLDING CO
- **DATE OF NAME CHANGE:** 19990414

?xml version='1.0' encoding='ASCII'? angpd-20250930

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

**(Mark One)**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended September 30, 2025**

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from ________ to ________** 

**Commission file number: 001-31911**

**American National Group Inc.**

(Exact name of Registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **42-1447959** |
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |

---

**One Moody Plaza** 

**Galveston, Texas 77550** 

(Address of principal executive offices, including zip code)

**(888) 221-1234**

(Registrant's telephone number, including area code)

**Not Applicable**

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Depositary Shares, each representing a 1/1,000th interest in a share of 7.375% Fixed-Rate Non-Cumulative Preferred Stock, Series D | ANGpD | New York Stock Exchange |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

------

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of November 12, 2025, 10,000 shares of our common shares were outstanding, all of which are held by Brookfield Wealth Solutions Ltd. and its affiliates.

**American National Group Inc. meets the conditions set forth in General Instruction (H)(1)(a) and (b) for Form 10-Q and therefore is filing this Form 10-Q in the reduced disclosure format.**

------

**TABLE OF CONTENTS** 

---

| | |
|:---|:---|
| | <u>Page</u> |
| <u>[PART I - FINANCIAL INFORMATION](#i54d49cb040d14c358dbc1409ee494653_10)</u> |  |
| <u>[Item 1: Financial Statements (unaudited):](#i54d49cb040d14c358dbc1409ee494653_13)</u> |  |
| &nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Financial Position (unaudited)](#i54d49cb040d14c358dbc1409ee494653_16)</u> | <u>[2](#i54d49cb040d14c358dbc1409ee494653_16)</u> |
| &nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Operations (unaudited)](#i54d49cb040d14c358dbc1409ee494653_19)</u> | <u>[4](#i54d49cb040d14c358dbc1409ee494653_19)</u> |
| &nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Comprehensive Income (unaudited)](#i54d49cb040d14c358dbc1409ee494653_22)</u> | <u>[5](#i54d49cb040d14c358dbc1409ee494653_22)</u> |
| &nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Changes in Equity (unaudited)](#i54d49cb040d14c358dbc1409ee494653_25)</u> | <u>[6](#i54d49cb040d14c358dbc1409ee494653_25)</u> |
| &nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Cash Flows (unaudited)](#i54d49cb040d14c358dbc1409ee494653_28)</u> | <u>[8](#i54d49cb040d14c358dbc1409ee494653_28)</u> |
| &nbsp;&nbsp;&nbsp;<u>[Notes to Condensed Consolidated Financial Statements (unaudited)](#i54d49cb040d14c358dbc1409ee494653_31)</u> | <u>[10](#i54d49cb040d14c358dbc1409ee494653_31)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 1. Organization and Description of the Company](#i54d49cb040d14c358dbc1409ee494653_34)</u> | <u>[10](#i54d49cb040d14c358dbc1409ee494653_34)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 2. Summary of Significant Accounting Policies](#i54d49cb040d14c358dbc1409ee494653_37)</u> | <u>[10](#i54d49cb040d14c358dbc1409ee494653_37)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 3. Available-For-Sale Fixed Maturity Securities](#i54d49cb040d14c358dbc1409ee494653_40)</u> | <u>[12](#i54d49cb040d14c358dbc1409ee494653_40)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 4. Equity Securities](#i54d49cb040d14c358dbc1409ee494653_43)</u> | <u>[15](#i54d49cb040d14c358dbc1409ee494653_43)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 5. Mortgage Loans on Real Estate](#i54d49cb040d14c358dbc1409ee494653_46)</u> | <u>[15](#i54d49cb040d14c358dbc1409ee494653_46)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 6. Private Loans](#i54d49cb040d14c358dbc1409ee494653_49)</u> | <u>[19](#i54d49cb040d14c358dbc1409ee494653_49)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 7. Real Estate and Real Estate Partnerships](#i54d49cb040d14c358dbc1409ee494653_52)</u> | <u>[20](#i54d49cb040d14c358dbc1409ee494653_52)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 8. Variable Interest Entities and Equity Method Investments](#i54d49cb040d14c358dbc1409ee494653_55)</u> | <u>[20](#i54d49cb040d14c358dbc1409ee494653_55)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 9. Derivative Instruments](#i54d49cb040d14c358dbc1409ee494653_58)</u> | <u>[22](#i54d49cb040d14c358dbc1409ee494653_58)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 10. Net Investment Income and Investment Related Gains (Losses)](#i54d49cb040d14c358dbc1409ee494653_73)</u> | <u>[27](#i54d49cb040d14c358dbc1409ee494653_73)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 11. Fair Value of Financial Instruments](#i54d49cb040d14c358dbc1409ee494653_76)</u> | <u>[28](#i54d49cb040d14c358dbc1409ee494653_76)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 12. Reinsurance](#i54d49cb040d14c358dbc1409ee494653_79)</u> | <u>[37](#i54d49cb040d14c358dbc1409ee494653_79)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 13. Separate Account Assets and Liabilities](#i54d49cb040d14c358dbc1409ee494653_82)</u> | <u>[38](#i54d49cb040d14c358dbc1409ee494653_82)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 14. Deferred Policy Acquisition Costs, Deferred Sales Inducements and Value of Business Acquired](#i54d49cb040d14c358dbc1409ee494653_85)</u> | <u>[39](#i54d49cb040d14c358dbc1409ee494653_85)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 15. Intangible Assets](#i54d49cb040d14c358dbc1409ee494653_88)</u> | <u>[41](#i54d49cb040d14c358dbc1409ee494653_88)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 16. Acquisitions](#i54d49cb040d14c358dbc1409ee494653_91)</u> | <u>[42](#i54d49cb040d14c358dbc1409ee494653_91)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 17. Future Policy Benefits](#i54d49cb040d14c358dbc1409ee494653_94)</u> | <u>[43](#i54d49cb040d14c358dbc1409ee494653_94)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 18. Policyholders' Account Balances](#i54d49cb040d14c358dbc1409ee494653_97)</u> | <u>[46](#i54d49cb040d14c358dbc1409ee494653_97)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 19. Market Risk Benefits](#i54d49cb040d14c358dbc1409ee494653_100)</u> | <u>[48](#i54d49cb040d14c358dbc1409ee494653_100)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 20. Liability for Unpaid Claims and Claim Adjustment Expenses](#i54d49cb040d14c358dbc1409ee494653_103)</u> | <u>[49](#i54d49cb040d14c358dbc1409ee494653_103)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 21. Long Term Borrowings](#i54d49cb040d14c358dbc1409ee494653_2748779070186)</u> | <u>[50](#i54d49cb040d14c358dbc1409ee494653_2748779070186)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 22. Income Taxes](#i54d49cb040d14c358dbc1409ee494653_109)</u> | <u>[50](#i54d49cb040d14c358dbc1409ee494653_109)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 23. Stockholders' Equity](#i54d49cb040d14c358dbc1409ee494653_112)</u> | <u>[51](#i54d49cb040d14c358dbc1409ee494653_112)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 24. Accumulated Other Comprehensive Income](#i54d49cb040d14c358dbc1409ee494653_118)</u> | <u>[52](#i54d49cb040d14c358dbc1409ee494653_118)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 25. Related Party Transactions](#i54d49cb040d14c358dbc1409ee494653_121)</u> | <u>[52](#i54d49cb040d14c358dbc1409ee494653_121)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 26. Segment Reporting](#i54d49cb040d14c358dbc1409ee494653_124)</u> | <u>[54](#i54d49cb040d14c358dbc1409ee494653_124)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 27. Financial Commitments and Contingencies](#i54d49cb040d14c358dbc1409ee494653_127)</u> | <u>[57](#i54d49cb040d14c358dbc1409ee494653_127)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Note 28. Subsequent Events](#i54d49cb040d14c358dbc1409ee494653_130)</u> | <u>[57](#i54d49cb040d14c358dbc1409ee494653_130)</u> |
| <u>[Item 2: Management's Discussion and Analysis of Financial Condition and Results of Operations](#i54d49cb040d14c358dbc1409ee494653_133)</u> | <u>[58](#i54d49cb040d14c358dbc1409ee494653_133)</u> |
| <u>[Item 3: Quantitative and Qualitative Disclosures about Market Risk](#i54d49cb040d14c358dbc1409ee494653_157)</u> | <u>[68](#i54d49cb040d14c358dbc1409ee494653_157)</u> |
| <u>[Item 4: Controls and Procedures](#i54d49cb040d14c358dbc1409ee494653_160)</u> | <u>[70](#i54d49cb040d14c358dbc1409ee494653_160)</u> |
| <u>[PART II - OTHER INFORMATION](#i54d49cb040d14c358dbc1409ee494653_163)</u> |  |
| <u>[Item 1: Legal Proceedings](#i54d49cb040d14c358dbc1409ee494653_166)</u> | <u>[70](#i54d49cb040d14c358dbc1409ee494653_166)</u> |
| <u>[Item 1A: Risk Factors](#i54d49cb040d14c358dbc1409ee494653_169)</u> | <u>[70](#i54d49cb040d14c358dbc1409ee494653_169)</u> |
| <u>[Item 2: Unregistered Sales of Equity Securities and Use of Proceeds](#i54d49cb040d14c358dbc1409ee494653_172)</u> | <u>[70](#i54d49cb040d14c358dbc1409ee494653_172)</u> |
| <u>[Item 3: Defaults Upon Senior Securities](#i54d49cb040d14c358dbc1409ee494653_175)</u> | <u>[70](#i54d49cb040d14c358dbc1409ee494653_175)</u> |
| <u>[Item 4: Mine Safety Disclosures](#i54d49cb040d14c358dbc1409ee494653_178)</u> | <u>[70](#i54d49cb040d14c358dbc1409ee494653_178)</u> |
| <u>[Item 5: Other Information](#i54d49cb040d14c358dbc1409ee494653_181)</u> | <u>[70](#i54d49cb040d14c358dbc1409ee494653_181)</u> |
| <u>[Item 6: Exhibits](#i54d49cb040d14c358dbc1409ee494653_184)</u> | <u>[71](#i54d49cb040d14c358dbc1409ee494653_184)</u> |
| <u>[Signatures](#i54d49cb040d14c358dbc1409ee494653_187)</u> | <u>[72](#i54d49cb040d14c358dbc1409ee494653_187)</u> |

---

------

**PART I - FINANCIAL INFORMATION**

**Item 1. Financial Statements**

---

| | | |
|:---|:---|:---|
| **AMERICAN NATIONAL GROUP INC. AND SUBSIDIARIES** | **AMERICAN NATIONAL GROUP INC. AND SUBSIDIARIES** | **AMERICAN NATIONAL GROUP INC. AND SUBSIDIARIES** |
| **CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION** | **CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION** | **CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION** |
| **(Dollars in millions, except share and per share data)** | **(Dollars in millions, except share and per share data)** | **(Dollars in millions, except share and per share data)** |
| **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
| | **September 30, 2025** | **December 31, 2024** |
| **Assets** | | |
| Investments: |  |  |
| &nbsp;&nbsp;&nbsp;Available-for-sale fixed maturity securities, at fair value (net of allowance for credit losses of $3 and $27, respectively; amortized cost of $54,104 and $47,127, respectively) | $55408 | $47292 |
| &nbsp;&nbsp;&nbsp;Equity securities, at fair value | 1212 | 1142 |
| &nbsp;&nbsp;&nbsp;Mortgage loans on real estate, at amortized cost (net of allowance for credit losses of $134 and $155, respectively) | 11090 | 12117 |
| &nbsp;&nbsp;&nbsp;Private loans, at amortized cost (net of allowance for credit loss of $142 and $66, respectively) | 8387 | 5732 |
| &nbsp;&nbsp;&nbsp;Real estate and real estate partnerships (net of accumulated depreciation of $252 and $228, respectively) | 6061 | 4992 |
| &nbsp;&nbsp;&nbsp;Investment funds | 3809 | 3015 |
| &nbsp;&nbsp;&nbsp;Policy loans | 253 | 274 |
| &nbsp;&nbsp;&nbsp;Short-term investments, at estimated fair value | 1435 | 4177 |
| &nbsp;&nbsp;&nbsp;Other invested assets | 2073 | 2014 |
| Total investments | 89728 | 80755 |
| Cash and cash equivalents | 11568 | 11330 |
| Accrued investment income | 786 | 761 |
| Deferred policy acquisition costs, deferred sales inducements and value of business acquired | 11384 | 10631 |
| Premiums due and other receivables | 499 | 437 |
| Ceded unearned premiums | 143 | 132 |
| Deferred tax asset | 303 | 529 |
| Reinsurance recoverables and deposit assets | 9531 | 10055 |
| Property and equipment (net of accumulated depreciation of $347 and $352, respectively) | 170 | 175 |
| Intangible assets (net of accumulated amortization of $127 and $56, respectively) | 1541 | 1545 |
| Goodwill | 783 | 783 |
| Other assets | 2928 | 2745 |
| Separate account assets | 1195 | 1343 |
| Total assets | $130559 | $121221 |

---

------

---

| | | |
|:---|:---|:---|
| **AMERICAN NATIONAL GROUP INC. AND SUBSIDIARIES** | **AMERICAN NATIONAL GROUP INC. AND SUBSIDIARIES** | **AMERICAN NATIONAL GROUP INC. AND SUBSIDIARIES** |
| **CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION** | **CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION** | **CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION** |
| **(Dollars in millions, except share and per share data)** | **(Dollars in millions, except share and per share data)** | **(Dollars in millions, except share and per share data)** |
| **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
| | **September 30, 2025** | **December 31, 2024** |
| **Liabilities** | | |
| &nbsp;&nbsp;&nbsp;Future policy benefits | $10345 | $9170 |
| &nbsp;&nbsp;&nbsp;Policyholders' account balances | 89469 | 83079 |
| &nbsp;&nbsp;&nbsp;Policy and contract claims | 1811 | 1867 |
| &nbsp;&nbsp;&nbsp;Market risk benefits | 4505 | 3655 |
| &nbsp;&nbsp;&nbsp;Unearned premium reserve | 733 | 1044 |
| &nbsp;&nbsp;&nbsp;Due to related parties | 115 | 80 |
| &nbsp;&nbsp;&nbsp;Other policyholder funds | 353 | 347 |
| &nbsp;&nbsp;&nbsp;Notes payable | 204 | 189 |
| &nbsp;&nbsp;&nbsp;Long term borrowings | 3449 | 2957 |
| &nbsp;&nbsp;&nbsp;Funds withheld for reinsurance liabilities | 3131 | 3321 |
| &nbsp;&nbsp;&nbsp;Other liabilities | 4268 | 4141 |
| &nbsp;&nbsp;&nbsp;Separate account liabilities | 1195 | 1343 |
| Total liabilities | 119578 | 111193 |
| **Equity** |  |  |
| &nbsp;&nbsp;&nbsp;Preferred stock, Series A; par value $1 per share; $25,000 per share liquidation preference; 20,000 shares authorized; issued and outstanding: <br>&nbsp;&nbsp;&nbsp;&nbsp; 2025 - no shares<br>&nbsp;&nbsp;&nbsp;&nbsp; 2024 - 16,000 shares |  | 389 |
| &nbsp;&nbsp;&nbsp;Preferred stock, Series B; par value $1 per share; $25,000 per share liquidation preference; 12,000 shares authorized; issued and outstanding: <br>&nbsp;&nbsp;&nbsp;&nbsp; 2025 - 12,000 shares<br>&nbsp;&nbsp;&nbsp;&nbsp; 2024 - 12,000 shares | 296 | 296 |
| &nbsp;&nbsp;&nbsp;Preferred stock, Series D; par value $1 per share; $25,000 per share liquidation preference; 12,000 shares authorized; issued and outstanding: <br>&nbsp;&nbsp;&nbsp;&nbsp; 2025 - 12,000 shares<br>&nbsp;&nbsp;&nbsp;&nbsp; 2024 - no shares | 292 |  |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | 7558 | 7569 |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive income, net of taxes | 1132 | 340 |
| &nbsp;&nbsp;&nbsp;Retained earnings | 1480 | 1356 |
| &nbsp;&nbsp;&nbsp;Non-controlling interests | 223 | 78 |
| Total equity | 10981 | 10028 |
| Total liabilities and equity | $130559 | $121221 |

---

&nbsp;&nbsp;&nbsp;&nbsp;

*See accompanying notes to the unaudited condensed consolidated financial statements.*

------

**AMERICAN NATIONAL GROUP INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**

**(Dollars in millions)**

**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Net premiums | $566 | $888 | $2207 | $3037 |
| Other policy revenue | 181 | 208 | 502 | 504 |
| Net investment income | 1285 | 1024 | 3720 | 2396 |
| Investment related gains (losses) | 2 | (128) | 71 | (160) |
| Other income | 24 | 12 | 83 | 12 |
| Total revenues | 2058 | 2004 | 6583 | 5789 |
| Policyholder benefits and claims incurred | 527 | 846 | 2243 | 2962 |
| Interest sensitive contract benefits | 523 | 523 | 1520 | 1068 |
| Amortization of deferred policy acquisition costs, deferred sales inducements and value of business acquired | 345 | 289 | 995 | 649 |
| Change in fair value of insurance-related derivatives and embedded derivatives | (187) | 344 | 143 | 346 |
| Change in fair value of market risk benefits | 310 | 134 | 624 | 292 |
| Operating expenses | 156 | 228 | 647 | 666 |
| Interest expense | 47 | 49 | 140 | 114 |
| Total benefits and expenses | 1721 | 2413 | 6312 | 6097 |
| Net income (loss) before income taxes | 337 | (409) | 271 | (308) |
| Income tax expense (benefit) | 119 | (77) | 102 | (337) |
| Net income (loss) | 218 | (332) | 169 | 29 |
| Less: Net income (loss) attributable to noncontrolling interests | (1) | (44) | 4 | (51) |
| Net income (loss) attributable to American National Group Inc. stockholders | 219 | (288) | 165 | 80 |
| Less: Preferred stock dividends and redemption | 11 | 11 | 52 | 22 |
| Net income (loss) attributable to American National Group Inc. common stockholder | $208 | $(299) | $113 | $58 |

---

*See accompanying notes to the unaudited condensed consolidated financial statements.*

------

**AMERICAN NATIONAL GROUP INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME**

**(Dollars in millions)**

**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Net income (loss) | $218 | $(332) | $169 | $29 |
| Other comprehensive income, net of tax: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Change in net unrealized investment gains (losses) | 517 | 1334 | 832 | 1677 |
| &nbsp;&nbsp;&nbsp;Foreign currency translation | (83) | 1 | 36 | 6 |
| &nbsp;&nbsp;&nbsp;Change in discount rate for future policy benefits | (41) | (231) | (117) | (49) |
| &nbsp;&nbsp;&nbsp;Change in instrument-specific credit risk for market risk benefits | 99 | (71) | 70 | (66) |
| &nbsp;&nbsp;&nbsp;Defined benefit pension plan adjustment | (24) | 3 | (29) | 22 |
| Total other comprehensive income | 468 | 1036 | 792 | 1590 |
| Comprehensive income | 686 | 704 | 961 | 1619 |
| &nbsp;&nbsp;&nbsp;Less: Comprehensive income (loss) attributable to noncontrolling interest | (1) | (44) | 4 | (51) |
| Comprehensive income attributable to American National Group Inc. | $687 | $748 | $957 | $1670 |

---

*See accompanying notes to the unaudited condensed consolidated financial statements.*

------

**AMERICAN NATIONAL GROUP INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY**

**(Dollars in millions)**

**(Unaudited)**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Preferred<br>Stock** | **Additional<br>Paid-In<br>Capital** | **Accumulated<br>Other<br>Comprehensive<br>Income** | **Retained<br>Earnings** | **Noncontrolling<br>Interest** | **Total<br>Equity** |
| **For the three months ended September 30, 2025** | | | | | | |
| Balance at June 30, 2025 | $588 | $7547 | $664 | $1283 | $135 | $10217 |
| &nbsp;&nbsp;&nbsp;Net income (loss) for period |  |  |  | 219 | (1) | 218 |
| &nbsp;&nbsp;&nbsp;Other comprehensive income (loss) |  |  | 468 |  |  | 468 |
| &nbsp;&nbsp;&nbsp;Consolidations (deconsolidations) of noncontrolling interests |  |  |  |  | 87 | 87 |
| &nbsp;&nbsp;&nbsp;Contributions from (distributions to) noncontrolling interests |  |  |  |  | 2 | 2 |
| &nbsp;&nbsp;&nbsp;Dividends |  |  |  | (11) |  | (11) |
| &nbsp;&nbsp;&nbsp;Other |  | 11 |  | (11) |  |  |
| Balance at September 30, 2025 | $588 | $7558 | $1132 | $1480 | $223 | $10981 |
|  | **Preferred<br>Stock** | **Additional<br>Paid-In<br>Capital** | **Accumulated<br>Other<br>Comprehensive<br>Income** | **Retained<br>Earnings** | **Noncontrolling<br>Interest** | **Total<br>Equity** |
| **For the three months ended September 30, 2024** |  |  |  |  |  |  |
| Balance at June 30, 2024 | $685 | $6935 | $445 | $1005 | $187 | $9257 |
| &nbsp;&nbsp;&nbsp;Net income (loss) for period |  |  |  | (288) | (44) | (332) |
| &nbsp;&nbsp;&nbsp;Other comprehensive income (loss) |  |  | 1036 |  |  | 1036 |
| &nbsp;&nbsp;&nbsp;Contributions from (distributions to) noncontrolling interests |  |  |  |  | 22 | 22 |
| &nbsp;&nbsp;&nbsp;Dividends |  |  |  | (8) |  | (8) |
| &nbsp;&nbsp;&nbsp;Other |  | 7 |  |  |  | 7 |
| Balance at September 30, 2024 | $685 | $6942 | $1481 | $709 | $165 | $9982 |

---

------

**AMERICAN NATIONAL GROUP INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Continued)**

**(Dollars in millions)**

**(Unaudited)**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Preferred<br>Stock** | **Additional<br>Paid-In<br>Capital** | **Accumulated<br>Other<br>Comprehensive<br>Income** | **Retained<br>Earnings** | **Noncontrolling<br>Interest** | **Total<br>Equity** |
| **For the nine months ended September 30, 2025** | | | | | | |
| Balance at December 31, 2024 | $685 | $7569 | $340 | $1356 | $78 | $10028 |
| &nbsp;&nbsp;&nbsp;Net income (loss) for period |  |  |  | 165 | 4 | 169 |
| &nbsp;&nbsp;&nbsp;Other comprehensive income (loss) |  |  | 792 |  |  | 792 |
| &nbsp;&nbsp;&nbsp;Consolidations (deconsolidations) of noncontrolling interests |  |  |  |  | 145 | 145 |
| &nbsp;&nbsp;&nbsp;Contributions from (distributions to) noncontrolling interests |  |  |  |  | (4) | (4) |
| &nbsp;&nbsp;&nbsp;Dividends |  |  |  | (41) |  | (41) |
| &nbsp;&nbsp;&nbsp;Preferred stock issuance | 292 |  |  |  |  | 292 |
| &nbsp;&nbsp;&nbsp;Preferred stock redemption | (389) |  |  | (11) |  | (400) |
| &nbsp;&nbsp;&nbsp;Other |  | (11) |  | 11 |  |  |
| Balance at September 30, 2025 | $588 | $7558 | $1132 | $1480 | $223 | $10981 |
|  | **Preferred<br>Stock** | **Additional<br>Paid-In<br>Capital** | **Accumulated<br>Other<br>Comprehensive<br>Income (Loss)** | **Retained<br>Earnings** | **Noncontrolling<br>Interest** | **Total<br>Equity** |
| **For the nine months ended September 30, 2024** |  |  |  |  |  |  |
| Balance at December 31, 2023 | $— | $5185 | $(109) | $716 | $107 | $5899 |
| &nbsp;&nbsp;&nbsp;Net income (loss) for period |  |  |  | 80 | (51) | 29 |
| &nbsp;&nbsp;&nbsp;Other comprehensive income (loss) |  |  | 1590 |  |  | 1590 |
| &nbsp;&nbsp;&nbsp;Contributions from (distributions to) noncontrolling interests |  |  |  |  | 109 | 109 |
| &nbsp;&nbsp;&nbsp;Dividends |  |  |  | (87) |  | (87) |
| &nbsp;&nbsp;&nbsp;Impact of common control acquisition | 685 | 1757 |  |  |  | 2442 |
| Balance at September 30, 2024 | $685 | $6942 | $1481 | $709 | $165 | $9982 |

---

*See accompanying notes to the unaudited condensed consolidated financial statements.*

------

**AMERICAN NATIONAL GROUP INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(Dollars in millions)**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** |
| **Operating activities:** |  |  |
| Net income | $169 | $29 |
| Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Other policy revenue | (502) | (484) |
| &nbsp;&nbsp;&nbsp;Accretion on investments | (551) | (308) |
| &nbsp;&nbsp;&nbsp;Amortization of deferred policy acquisition costs, deferred sales inducements and value of business acquired | 995 | 649 |
| &nbsp;&nbsp;&nbsp;Deferral of policy acquisition costs | (1164) | (856) |
| &nbsp;&nbsp;&nbsp;Gains on investments and derivatives | (312) | (614) |
| &nbsp;&nbsp;&nbsp;Other losses (gains) | 16 | (5) |
| &nbsp;&nbsp;&nbsp;Provisions for credit losses | 44 | 30 |
| &nbsp;&nbsp;&nbsp;Income from real estate partnerships, investment funds and corporations | (278) | (294) |
| &nbsp;&nbsp;&nbsp;Distributions from real estate partnerships, investment funds and corporations | 237 | 262 |
| &nbsp;&nbsp;&nbsp;Interest credited to policyholders' account balances | 1520 | 1300 |
| &nbsp;&nbsp;&nbsp;Change in fair value of embedded derivatives | 389 | 1091 |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 122 | 109 |
| &nbsp;&nbsp;&nbsp;Deferred income taxes | 138 | (635) |
| &nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insurance-related liabilities | 678 | 989 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Premiums due and other receivables | (62) | (19) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Funds withheld for reinsurance liabilities | (238) | (278) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reinsurance recoverables and deposit assets | 761 | 1080 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued investment income | (25) | (80) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Working capital and other | (301) | 138 |
| Cash flows provided by operating activities | 1636 | 2104 |
| **Investing activities:** |  |  |
| Acquisition of subsidiary, net of cash acquired |  | 10836 |
| Purchase of investments: |  |  |
| &nbsp;&nbsp;&nbsp;Available-for-sale fixed maturity securities | (13018) | (4819) |
| &nbsp;&nbsp;&nbsp;Equity securities | (73) | (341) |
| &nbsp;&nbsp;&nbsp;Mortgage loans on real estate | (984) | (778) |
| &nbsp;&nbsp;&nbsp;Private loans | (2422) | (2140) |
| &nbsp;&nbsp;&nbsp;Investment real estate and real estate partnerships | (1144) | (1622) |
| &nbsp;&nbsp;&nbsp;Investment funds | (1848) | (203) |
| &nbsp;&nbsp;&nbsp;Short-term investments | (11363) | (6290) |
| &nbsp;&nbsp;&nbsp;Other invested assets | (235) | (325) |
| Proceeds from sales and maturities of investments: |  |  |
| &nbsp;&nbsp;&nbsp;Available-for-sale fixed maturity securities | 6749 | 3484 |
| &nbsp;&nbsp;&nbsp;Equity securities | 84 | 22 |
| &nbsp;&nbsp;&nbsp;Mortgage loans on real estate | 2114 | 1184 |
| &nbsp;&nbsp;&nbsp;Private loans | 956 | 594 |
| &nbsp;&nbsp;&nbsp;Investment real estate and real estate partnerships | 90 | 319 |
| &nbsp;&nbsp;&nbsp;Investment funds | 317 | 379 |
| &nbsp;&nbsp;&nbsp;Short-term investments | 13880 | 5513 |
| &nbsp;&nbsp;&nbsp;Other invested assets | 258 | 38 |
| Purchases of derivatives | (714) | (387) |
| Proceeds from sales and maturities of derivatives | 813 | 706 |

---

------

**AMERICAN NATIONAL GROUP INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)**

**(Dollars in millions)**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** |
| Purchase of intangibles and property and equipment | (42) | (61) |
| Proceeds from sales of intangibles and property and equipment |  | 28 |
| Change in collateral held for derivatives | 75 | 417 |
| Other | 22 | 11 |
| Cash flows provided by (used in) investing activities | (6485) | 6565 |
| **Financing activities:** |  |  |
| Issuance of preferred equity | 292 |  |
| Redemption of preferred equity | (400) |  |
| Dividends paid to stockholders | (41) | (22) |
| Payments to noncontrolling interests |  | (1) |
| Borrowings from related parties | 206 |  |
| Repayment of borrowings to related parties | (57) |  |
| Borrowings from external parties | 1222 | 1900 |
| Repayment of borrowings to external parties | (700) | (1501) |
| Policyholders' account deposits | 12018 | 7785 |
| Policyholders' account withdrawals | (7485) | (6117) |
| Debt issuance costs | (13) | (4) |
| Issuance of equity, noncontrolling interests | 64 |  |
| Distributions to noncontrolling interests | (19) | (28) |
| Cash flows provided by financing activities | 5087 | 2012 |
| **Cash and cash equivalents** |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents, beginning of period | 11330 | 3192 |
| &nbsp;&nbsp;&nbsp;Net change during the period | 238 | 10681 |
| Cash and cash equivalents, at end of period | $11568 | $13873 |
| **Supplementary cash flow disclosure:** |  |  |
| &nbsp;&nbsp;&nbsp;Cash taxes paid (net of refunds received) | $55 | $62 |
| &nbsp;&nbsp;&nbsp;Cash interest paid | 97 | 98 |
| **Non-cash transactions:** |  |  |
| &nbsp;&nbsp;&nbsp;Available-for-sale fixed maturity securities received in connection with pension risk transfer transactions | $— | $462 |
| &nbsp;&nbsp;&nbsp;Equity securities transferred as consideration paid for acquisition of a subsidiary |  | 218 |
| &nbsp;&nbsp;&nbsp;Non-cash deposit on reinsurance |  | 3394 |
| &nbsp;&nbsp;&nbsp;Transfer of invested assets |  | (1810) |
| &nbsp;&nbsp;&nbsp;Fixed maturities received as proceeds from investment fund sales | 786 |  |

---

*See accompanying notes to the unaudited condensed consolidated financial statements.*

------

**AMERICAN NATIONAL GROUP INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**September 30, 2025**

**(Unaudited)**

**1. Organization and Description of the Company**

American National Group Inc., together with its subsidiaries (collectively, "ANGI", "we", "our", "us", or the "Company") is primarily focused on providing insurance solutions to individuals and institutions through a broad range of annuity and retirement products and services. Our business is presently conducted through our subsidiaries under three operating segments, which we refer to as our Annuities, Property and Casualty ("P&C"), and Life Insurance segments. We conduct our business in 50 states, the District of Columbia and Puerto Rico.

On May 2, 2024, the Company's predecessor, American Equity Investment Life Holding Company, an Iowa corporation ("AEL" or "American Equity") merged with and into Arches Merger Sub Inc. ("Merger Sub"), an indirect wholly-owned subsidiary of Brookfield Wealth Solutions Ltd. ("Brookfield Wealth Solutions"), with AEL surviving and becoming an indirect wholly-owned subsidiary of Brookfield Wealth Solutions (the "Merger"). In connection with the Merger, each issued and outstanding share of AEL's common stock was converted into the right to receive cash and class A limited voting shares of Brookfield Asset Management Ltd. ("BAM"). On May 7, 2024, American National Group, LLC ("American National"), an indirect, wholly-owned subsidiary of Brookfield Wealth Solutions, merged with and into AEL, with AEL surviving as an indirect, wholly-owned subsidiary of Brookfield Wealth Solutions (the "Post-Effective Merger"). Subsequently, AEL discontinued its existence as an Iowa corporation and continued its existence as a corporation incorporated in the State of Delaware (the "Reincorporation"). In connection with the Reincorporation, AEL changed its name to American National Group Inc. ANGI is an indirect, wholly-owned subsidiary of Brookfield Wealth Solutions. In September 2024, Brookfield Wealth Solutions changed its name from Brookfield Reinsurance Ltd. to Brookfield Wealth Solutions Ltd. and changed its trading symbol from "BNRE" to "BNT". For purposes of these notes to the unaudited condensed consolidated financial statements ("financial statements"), the "Company" refers to either ANGI, American National or AEL, as required by the context.

As a result of the Post-Effective Merger, the condensed consolidated financial statements for the periods prior to the Post-Effective Merger represent the results of American National as the accounting acquirer. For periods subsequent to the Post-Effective Merger, the condensed consolidated financial statements represent the combined results of American National and AEL.

**2. Summary of Significant Accounting Policies**

The unaudited condensed consolidated financial statements and notes thereto, including all prior periods presented, have been prepared under accounting principles generally accepted in the United States of America ("GAAP"). The financial statements are prepared on a going concern basis and have been presented in U.S. dollars ("USD") rounded to the nearest million unless otherwise indicated. The financial statements should be read in conjunction with the December 31, 2024 audited consolidated financial statements of the Company included in the Form 10-K, filed with the SEC on March 31, 2025. The results of operations for the three and nine months ended September 30, 2025 are not necessarily indicative of the results for any subsequent period or the entire fiscal year ending December 31, 2025. These financial statements reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair and comparable statement of results for the interim periods presented in accordance with GAAP.

The preparation of the financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Included among the material (or potentially material) reported amounts and disclosures that require use of estimates are: fair value of certain financial assets, derivatives, allowances for credit losses, deferred policy acquisition costs ("DAC"), value of business acquired ("VOBA"), reinsurance funds withheld, goodwill and other intangibles, market risk benefits ("MRB"), future policy benefits ("FPB"), policyholder account balances ("PAB") including the fair value of embedded derivatives, policy and contract claims, income taxes including the recoverability of deferred tax assets and the potential effects of resolving litigated matters. Such estimates and assumptions are subject to inherent uncertainties, which may result in actual amounts differing from reported amounts.

*Basis of Consolidation*

These financial statements include the accounts of the Company and its consolidated subsidiaries, which are legal entities in which the Company has a controlling financial interest either by holding a majority voting interest or as the primary beneficiary of the variable interest entity ("VIE"). All intra-group transactions, balances, income and expenses are eliminated in full on consolidation.

The consolidation assessment depends on the specific facts and circumstances for each entity and requires judgment. Refer to Note 2 of the Company's December 31, 2024 audited consolidated financial statements for a further description of the Company's accounting policies regarding consolidation.

------

*Adoption of New Accounting Pronouncements*

In the current period, the Company did not adopt any Accounting Standard Update ("ASU") issued by the Financial Accounting Standards Board ("FASB") that was material in presentation or amount.

*Recently Issued Accounting Pronouncements*

The Company continues to assess the impacts on the financial statements of the following ASUs issued but not yet adopted as of September 30, 2025. ASUs not listed below were assessed and determined to be either not applicable or insignificant in presentation or amount.

**ASU 2023-09** – On December 14, 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments in this update require that public business entities on an annual basis (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5 percent of the amount computed by multiplying pretax income or loss by the applicable statutory income tax rate). This ASU will be effective for annual reporting periods beginning after December 15, 2024, to be applied prospectively with an option for retrospective application, with early adoption permitted. However, as they apply to disclosure requirements, the adoption of this ASU is not anticipated to have a material impact on our profitability, financial position or cash flows.

**ASU 2024-03** – On November 4, 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. The amendments in this ASU require public business entities to disclose additional information about specific expense categories in the notes to financial statements at interim and annual reporting periods. This ASU will be effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, to be applied on either a retrospective or prospective basis subject to certain exceptions, with early adoption permitted. We are currently evaluating the impact of this ASU on our financial statements. However, as they apply to disclosure requirements, the adoption of this ASU is not anticipated to have a material impact on our profitability, financial position or cash flows.

**ASU 2025-06** – On September 18, 2025, the FASB issued ASU 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Improvements to Accounting for Internal-Use Software. The amendments in this ASU aim to simplify and modernize the guidance for internal-use software costs by removing stage-based development references and introducing a principle-based approach for capitalization criteria. Among other things, it clarifies when costs should be capitalized versus expensed, eliminates certain terminology, and aligns the guidance more closely with current software development practices. This ASU will be effective for fiscal years beginning after December 15, 2027, including interim periods within those fiscal years, and should be applied prospectively, with early adoption permitted. Entities may also elect retrospective application or a modified retrospective application. The Company is currently assessing the potential impact of adopting this standard on its consolidated financial statements and related disclosures.

------

**3. Available-For-Sale Fixed Maturity Securities**

The total amortized cost, fair value, allowance for credit losses, and gross unrealized gains and losses of available-for-sale fixed maturity securities are shown below:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Amortized Cost** | **Gross Unrealized Gains** | **Gross Unrealized Losses** | **Allowance for Credit Losses** | **Fair Value** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **September 30, 2025** | | | | | |
| U.S. treasury and government | $92 | $1 | $— | $— | $93 |
| U.S. state and municipal | 3043 | 115 | (21) | (3) | 3134 |
| Foreign governments | 1199 | 45 | (4) |  | 1240 |
| Corporate debt securities | 40596 | 1089 | (104) |  | 41581 |
| Residential mortgage-backed securities | 953 | 41 | (2) |  | 992 |
| Commercial mortgage-backed securities | 3219 | 104 | (32) |  | 3291 |
| Collateralized debt securities | 5002 | 114 | (39) |  | 5077 |
| Total fixed maturity securities | $54104 | $1509 | $(202) | $(3) | $55408 |
| **December 31, 2024** |  |  |  |  |  |
| U.S. treasury and government | $87 | $— | $(1) | $— | $86 |
| U.S. state and municipal | 3200 | 37 | (30) |  | 3207 |
| Foreign governments | 1568 | 6 | (33) |  | 1541 |
| Corporate debt securities | 32770 | 454 | (350) | (26) | 32848 |
| Residential mortgage-backed securities | 1086 | 25 | (4) | (1) | 1106 |
| Commercial mortgage-backed securities | 2755 | 65 | (24) |  | 2796 |
| Collateralized debt securities | 5661 | 77 | (30) |  | 5708 |
| Total fixed maturity securities | $47127 | $664 | $(472) | $(27) | $47292 |

---

The amortized cost and fair value of available-for-sale fixed maturity securities at September 30, 2025, by contractual maturity are shown below. Actual maturities may differ from contractual maturities as borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Residential and commercial mortgage-backed securities and collateralized debt securities, which are not due at a single maturity, have been separately presented below.

---

| | | |
|:---|:---|:---|
| | **Available-For-Sale** | **Available-For-Sale** |
| | **Amortized Cost** | **Fair Value** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| Due in one year or less | $1888 | $1894 |
| Due after one year through five years | 20040 | 20434 |
| Due after five years through ten years | 7854 | 8052 |
| Due after ten years | 15148 | 15668 |
|  | 44930 | 46048 |
| Residential mortgage-backed securities | 953 | 992 |
| Commercial mortgage-backed securities | 3219 | 3291 |
| Collateralized debt securities | 5002 | 5077 |
| Total | $54104 | $55408 |

---

Proceeds from sales of available-for-sale fixed maturity securities, with the related gross realized gains and losses, are shown below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Proceeds from sales of available-for-sale fixed maturity securities | $1868 | $1071 | $6749 | $3484 |
| Gross realized gains | 46 | 2 | 56 | 6 |
| Gross realized (losses) | (6) | (97) | (68) | (120) |

---

------

The Company has pledged bonds in connection with certain agreements and transactions, such as financing and reinsurance agreements. The carrying value of bonds pledged was $10.1 billion and $8.8 billion as of September 30, 2025 and December 31, 2024, respectively.

In accordance with various regulations, the Company has securities on deposit with regulating authorities with a carrying value of $66 million and $65 million as of September 30, 2025 and December 31, 2024, respectively. There are no restrictions on these assets.

As of September 30, 2025 and December 31, 2024, amounts loaned under reverse repurchase agreements were $400 million and $400 million, respectively, and the fair value of the collateral, comprised of equity securities, was $815 million and $783 million, respectively.

The gross unrealized losses and fair value of available-for-sale fixed maturity securities, aggregated by investment category and the length of time individual securities have been in a continuous unrealized loss position due to market factors are shown below:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Less than 12 months** | **Less than 12 months** | **Less than 12 months** | **12 months or more** | **12 months or more** | **12 months or more** | **Total** | **Total** | **Total** |
| | **Number of Issues** | **Gross Unrealized Losses (1)** | **Fair Value** | **Number of Issues** | **Gross Unrealized Losses (1)** | **Fair Value** | **Number of Issues** | **Gross Unrealized Losses (1)** | **Fair Value** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **September 30, 2025** | | | | | | | | | |
| U.S. treasury and government | 1 | $— | $3 | 3 | $— | $55 | 4 | $— | $58 |
| U.S. state and municipal | 77 | (4) | 277 | 84 | (17) | 243 | 161 | (21) | 520 |
| Foreign governments | 5 | (4) | 191 | 2 |  | 14 | 7 | (4) | 205 |
| Corporate debt securities | 560 | (29) | 3230 | 241 | (75) | 2548 | 801 | (104) | 5778 |
| Residential mortgage-backed securities | 22 |  | 50 | 16 | (2) | 97 | 38 | (2) | 147 |
| Commercial mortgage-backed securities | 34 | (15) | 352 | 29 | (17) | 245 | 63 | (32) | 597 |
| Collateralized debt securities | 97 | (16) | 922 | 20 | (23) | 297 | 117 | (39) | 1219 |
| Total | 796 | $(68) | $5025 | 395 | $(134) | $3499 | 1191 | $(202) | $8524 |
| **December 31, 2024** |  |  |  |  |  |  |  |  |  |
| U.S. treasury and government | 3 | $— | $29 | 1 | $(1) | $36 | 4 | $(1) | $65 |
| U.S. state and municipal | 174 | (20) | 851 | 190 | (10) | 280 | 364 | (30) | 1131 |
| Foreign governments | 8 | (33) | 1206 |  |  |  | 8 | (33) | 1206 |
| Corporate debt securities | 1514 | (165) | 6615 | 384 | (185) | 4015 | 1898 | (350) | 10630 |
| Residential mortgage-backed securities | 47 | (3) | 178 | 16 | (1) | 61 | 63 | (4) | 239 |
| Commercial mortgage-backed securities | 104 | (24) | 667 |  |  |  | 104 | (24) | 667 |
| Collateralized debt securities | 178 | (29) | 1182 | 5 | (1) | 22 | 183 | (30) | 1204 |
| Total | 2028 | $(274) | $10728 | 596 | $(198) | $4414 | 2624 | $(472) | $15142 |

---

(1)Unrealized losses have been reduced to exclude the allowance for credit losses of $3 million and $27 million as of September 30, 2025 and December 31, 2024, respectively.

The unrealized losses as of September 30, 2025 and December 31, 2024 are principally related to the timing of the purchases of certain securities, which carry less yield than those available as of those dates. Approximately 94% and 89% of the unrealized losses on fixed maturity securities shown in the above table for September 30, 2025 and December 31, 2024, respectively, are on securities that are rated investment grade, defined as being the highest two National Association of Insurance Commissioners ("NAIC") designations.

The Company expects to recover the amortized cost on all securities except for those securities on which it recognized an allowance for credit loss. In addition, as the Company did not have the intent to sell fixed maturity securities with unrealized losses and it was not more likely than not that the Company would be required to sell these securities prior to recovery of the amortized cost, which may be maturity, the Company did not write down these investments to fair value through the Condensed Consolidated Statements of Operations.

*Allowance for Credit Losses*

Several assumptions and underlying estimates are made in the evaluation of allowance for credit loss. Examples include financial condition, near-term and long-term prospects of the issue or issuer, including relevant industry conditions and trends and implications of rating agency actions and offering prices. Based on this evaluation, unrealized losses on available-for-sale securities where an allowance for credit loss was not recorded were concentrated within the financials sector as of September 30, 2025 and December 31, 2024.

------

The rollforward of the allowance for credit losses for available-for-sale fixed maturity securities is shown below:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
| | **U.S. State and Political Subdivisions** | **Corporate Securities** | **Residential Mortgage Backed Securities** | **Collateralized Debt Securities** | **Total** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Beginning balance | $— | $(1) | $— | $(1) | $(2) |
| &nbsp;&nbsp;&nbsp;Credit losses recognized on securities for which credit losses were not previously recorded | (3) |  |  |  | (3) |
| &nbsp;&nbsp;&nbsp;Allowance on securities that had an allowance recorded in a previous period |  | 1 |  | 1 | 2 |
| Balance as of September 30, 2025 | $(3) | $— | $— | $— | $(3) |
|  | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
|  | **U.S. State and Political Subdivisions** | **Corporate Securities** | **Residential Mortgage Backed Securities** | **Collateralized Debt Securities** | **Total** |
|  | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Beginning balance | $— | $(34) | $(1) | $(2) | $(37) |
| &nbsp;&nbsp;&nbsp;Credit losses recognized on securities for which credit losses were not previously recorded |  | (3) |  |  | (3) |
| &nbsp;&nbsp;&nbsp;Reductions for securities sold during the period |  | 2 |  |  | 2 |
| &nbsp;&nbsp;&nbsp;Allowance on securities that had an allowance recorded in a previous period |  | 15 |  | 1 | 16 |
| Balance as of September 30, 2024 | $— | $(20) | $(1) | $(1) | $(22) |
|  | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
|  | **U.S. State and Political Subdivisions** | **Corporate Securities** | **Residential Mortgage Backed Securities** | **Collateralized Debt Securities** | **Total** |
|  | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Beginning balance | $— | $(26) | $(1) | $— | $(27) |
| &nbsp;&nbsp;&nbsp;Credit losses recognized on securities for which credit losses were not previously recorded | (3) | (10) |  | (2) | (15) |
| &nbsp;&nbsp;&nbsp;Reductions for securities sold during the period |  | 16 |  |  | 16 |
| &nbsp;&nbsp;&nbsp;Allowance on securities that had an allowance recorded in a previous period |  | 20 | 1 | 2 | 23 |
| Balance as of September 30, 2025 | $(3) | $— | $— | $— | $(3) |
|  | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
|  | **U.S. State and Political Subdivisions** | **Corporate Securities** | **Residential Mortgage Backed Securities** | **Collateralized Debt Securities** | **Total** |
|  | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Beginning balance | $— | $(19) | $(1) | $(4) | $(24) |
| &nbsp;&nbsp;&nbsp;Credit losses recognized on securities for which credit losses were not previously recorded |  | (36) |  |  | (36) |
| &nbsp;&nbsp;&nbsp;Reductions for securities sold during the period |  | 3 |  |  | 3 |
| &nbsp;&nbsp;&nbsp;Allowance on securities that had an allowance recorded in a previous period |  | 32 |  | 3 | 35 |
| Balance as of September 30, 2024 | $— | $(20) | $(1) | $(1) | $(22) |

---

------

**4. Equity Securities**

The net gains on equity securities recognized in "Investment related gains (losses)" on the Condensed Consolidated Statements of Operations are shown below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Unrealized gains on equity securities | $47 | $21 | $144 | $43 |
| Net gains on equity securities sold | 13 | 2 | 14 | 4 |
| &nbsp;&nbsp;&nbsp;Net gains on equity securities | $60 | $23 | $158 | $47 |

---

Equity securities by market sector distribution are shown below, based on carrying value:

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| Consumer goods | 8% | 5% |
| Education | 21% | 20% |
| Energy and utilities | 38% | 10% |
| Finance | 4% | 48% |
| Healthcare | 3% | 2% |
| Industrials | 19% | 12% |
| Information technology | 1% | —% |
| Other | 6% | 3% |
| &nbsp;&nbsp;&nbsp;Total | 100% | 100% |

---

**5. Mortgage Loans on Real Estate**

The Company disaggregates its mortgage loan investments into two portfolio segments: commercial and residential. Commercial mortgage loans include agricultural mortgage loans. The breakdown of mortgage loans on real estate by portfolio segment is as follows:

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| Commercial mortgage loans | $8716 | $9576 |
| Residential mortgage loans | 2508 | 2696 |
| &nbsp;&nbsp;&nbsp;Total | 11224 | 12272 |
| Allowance for credit losses | (134) | (155) |
| &nbsp;&nbsp;&nbsp;Total, net of allowance | $11090 | $12117 |

---

------

The Company's commercial mortgage loan portfolio consists of loans collateralized by the related properties and diversified as to property type, location and loan size. The geographic categories come from the U.S. Census Bureau's "Census Regions and Divisions of the United States". The commercial mortgage loan portfolio is summarized by geographic region and property type as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| | **Amount** | **Percentage** | **Amount** | **Percentage** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **Geographic distribution** | | | | |
| Pacific | $1974 | 22.7% | $2060 | 21.5% |
| Mountain | 1391 | 16.0% | 1678 | 17.5% |
| West North Central | 254 | 2.9% | 280 | 2.9% |
| West South Central | 1287 | 14.8% | 1443 | 15.1% |
| East North Central | 865 | 9.9% | 1012 | 10.6% |
| East South Central | 135 | 1.5% | 144 | 1.5% |
| Middle Atlantic | 530 | 6.1% | 591 | 6.2% |
| South Atlantic | 1919 | 22.0% | 1993 | 20.8% |
| New England | 143 | 1.6% | 133 | 1.4% |
| Other (multi-region, non-US) | 218 | 2.5% | 242 | 2.5% |
|  | 8716 | 100.0% | 9576 | 100.0% |
| Allowance for credit losses | (125) |  | (146) |  |
| Total, net of allowance | $8591 |  | $9430 |  |
| **Property type distribution** |  |  |  |  |
| Agricultural | $361 | 4.2% | $447 | 4.7% |
| Apartment | 2242 | 25.7% | 2325 | 24.3% |
| Hotel | 931 | 10.7% | 1246 | 13.0% |
| Industrial | 1860 | 21.3% | 1859 | 19.4% |
| Office | 1274 | 14.6% | 1425 | 14.9% |
| Parking | 250 | 2.9% | 326 | 3.4% |
| Retail | 1421 | 16.3% | 1572 | 16.4% |
| Storage | 140 | 1.6% | 176 | 1.8% |
| Other | 237 | 2.7% | 200 | 2.1% |
|  | 8716 | 100.0% | 9576 | 100.0% |
| Allowance for credit losses | (125) |  | (146) |  |
| Total, net of allowance | $8591 |  | $9430 |  |

---

There was $3 million and $4 million interest income recognized on loans in non-accrual status for the three and nine months ended September 30, 2025. There was $1 million and $2 million interest income recognized on loans in non-accrual status for the three and nine months ended September 30, 2024. Impaired loans were not significant for any of the periods presented.

*Allowance for Credit Losses*

The Company establishes a valuation allowance to provide for the risk of credit losses inherent in its mortgage loan portfolios. The valuation allowance is maintained at a level believed adequate by management to absorb estimated expected credit losses. The valuation allowance is based on amortized cost, which excludes accrued interest receivable. The Company does not measure a credit loss allowance on accrued interest receivable as any uncollectible accrued interest receivable balances are written off to net investment income in a timely manner. The Company charged off $0 million and $5 million of uncollectible accrued interest receivable on its mortgage loan portfolios for the three and nine months ended September 30, 2025. We charged off $0 million and $1 million of uncollectible accrued interest receivable on our mortgage loan portfolios for the three and nine months ended September 30, 2024.

------

The rollforward of the allowance for credit losses for mortgage loans for the three and nine months ended September 30, 2025 and 2024 is shown below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **2025** | **2025** | **2024** | **2024** |
| | **Commercial<br>Mortgage<br>Loans** | **Residential<br>Mortgage<br>Loans** | **Commercial<br>Mortgage<br>Loans** | **Residential<br>Mortgage<br>Loans** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **Balance, as of January 1** | $(146) | $(9) | $(53) | $— |
| &nbsp;&nbsp;&nbsp;Provision | (1) | (1) | (1) |  |
| &nbsp;&nbsp;&nbsp;Writeoffs charged against the allowance | 3 |  |  |  |
| **Balance, as of March 31** | (144) | (10) | (54) |  |
| &nbsp;&nbsp;&nbsp;Provision | 15 | (3) |  |  |
| &nbsp;&nbsp;&nbsp;Recoveries of amounts previously written off | 4 |  |  |  |
| **Balance, as of June 30** | (125) | (13) | (54) |  |
| &nbsp;&nbsp;&nbsp;Provision | (2) | 4 | (26) | (8) |
| &nbsp;&nbsp;&nbsp;Writeoffs charged against the allowance | 2 |  |  |  |
| **Balance, as of September 30** | $(125) | $(9) | $(80) | $(8) |

---

------

*Credit Quality Indicators*

Mortgage loans are segregated by property-type and quantitative and qualitative allowance factors are applied. Qualitative factors are developed quarterly based on the pooling of assets with similar risk characteristics and historical loss experience adjusted for the expected trend in the current market environment. Credit losses are pooled by property type as it represents the most similar and reliable risk characteristics in our portfolio. The amortized cost of mortgage loans by year of origination by aging category are shown below:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Amortized Cost Basis by Origination Year** | **Amortized Cost Basis by Origination Year** | **Amortized Cost Basis by Origination Year** | **Amortized Cost Basis by Origination Year** | **Amortized Cost Basis by Origination Year** | **Amortized Cost Basis by Origination Year** | |
| | **2025** | **2024** | **2023** | **2022** | **2021** | **Prior** |<br>**Total** |
| **As of September 30, 2025:** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **Commercial mortgage loans** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Current | $548 | $429 | $527 | $2063 | $1080 | $3795 | $8442 |
| &nbsp;&nbsp;&nbsp;30 - 59 days past due | 1 |  |  | 9 | 4 |  | 14 |
| &nbsp;&nbsp;&nbsp;60 - 89 days past due |  |  |  | 40 |  | 14 | 54 |
| &nbsp;&nbsp;&nbsp;Non-accrual |  |  |  | 4 | 5 | 197 | 206 |
| **Residential mortgage loans** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Current | 297 | 314 | 494 | 817 | 195 | 116 | 2233 |
| &nbsp;&nbsp;&nbsp;30 - 59 days past due | 3 | 5 | 22 | 30 | 5 | 8 | 73 |
| &nbsp;&nbsp;&nbsp;60 - 89 days past due | 2 | 4 | 9 | 26 | 4 | 3 | 48 |
| &nbsp;&nbsp;&nbsp;Non-accrual | 2 | 3 | 68 | 63 | 10 | 8 | 154 |
| Total mortgage loans on real estate | $853 | $755 | $1120 | $3052 | $1303 | $4141 | 11224 |
| Allowance for credit losses |  |  |  |  |  |  | (134) |
| &nbsp;&nbsp;&nbsp;Total, net of allowance |  |  |  |  |  |  | $11090 |
|  | **Amortized Cost Basis by Origination Year** | **Amortized Cost Basis by Origination Year** | **Amortized Cost Basis by Origination Year** | **Amortized Cost Basis by Origination Year** | **Amortized Cost Basis by Origination Year** | **Amortized Cost Basis by Origination Year** |  |
|  | **2024** | **2023** | **2022** | **2021** | **2020** | **Prior** | **Total** |
| **As of December 31, 2024:** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **Commercial mortgage loans** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Current | $487 | $649 | $2204 | $1270 | $943 | $3736 | $9289 |
| &nbsp;&nbsp;&nbsp;30 - 59 days past due |  | 25 | 4 |  | 10 | 48 | 87 |
| &nbsp;&nbsp;&nbsp;60 - 89 days past due |  |  | 50 | 30 |  |  | 80 |
| &nbsp;&nbsp;&nbsp;Non-accrual |  | 8 | 42 | 16 | 6 | 48 | 120 |
| **Residential mortgage loans** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Current | 294 | 790 | 970 | 222 | 121 | 7 | 2404 |
| &nbsp;&nbsp;&nbsp;30 - 59 days past due | 3 | 41 | 45 | 2 | 4 |  | 95 |
| &nbsp;&nbsp;&nbsp;60 - 89 days past due |  | 7 | 20 | 2 | 4 | 5 | 38 |
| &nbsp;&nbsp;&nbsp;Non-accrual | 3 | 51 | 76 | 18 | 8 | 3 | 159 |
| Total mortgage loans on real estate | $787 | $1571 | $3411 | $1560 | $1096 | $3847 | 12272 |
| Allowance for credit losses |  |  |  |  |  |  | (155) |
| &nbsp;&nbsp;&nbsp;Total, net of allowance |  |  |  |  |  |  | $12117 |

---

Generally, mortgage loans are secured by first liens on income-producing real estate with a loan-to-value ratio of up to 75%. It is the Company's policy to not accrue interest on loans that are 90 days delinquent and where amounts are determined to be uncollectible. As of September 30, 2025 and December 31, 2024, 275 mortgage loans and 263 mortgage loans, respectively, were past due over 90 days or in nonaccrual status.

The Company's commercial and residential mortgage loans may be subject to loan modifications. Loan modifications may be granted to borrowers experiencing financial difficulty and could include principal forgiveness, interest rate reduction, an other-than-significant delay or a term extension. A loan modification typically does not result in a change in valuation allowance as it is already incorporated into the Company's allowance methodology. However, if the Company grants a borrower experiencing financial difficulty principal forgiveness, the amount of principal forgiven would be written off, which would reduce the amortized cost of the loan and result in an adjustment to the valuation allowance. The carrying amount of mortgage loans experiencing financial difficulty, for which modifications have been granted, was $84 million and $143 million for the nine months ended September 30, 2025 and 2024, respectively.

------

**6. Private Loans**

The following table summarizes the credit ratings of our private loans:

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| A or higher | $2005 | $1443 |
| BBB | 1246 | 669 |
| BB and below | 2825 | 710 |
| Unrated (1) | 2311 | 2910 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $8387 | $5732 |

---

(1)Due to the nature of private loans, external agency credit ratings may not be readily available. Where appropriate, the Company obtains non-published credit ratings from one or more third-party rating agencies, which are determined based on an independent evaluation of the transaction. For other loans without published or private credit ratings, the Company assigns internal risk ratings, based on its investment selection and monitoring process and policies. These internal risk ratings are categorized as "Unrated" above.

*Allowance for Credit Losses*

The rollforward of the allowance for credit losses for private loans for the three and nine months ended September 30, 2025 and 2024 is shown below:

---

| | | |
|:---|:---|:---|
| | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| **Balance at January 1** | $(66) | $(8) |
| &nbsp;&nbsp;&nbsp;Provision | (11) | 1 |
| **Balance at March 31** | (77) | (7) |
| &nbsp;&nbsp;&nbsp;Provision | (8) | (14) |
| &nbsp;&nbsp;&nbsp;Writeoffs charged against the allowance | (2) |  |
| **Balance at June 30** | (87) | (21) |
| &nbsp;&nbsp;&nbsp;Provision | (55) | (5) |
| **Balance at September 30** | $(142) | $(26) |

---

The Company's private loans may be subject to loan modifications. Loan modifications may be granted to borrowers experiencing financial difficulties and could include term extensions. For the nine months ended September 30, 2025 and 2024, the Company did not have a significant amount of private loans that it modified to borrowers experiencing financial difficulty. Impaired loans were not significant for any of the periods presented.

------

**7. Real Estate and Real Estate Partnerships**

The carrying amounts of investment real estate, net of accumulated depreciation, and by property-type are as follows:

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** |
| | **Real Estate** | **Real Estate** |
| | **Amount** | **Percentage** |
| | **(Dollars in millions)** | |
| Hotel | $134 | 5% |
| Industrial | 62 | 2% |
| Land | 601 | 23% |
| Office | 152 | 6% |
| Retail | 208 | 8% |
| Apartments | 46 | 2% |
| Single family residential | 1312 | 51% |
| Other | 63 | 2% |
| &nbsp;&nbsp;&nbsp;Total real estate | 2578 | 100% |
| Real estate partnerships | 3483 |  |
| &nbsp;&nbsp;&nbsp;Total real estate and real estate partnerships | $6061 |  |
|  | **December 31, 2024** | **December 31, 2024** |
|  | **Real Estate** | **Real Estate** |
|  | **Amount** | **Percentage** |
|  | **(Dollars in millions)** |  |
| Hotel | $135 | 6% |
| Industrial | 14 | 1% |
| Land | 288 | 13% |
| Office | 208 | 9% |
| Retail | 186 | 8% |
| Apartments | 47 | 2% |
| Single family residential | 1342 | 60% |
| Other | 15 | 1% |
| &nbsp;&nbsp;&nbsp;Total real estate | 2235 | 100% |
| Real estate partnerships | 2757 |  |
| &nbsp;&nbsp;&nbsp;Total real estate and real estate partnerships | $4992 |  |

---

As of September 30, 2025 and December 31, 2024, real estate investments of $59 million and $12 million, respectively, met the criteria as held-for-sale.

**8. Variable Interest Entities and Equity Method Investments**

Through its investment activities, the Company regularly invests in various entities including limited partnerships ("LPs") and limited liability companies ("LLCs") and frequently participates in the design with their sponsors, but in most cases, its involvement is limited to financing. Some of these entities have been determined to be variable interest entities ("VIEs"). In certain instances, in addition to an economic interest in the entity, the Company holds the power to direct the most significant activities of the entity and is deemed the primary beneficiary. The Company consolidates all VIEs for which it is the primary beneficiary. The assets of consolidated VIEs are restricted and must first be used to settle their liabilities. Creditors or beneficial interest holders of these VIEs have no recourse to the general credit of the Company, as its obligation is limited to the amount of its committed investment. The Company has not provided financial or other support to these consolidated VIEs in the form of liquidity arrangements, guarantees or other commitments to third-parties that may affect the fair value or risk of its variable interest in these VIEs as of September 30, 2025 and December 31, 2024.

In addition to investment activities, certain of the Company's subsidiaries are deemed VIEs. The Company is the primary beneficiary and consolidates these entities in the same manner as other entities in which the Company has a controlling financial interest by holding a majority voting interest.

------

*Consolidated Variable Interest Entities*

The assets and liabilities relating to the consolidated VIEs from the Company's investment activities included in the financial statements are as follows:

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| Available-for-sale fixed maturity securities | $75 | $107 |
| Equity securities | 99 | 93 |
| Mortgage loans on real estate, net of allowance | 208 | 206 |
| Private loans, net of allowance | 1950 | 1373 |
| Investment real estate | 2411 | 2046 |
| Real estate partnerships | 2191 | 1398 |
| Investment funds | 3273 | 2331 |
| Short-term investments | 43 | 75 |
| Other invested assets | 203 | 337 |
| Cash and cash equivalents | 243 | 223 |
| Other assets | 180 | 327 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets of consolidated VIEs | $10876 | $8516 |
| Notes payable | $204 | $189 |
| Other liabilities | 443 | 587 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities of consolidated VIEs | $647 | $776 |

---

*Unconsolidated Variable Interest Entities*

For certain of the Company's investments in various entities that are determined to be VIEs, the Company is not the primary beneficiary as it does not take an active role in the management of these investments. Such investments are reported in certain investment line items on the statements of financial position, including "Available-for-sale fixed maturity securities, fair value", "Equity securities, at fair value", "Mortgage loans on real estate, at amortized cost", "Investment funds", "Short-term investments, at estimated fair value" and "Other invested assets". In some instances, a consolidated VIE involves one or more underlying entities for which the Company is not the primary beneficiary because it does not have the power to direct the most significant activities of these entities. These unconsolidated VIEs that are part of consolidated VIEs are reported primarily in "Real estate and real estate partnerships" on the statements of financial position. Creditors or beneficial interest holders of the unconsolidated VIEs have no recourse to the general credit of the Company, as its obligation is limited to the amount of its committed investment. The Company has not provided financial or other support to these unconsolidated VIEs in the form of liquidity arrangements, guarantees or other commitments to third-parties that may affect the fair value or risk of its variable interest in these VIEs as of September 30, 2025 and December 31, 2024.

The carrying amount and maximum exposure to loss relating to these unconsolidated VIEs are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| | **Carrying<br>Amount** | **Maximum<br>Exposure to Loss** | **Carrying<br>Amount** | **Maximum<br>Exposure to Loss** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Available-for-sale fixed maturity securities | $1156 | $1308 | $2146 | $3007 |
| Equity securities | 480 | 480 | 291 | 291 |
| Mortgage loans on real estate, net of allowance | 692 | 693 | 716 | 731 |
| Private loans, net of allowance | 1502 | 1521 | 1160 | 1160 |
| Real estate partnerships | 2786 | 2789 | 2689 | 2720 |
| Investment funds | 892 | 1074 |  |  |
| Short-term investments | 455 | 455 | 99 | 99 |
| Other invested assets | 1223 | 1270 | 2084 | 2100 |
| Cash and cash equivalents |  |  | 7 | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $9186 | $9590 | $9192 | $10115 |

---

------

*Equity Method Investments*

Our investments in investment funds, real estate partnerships, and other partnerships, of which substantially all are LPs or LLCs, are accounted for using the equity method of accounting, except for certain investments that are fair valued due to the application of fair value option under ASC 825 or the consolidation of investment company VIE under ASC 946. As of September 30, 2025 and December 31, 2024, the Company's equity method investments totaled $6.1 billion and $5.3 billion, respectively.

The Company generally recognizes its share of earnings in its equity method investments within "Net investment income" using a three-month lag in instances where the investee's financial information is not sufficiently timely or when the investee's reporting period differs from the Company's reporting period.

**9. Derivative Instruments**

The Company manages risks associated with certain assets and liabilities by using derivative instruments. Derivative instruments are financial contracts whose value is derived from underlying interest rates, exchange rates or other financial instruments. The Company does not invest in derivatives for speculative purposes.

Foreign exchange forwards and equity-indexed options are over-the-counter contractual agreements negotiated between counterparties. The Company purchases equity-indexed options as economic hedges against fluctuations in the equity markets to which equity-indexed products are exposed. Equity-indexed contracts include a fixed host universal-life insurance or annuity contract and an equity-indexed embedded derivative.

The notional principal represents the amount to which a rate or price is applied to determine the cash flows to be exchanged periodically and does not represent credit exposure. Maximum credit risk is the estimated cost of replacing derivative instruments which have a positive value, should the counterparty default.

Derivatives, except for embedded derivatives, are included in "Other invested assets" or "Other liabilities", at fair value in the Condensed Consolidated Statements of Financial Position. Embedded derivative liabilities on funds withheld and modified coinsurance ("Modco") arrangements and embedded derivative liabilities on indexed annuity and variable annuity products are included in the Condensed Consolidated Statements of Financial Position within the "Reinsurance funds withheld" and "Policyholders' account balances" lines respectively, at fair value.

------

The notional and fair values of derivative instruments, presented in the Condensed Consolidated Statements of Financial Position, are shown below:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Primary<br>Underlying<br>Risk** | **Location in the Condensed<br>Consolidated Statements of<br>Financial Position** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Primary<br>Underlying<br>Risk** | **Location in the Condensed<br>Consolidated Statements of<br>Financial Position** | **Notional<br>Amount** | **Carrying Value / Fair Value** | **Carrying Value / Fair Value** | **Notional<br>Amount** | **Carrying Value / Fair Value** | **Carrying Value / Fair Value** |
| | **Primary<br>Underlying<br>Risk** | **Location in the Condensed<br>Consolidated Statements of<br>Financial Position** | **Notional<br>Amount** | **Assets** | **Liabilities** | **Notional<br>Amount** | **Assets** | **Liabilities** |
| | | | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **Derivatives Designated as Hedging Instruments:** | **Derivatives Designated as Hedging Instruments:** | | | | | | | |
| Foreign exchange forwards | Foreign Currency | Other invested assets, Other liabilities | $1088 | $— | $46 | $897 | $20 | $— |
| Interest rate swaps | Interest rate | Other invested assets, Other liabilities | 1789 | 20 |  |  |  |  |
| **Derivatives Not Designated as Hedging Instruments:** | **Derivatives Not Designated as Hedging Instruments:** |  |  |  |  |  |  |  |
| Equity-indexed options | Equity | Other invested assets, Other liabilities | 46599 | 1486 | 2 | 46374 | 1303 | 5 |
| Foreign exchange forwards | Foreign Currency | Other invested assets, Other liabilities | 2621 | 4 | 81 | 1066 | 23 |  |
| Cross currency swaps | Foreign Currency | Other invested assets, Other liabilities | 792 | 6 | 15 |  |  |  |
| **Embedded Derivatives:** |  |  |  |  |  |  |  |  |
| Indexed annuity and variable annuity product | Interest rate | Policyholders' account balances |  |  | 6341 |  |  | 1123 |
| Funds withheld and Modco arrangements | Interest rate | Funds withheld for reinsurance liabilities |  |  | 83 |  |  | 37 |
|  |  |  | $52889 | $1516 | $6568 | $48337 | $1346 | $1165 |

---

------

*Derivatives Designated as Hedging Instruments*

The Company has designated and accounted for certain foreign exchange forwards ("foreign currency derivatives") as fair value hedges to protect a portion of the available-for-sale fixed maturity securities against changes in fair value due to changes in exchange rates. The Company has also designated and accounted for certain interest rate swaps ("interest rate derivatives") as fair value hedges to convert a portion of PAB from a fixed rate liability to a floating rate liability.

For derivative financial instruments that were designated and qualified as fair value hedges, the gain or loss on the portion of the derivative instrument included in the assessment of hedge effectiveness and the offsetting gain or loss on the hedged item attributable to the hedged risk are recognized in the same line item in the Condensed Consolidated Statements of Operations. The unrealized gain or loss attributable to changes in exchange rates on the available-for-sale fixed maturity securities that were designated as part of the hedge are reclassified out of other comprehensive income ("OCI") into "Investment related gains (losses)" in the Condensed Consolidated Statements of Operations. The remaining change in unrealized gain or loss on the hedged item not associated with the risk being hedged remains as a component of OCI. The gains (losses) on interest rate derivatives designated as hedging instruments for certain PAB are included in "Interest sensitive contract benefits" in the Condensed Consolidated Statements of Operations.

The following represents the amount of gains (losses) related to the derivatives and hedged items that qualify for fair value hedges:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Foreign currency derivatives: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Hedged items | $(7) | $13 | $66 | $13 |
| &nbsp;&nbsp;&nbsp;Derivatives designated as hedging instruments | 7 | (13) | (66) | (13) |
| Interest rate derivatives: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Hedged items | (38) |  | (20) |  |
| &nbsp;&nbsp;&nbsp;Derivatives designated as hedging instruments | 38 |  | 20 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gains (losses) on fair value hedges | $— | $— | $— | $— |

---

The following table presents the carrying amount and cumulative fair value hedging adjustments for a portion of PAB designated and qualifying as hedged items in fair value hedges:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Carrying Amount of the<br>Hedged Assets (Liabilities)** | **Carrying Amount of the<br>Hedged Assets (Liabilities)** | **Cumulative Amount of Fair**<br>**Value Hedging Adjustments Included**<br>**in the Carrying Amount of**<br>**Hedge Assets (Liabilities)** | **Cumulative Amount of Fair**<br>**Value Hedging Adjustments Included**<br>**in the Carrying Amount of**<br>**Hedge Assets (Liabilities)** |
| | **September 30, 2025** | **December 31, 2024** | **September 30, 2025** | **December 31, 2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **Location in the Condensed Consolidated<br>Statements of Financial Position:** | | | | |
| Policyholders' account balances | $(912) | $— | $(20) | $— |

---

------

*Derivatives Not Designated as Hedging Instruments*

The following represents the financial statement location and amount of gains (losses) related to the derivatives not designated as hedging instruments:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Derivative Gains (Losses) Recognized in Income** | **Derivative Gains (Losses) Recognized in Income** | **Derivative Gains (Losses) Recognized in Income** | **Derivative Gains (Losses) Recognized in Income** |
| | | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| |<br>**Location in the Condensed Consolidated<br>Statements of Operations** | **2025** | **2024** | **2025** | **2024** |
| | | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Equity-indexed options | Change in fair value of insurance-related derivatives and embedded derivatives | $348 | $382 | $246 | $747 |
| Equity total return swaps | Investment related gains (losses) |  | (18) |  | (18) |
| Foreign exchange forwards | Investment related gains (losses) | 122 |  | (82) |  |
| Cross currency swaps | Investment related gains (losses) | (23) |  | (8) |  |
| Embedded derivatives: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Indexed annuity and variable annuity product | Change in fair value of insurance-related derivatives and embedded derivatives | (141) | (527) | (340) | (815) |
| &nbsp;&nbsp;&nbsp;Funds withheld and Modco arrangements | Change in fair value of insurance-related derivatives and embedded derivatives | (20) | (199) | (49) | (278) |
|  |  | $286 | $(362) | $(233) | $(364) |

---

------

*Derivative Exposure*

The Company's use of derivative instruments exposes it to credit risk in the event of non-performance by counterparties. The Company has a policy of only dealing with counterparties it believes are creditworthy and obtaining sufficient collateral where appropriate, as a means of mitigating the financial loss from defaults. The minimum credit rating of our counterparties is A- as of September 30, 2025 and BBB+ as of December 31, 2024, and all derivatives have been appropriately collateralized by the Company and the counterparties in accordance with the terms of the derivative agreements. The Company holds collateral in cash and notes secured by U.S. government-backed assets. The non-performance risk is the net counterparty exposure based on fair value of open contracts less fair value of collateral held. The Company maintains master netting agreements with its current active trading partners. A right of offset has been applied to cash collateral that supports credit risk and has been recorded in the Condensed Consolidated Statements of Financial Position as an offset to "Other invested assets" with an associated payable to "Other liabilities" for non-cash and excess collateral. A right of offset has also been applied to derivative assets and liabilities with the same counterparty under the same master netting agreement, and such derivative instruments are presented on a net basis in the Condensed Consolidated Statements of Financial Position.

Information regarding the Company's exposure to credit loss on the derivatives it holds, including the effect of rights of offset, is presented below:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Gross Amount<br>of Derivative<br>Instruments<br>(1)** | **Gross Amount<br>Offset in the<br>Condensed<br>Consolidated<br>Statements of<br>Financial Position (2)** | **Net Amount<br>Presented in the<br>Condensed<br>Consolidated <br>Statements of<br>Financial Position** | **Collateral<br>(Received)<br>Pledged<br>in Cash<br>(3)** | **Collateral<br>(Received)<br>Pledged in<br>Invested Assets<br>(3)** | **Exposure<br>of Net<br>Collateral** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **As of September 30, 2025** | | | | | | |
| Derivative assets |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Equity-indexed options | $1486 | $(54) | $1432 | $(1364) | $— | $68 |
| &nbsp;&nbsp;&nbsp;Foreign exchange forwards | 4 | (4) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cross currency swaps | 6 |  | 6 |  |  | 6 |
| &nbsp;&nbsp;&nbsp;Interest rate swaps | 20 |  | 20 | (20) |  |  |
| Total derivative assets | $1516 | $(58) | $1458 | $(1384) | $— | $74 |
| Derivative liabilities |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Equity-indexed options | $(2) | $2 | $— | $— | $— | $— |
| &nbsp;&nbsp;&nbsp;Foreign exchange forwards | (127) | 56 | (71) |  |  | (71) |
| &nbsp;&nbsp;&nbsp;Cross currency swaps | (15) |  | (15) |  |  | (15) |
| Total derivative liabilities | $(144) | $58 | $(86) | $— | $— | $(86) |
| **As of December 31, 2024** |  |  |  |  |  |  |
| Derivative assets |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Equity-indexed options | $1303 | $(5) | $1298 | $(1298) | $— | $— |
| &nbsp;&nbsp;&nbsp;Foreign exchange forwards | 43 |  | 43 |  |  | 43 |
| Total derivative assets | $1346 | $(5) | $1341 | $(1298) | $— | $43 |
| Derivative liabilities |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Equity-indexed options | $(5) | $5 | $— | $— | $— | $— |
| Total derivative liabilities | $(5) | $5 | $— | $— | $— | $— |

---

(1)Represents derivative assets and liabilities on a gross basis, which are not offset under enforceable master netting agreements that meet all offsetting criteria.

(2)Represents netting of derivative exposures covered by qualifying master netting agreements.

(3)Excludes a portion of collateral held in cash and invested assets that are excess collateral. As of September 30, 2025 and December 31, 2024, the Company held excess collateral of $56 million and $76 million, respectively.

------

**10. Net Investment Income and Investment Related Gains (Losses)**

Net investment income is shown below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Available-for-sale fixed maturity securities | $840 | $604 | $2075 | $1265 |
| Equity securities | 15 | 17 | 35 | 38 |
| Mortgage loans | 188 | 190 | 574 | 428 |
| Private loans | 154 | 24 | 356 | 25 |
| Real estate | 20 | (6) | 40 | 46 |
| Real estate partnerships | 45 | (3) | 61 | 3 |
| Investment funds | 153 | 55 | 282 | 223 |
| Policy loans | 3 | 6 | 15 | 12 |
| Short-term investments | (20) | 63 | 159 | 140 |
| Other | (113) | 74 | 123 | 216 |
| &nbsp;&nbsp;&nbsp;Total net investment income | $1285 | $1024 | $3720 | $2396 |

---

Net unrealized and realized investment gains (losses) are shown below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Available-for-sale fixed maturity securities | $(111) | $(100) | $(14) | $(125) |
| Equity securities | 60 | 23 | 158 | 47 |
| Mortgage loans | 16 | (22) | 23 | (28) |
| Private loans | (75) |  | (40) | (3) |
| Investment real estate | (2) |  | (3) |  |
| Real estate partnerships |  |  | 1 |  |
| Investments funds | (7) |  | (9) |  |
| Short-term investments and other invested assets | 121 | (29) | (45) | (51) |
| &nbsp;&nbsp;&nbsp;Total investment related gains (losses), net | $2 | $(128) | $71 | $(160) |

---

------

**11. Fair Value of Financial Instruments**

The carrying amount and fair value of financial instruments are shown below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| | **Carrying<br>Amount** | **Fair<br>Value** | **Carrying<br>Amount** | **Fair<br>Value** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Financial assets: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Available-for-sale fixed maturity securities | $55408 | $55408 | $47292 | $47292 |
| &nbsp;&nbsp;&nbsp;Equity securities | 1212 | 1212 | 1142 | 1142 |
| &nbsp;&nbsp;&nbsp;Mortgage loans on real estate, net of allowance | 11090 | 11094 | 12117 | 11928 |
| &nbsp;&nbsp;&nbsp;Private loans, net of allowance | 8387 | 8446 | 5732 | 5790 |
| &nbsp;&nbsp;&nbsp;Real estate partnerships (1) | 1714 | 1714 | 932 | 932 |
| &nbsp;&nbsp;&nbsp;Investment funds (2) | 147 | 147 | 124 | 124 |
| &nbsp;&nbsp;&nbsp;Policy loans | 253 | 253 | 274 | 274 |
| &nbsp;&nbsp;&nbsp;Short-term investments (3) | 1435 | 1435 | 4177 | 4177 |
| &nbsp;&nbsp;&nbsp;Other invested assets: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Derivative assets | 1458 | 1458 | 1341 | 1341 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collaterals received on derivatives (excluding excess collateral) | (1384) | (1384) | (1298) | (1298) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Separately managed accounts | 56 | 56 | 71 | 71 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other (4) | 991 | 1017 | 941 | 943 |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | 11568 | 11568 | 11330 | 11330 |
| &nbsp;&nbsp;&nbsp;Other assets - market risk benefits | 1110 | 1110 | 857 | 857 |
| &nbsp;&nbsp;&nbsp;Separate account assets (5) | 1195 | 1195 | 1343 | 1343 |
| Total financial assets | $94640 | $94729 | $86375 | $86245 |
| Financial liabilities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Policyholders' account balances – embedded derivative | $6341 | $6341 | $1123 | $1123 |
| &nbsp;&nbsp;&nbsp;Market risk benefits | 4505 | 4505 | 3655 | 3655 |
| &nbsp;&nbsp;&nbsp;Other liabilities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Derivative liabilities | 86 | 86 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Funds withheld for reinsurance liabilities | 83 | 83 | 37 | 37 |
| &nbsp;&nbsp;&nbsp;Notes payable | 204 | 206 | 189 | 189 |
| &nbsp;&nbsp;&nbsp;Long term borrowings | 3449 | 3566 | 2957 | 2977 |
| &nbsp;&nbsp;&nbsp;Separate account liabilities (5) | 1195 | 1195 | 1343 | 1343 |
| Total financial liabilities | $15863 | $15982 | $9304 | $9324 |

---

(1)Balances represent real estate partnerships in which the Company has elected the fair value option under ASC 825. Real estate partnerships accounted for as equity method investments are $1.8 billion and directly held real estate is $2.6 billion as of September 30, 2025. Real estate partnerships accounted for as equity method investments are $1.8 billion and directly held real estate is $2.2 billion as of December 31, 2024.

(2)Balances represent financial assets that are fair valued as a result of consolidation of investment company VIEs in accordance with ASC 946. Investment funds accounted for as equity method investments are $3.3 billion and investment funds measured using NAV as a practical expedient are $334 million as of September 30, 2025. Investment funds accounted for as equity method investments are $2.5 billion and investment funds measured using NAV as a practical expedient are $353 million as of December 31, 2024.

(3)Balance as of September 30, 2025 includes $400 million of amounts loaned under reverse repurchase agreements. The fair value of the collateral received under these agreements was $815 million as of September 30, 2025. Balance as of December 31, 2024 includes $400 million of amounts loaned under reverse repurchase agreements. The fair value of the collateral received under these agreements was $783 million as of December 31, 2024.

(4)Other invested assets accounted for as equity method investments, and therefore excluded from the table, are $973 million and $959 million as of September 30, 2025 and December 31, 2024.

(5)Balance includes $29 million and $31 million of assets, and corresponding liabilities, that are not subject to the fair value hierarchy as of September 30, 2025 and December 31, 2024, respectively.

------

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability. A fair value hierarchy is used to determine fair value based on a hypothetical transaction as of the measurement date from the perspective of a market participant. The Company has evaluated the types of securities in its investment portfolio to determine an appropriate hierarchy level based upon trading activity and the observability of market inputs. The classification of assets or liabilities within the fair value hierarchy is based on the lowest level of significant input to its valuation. The input levels are defined as follows:

Level 1 - Unadjusted quoted prices in active markets for identical assets or liabilities

Level 2 - Quoted prices in markets that are not active or inputs that are observable directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities other than quoted prices in Level 1; quoted prices in markets that are not active; or other inputs that are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities

Level 3 - Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. Unobservable inputs reflect the Company's own assumptions about the assumptions that market participants would use in pricing the asset or liability. Level 3 assets and liabilities include financial instruments whose values are determined using pricing models and third-party evaluation, as well as instruments for which the determination of fair value requires significant management judgment or estimation

*Valuation Techniques for Financial Instruments Recorded at Fair Value*

**Available-for-sale Fixed Maturity Securities** — The Company utilizes pricing services to estimate fair value measurements. The fair value for available-for-sale fixed maturity securities that are disclosed as Level 1 measurements are based on unadjusted quoted market prices for identical assets that are readily available in an active market. The estimates of fair value for most available-for-sale fixed maturity securities, including municipal bonds, provided by the pricing service are disclosed as Level 2 measurements as the estimates are based on observable market information rather than market quotes. The pricing service utilizes market quotations for available-for-sale fixed maturity securities that have quoted prices in active markets. Since available-for-sale fixed maturity securities generally do not trade on a daily basis, the pricing service prepares estimates of fair value measurements for these securities using its proprietary pricing applications, which include available relevant market information, benchmark curves, benchmarking of like securities, sector groupings and matrix pricing. Additionally, an option adjusted spread model is used to develop prepayment and interest rate scenarios.

The pricing service evaluates each asset class based on relevant market information, credit information, perceived market movements and sector news. The market inputs utilized in the pricing evaluation, listed in the approximate order of priority, include: benchmark yields, reported trades, pricing source quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, reference data, and economic events. The extent of the use of each market input depends on asset class and the market conditions. Depending on the security, the priority of the use of inputs may change or some market inputs may not be relevant. For some securities, additional inputs may be necessary.

The Company has reviewed the inputs and methodology used and the techniques applied by the pricing service to produce quotes that represent the fair value of a specific security. The review confirms that the pricing service is utilizing information from observable transactions or a technique that represents a market participant's assumptions. The Company does not adjust quotes received from the pricing service. The pricing service utilized by the Company has indicated that they will only produce an estimate of fair value if there is objectively verifiable information available.

The Company holds a small amount of private placement debt and available-for-sale fixed maturity securities that have characteristics that make them unsuitable for matrix pricing. For these securities, a quote from an independent pricing source (typically a market maker) is obtained. Due to the disclaimers on the quotes that indicate the price is indicative only, the Company includes these fair value estimates in Level 3.

For securities priced using a quote from an independent pricing source, such as certain available-for-sale fixed maturity securities, the Company uses a market-based fair value analysis to validate the reasonableness of prices received. Price variances above a certain threshold are analyzed further to determine if any pricing issue exists. This analysis is performed quarterly.

**Equity Securities** — For publicly-traded equity securities, prices are received from a nationally recognized pricing service that are based on observable market transactions, and these securities are classified as Level 1 measurements. For certain preferred stock, current market quotes in active markets are unavailable. In these instances, an estimated fair value is received from the pricing service. The service utilizes similar methodologies to price preferred stocks as it does for available-for-sale fixed maturity securities. If applicable, these estimates would be disclosed as Level 2 or Level 3 measurements, depending on the use of at least one significant unobservable input. The Company tests the accuracy of the information provided by reference to other services annually.

**Short-term Investments** — Short-term investments include fixed maturity securities with original maturities of over 90 days and less than one year at the date of acquisition, some of which are disclosed as Level 1 measurements as their fair values are based on unadjusted quoted market prices for identical assets that are readily available in an active market. Short-term investments also include commercial paper rated A2 or P2 or better by Standard & Poor's and Moody's, respectively, as well as certain private loans with original maturities of less than one year at the date of acquisition and amounts loaned under reverse repurchase agreements. Commercial paper, short-term private loans and amounts loaned under reverse repurchase agreements are carried at amortized cost which approximates fair value. These investments are classified as Level 2 or Level 3 measurements, depending on the use of at least one significant unobservable input.

------

**Real Estate and Real Estate Partnerships** — The fair values of residential real estate investments held through consolidation of investment company VIEs are initially recorded based on the cost to purchase the properties and subsequently recorded at fair value on a recurring basis and falls within Level 3 of the fair value hierarchy. The fair value of the residential real estate properties was determined using broker price opinions ("BPO"). A BPO is an appraisal methodology commonly used in the industry to estimate net proceeds from the sale of a home. The significant inputs into the valuation include market comparable home sales, age and size of the home, location and property conditions.

For certain of the Company's interest in consolidated VIEs, the Company elected the fair value option in accordance with ASC 825. The fair value of such interest is derived using discounted cash flow methodology and falls within Level 3 of the fair value hierarchy.

Certain of the Company's consolidated VIEs that are fair valued on a recurring basis invest in LLCs that invest in operating entities which hold multi-family real estate properties. The fair value of the LLCs is obtained from a third party and is based on the fair value of the underlying real estate held by the various operating entities. The real estate is initially calculated based on the cost to purchase the properties and subsequently calculated based on a discounted cash flow methodology. Such investments are classified as Level 3 measurements.

**Investment Funds** — The Company owns certain investments in infrastructure LLCs through a consolidated VIE that is measured at fair value on a recurring basis. We initially recorded the investment at the cost to purchase the investment and subsequently recorded based on a discounted cash flow methodology.

**Other Invested Asset**s – The Company holds interest in an investment company limited partnership, which invests in residual tranche investments, and is a consolidated VIE. We also hold residual tranche investments to which we applied the fair value option in accordance with ASC 825. These investments were initially recorded at cost and are subsequently recorded at fair value using discounted cash flow methodology and fall within Level 3 of the fair value hierarchy.

**Separate Account Assets and Liabilities** — The separate account assets included on the quantitative disclosures fair value hierarchy table are comprised of short-term investments, equity securities, and available-for-sale fixed maturity securities. Equity securities are classified as Level 1 measurements. Short-term investments and available-for-sale fixed maturity securities are classified as Level 2 measurements. These classifications for separate account assets reflect the same fair value level methodologies as listed above as they are derived from the same vendors and follow the same process. The separate account assets also include cash and cash equivalents, investment funds, accrued investment income, and receivables for securities. These are not included in the quantitative disclosures of fair value hierarchy table.

**Market Risk Benefits** — **MRBs** are valued using stochastic models that incorporate a spread reflecting our non-performance risk. The key assumptions for calculating the fair value of the MRBs are market assumptions such as equity market returns, interest rate levels, market volatility and correlations and policyholder behavior assumptions such as lapse, mortality, utilization and withdrawal patterns. Risk margins are included in the policyholder behavior assumptions. The assumptions are based on a combination of historical data and actuarial judgment. MRBs are classified as Level 3 fair value measurements as the fair value is based on unobservable inputs. The following significant unobservable inputs are used for measuring the fair value:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Utilization – The utilization assumption represents the percentage of policyholders who will elect to receive lifetime income benefit payments in a given year. The range and weighted average of this assumption can vary from year to year depending on the characteristics of policies in a given cohort within the rate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Option budget – The option budget assumption represents the expected cost of annual call options we will purchase in the future.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Nonperformance risk – The nonperformance risk assumption impacts the discount rate used in the discounted future cash flow valuation and includes the Company's own credit risk based on the current market credit spreads for debt-like instruments the Company has issued and are available in the market. Additionally, the nonperformance risk assumption includes the counterparty credit risk used in the fair value measurement of ceded market risk benefits which is determined using the current market credit spreads based on the counterparty credit rating.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Mortality rates – The mortality rate assumptions are set based on a combination of company and industry experience, adjusted for improvement factors. Mortality rates vary by age and by demographic characteristics such as gender.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Lapse rates – The lapse rate assumptions represent the expected rate of full surrenders which are set based on product type or feature and whether a policy is subject to surrender charges.

**Derivative Assets/Derivative Liabilities —**

Equity-index options — Equity index options are valued using industry accepted valuation models and are adjusted for the nonperformance risk of each counterparty net of any collateral held. Inputs include market volatility and risk-free interest rates and are used in income valuation techniques in arriving at a fair value for each option contract. The nonperformance risk for each counterparty is based upon its credit default swap rate. The Company has no performance obligations related to the equity-index options purchased to fund its fixed index annuity and equity-indexed universal life policy liabilities. Certain equity-index options are valued based on vendor sourced prices and are classified as Level 3 measurements due to the use of significant unobservable inputs used by the vendor.

Foreign exchange forwards — Foreign exchange forwards are valued using observable market inputs, including forward currency exchange rates. These are classified as Level 2 measurements.

------

**Policyholders' Account Balances – Embedded Derivatives** —The fair value of the embedded derivative component of the Company's fixed index annuity and equity-indexed universal life policyholders' account balances is estimated at each valuation date by (i) projecting policy contract values and minimum guaranteed contract values over the expected lives of the contracts and (ii) discounting the excess of the projected contract value amounts at the applicable risk free interest rates adjusted for the Company's nonperformance risk related to those liabilities. The following significant unobservable inputs are used for measuring the fair value: (i) option budget; (ii) lapse rates; and (iii) nonperformance risk. For the details of these significant unobservable inputs, refer to significant unobservable inputs for "Market risk benefits".

**Funds Withheld for Reinsurance Liabilities – Embedded Derivatives —** The fair value of the embedded derivative is estimated based on the fair value of the assets supporting the funds withheld payable under modified coinsurance and funds withheld coinsurance reinsurance agreements. The fair value of the embedded derivative is classified as Level 3 based on valuation methods used for the assets held supporting the reinsurance agreements.

**Separately Managed Accounts —** The separately managed account manager uses the mid-point of a range from a third-party to price these securities. Discounted cash flows (yield analysis) and market transactions approach are used in the valuation. They use discount rates which is considered an unobservable input.

------

The fair value hierarchy measurements for assets and liabilities measured at fair value on a recurring basis are shown below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Total<br>Fair Value** | **Level 1** | **Level 2** | **Level 3** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **September 30, 2025** | | | | |
| **Financial assets** | | | | |
| &nbsp;&nbsp;&nbsp;Available-for-sale fixed maturity securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;U.S. treasury and government | $93 | $80 | $13 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;U.S. state and municipal | 3134 |  | 3077 | 57 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign governments | 1240 |  | 1240 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Corporate debt securities | 41581 |  | 40830 | 751 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Residential mortgage-backed securities | 992 |  | 964 | 28 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commercial mortgage-backed securities | 3291 |  | 3261 | 30 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateralized debt securities | 5077 |  | 2316 | 2761 |
| &nbsp;&nbsp;&nbsp;Total available-for-sale fixed maturity securities | 55408 | 80 | 51701 | 3627 |
| &nbsp;&nbsp;&nbsp;Equity securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock | 778 | 771 | 2 | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preferred stock | 434 | 5 | 45 | 384 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Private equity and other |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Total equity securities | 1212 | 776 | 47 | 389 |
| &nbsp;&nbsp;&nbsp;Real estate at fair value (1) | 1254 |  |  | 1254 |
| &nbsp;&nbsp;&nbsp;Real estate partnerships at fair value (1) | 1714 |  |  | 1714 |
| &nbsp;&nbsp;&nbsp;Investment funds (1)(2) | 147 |  |  | 147 |
| &nbsp;&nbsp;&nbsp;Short-term investments | 1435 | 38 | 872 | 525 |
| &nbsp;&nbsp;&nbsp;Other invested assets: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Derivative assets | 1458 |  | 1245 | 213 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collaterals received on derivatives (excluding excess collateral) | (1384) | (1384) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Separately managed accounts | 56 |  |  | 56 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 201 |  | 2 | 199 |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | 11568 | 11568 |  |  |
| &nbsp;&nbsp;&nbsp;Other assets – market risk benefit assets | 1110 |  |  | 1110 |
| &nbsp;&nbsp;&nbsp;Separate account assets (3) | 1166 | 1027 | 139 |  |
| Total financial assets | $75345 | $12105 | $54006 | $9234 |
| **Financial liabilities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Policyholders' account balances – embedded derivative | $6341 | $— | $— | $6341 |
| &nbsp;&nbsp;&nbsp;Market risk benefits | 4505 |  |  | 4505 |
| &nbsp;&nbsp;&nbsp;Funds withheld for reinsurance liabilities – embedded derivatives | 83 |  |  | 83 |
| &nbsp;&nbsp;&nbsp;Other liabilities – derivative liabilities | 86 |  | 86 |  |
| &nbsp;&nbsp;&nbsp;Separate account liabilities (3) | 1166 | 1027 | 139 |  |
| Total financial liabilities | $12181 | $1027 | $225 | $10929 |

---

(1)Balances represent financial assets that are fair valued in accordance with ASC 825 as well as financial assets that are fair valued as a result of consolidation of investment company VIE in accordance with ASC 946.

(2)Balance excludes $334 million of investments measured at estimated fair value using NAV as a practical expedient.

(3)Balance includes $29 million of assets, and corresponding liabilities, that are not subject to fair value hierarchy.

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Total<br>Fair Value** | **Level 1** | **Level 2** | **Level 3** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **December 31, 2024** | | | | |
| **Financial assets** | | | | |
| &nbsp;&nbsp;&nbsp;Available-for-sale fixed maturity securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;U.S. treasury and government | $86 | $76 | $10 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;U.S. state and municipal | 3207 |  | 3151 | 56 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign governments | 1541 |  | 1541 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Corporate debt securities | 32848 |  | 30192 | 2656 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Residential mortgage-backed securities | 1106 |  | 1087 | 19 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commercial mortgage-backed securities | 2796 |  | 2721 | 75 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collateralized debt securities | 5708 |  | 3077 | 2631 |
| &nbsp;&nbsp;&nbsp;Total available-for-sale fixed maturity securities | 47292 | 76 | 41779 | 5437 |
| &nbsp;&nbsp;&nbsp;Equity securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock | 747 | 606 | 25 | 116 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preferred stock | 391 | 22 | 12 | 357 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Private equity and other | 4 |  |  | 4 |
| &nbsp;&nbsp;&nbsp;Total equity securities | 1142 | 628 | 37 | 477 |
| &nbsp;&nbsp;&nbsp;Real estate at fair value (1) | 1283 |  |  | 1283 |
| &nbsp;&nbsp;&nbsp;Real estate partnerships at fair value (1) | 932 |  |  | 932 |
| &nbsp;&nbsp;&nbsp;Investment funds (1)(2) | 124 |  |  | 124 |
| &nbsp;&nbsp;&nbsp;Short-term investments | 4177 | 3003 | 821 | 353 |
| &nbsp;&nbsp;&nbsp;Other invested assets: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Derivative assets | 1341 |  | 1118 | 223 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collaterals received on derivatives (excluding excess collateral) | (1298) | (1298) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Separately managed accounts | 71 |  |  | 71 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 315 |  | 11 | 304 |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | 11330 | 11330 |  |  |
| &nbsp;&nbsp;&nbsp;Other assets – market risk benefit assets | 857 |  |  | 857 |
| &nbsp;&nbsp;&nbsp;Separate account assets (3) | 1312 | 258 | 1054 |  |
| Total financial assets | $68878 | $13997 | $44820 | $10061 |
| **Financial liabilities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Policyholders' account balances – embedded derivative | $1123 | $— | $— | $1123 |
| &nbsp;&nbsp;&nbsp;Market risk benefits | 3655 |  |  | 3655 |
| &nbsp;&nbsp;&nbsp;Funds withheld for reinsurance liabilities – embedded derivatives | 37 |  |  | 37 |
| &nbsp;&nbsp;&nbsp;Separate account liabilities (3) | 1312 | 258 | 1054 |  |
| Total financial liabilities | $6127 | $258 | $1054 | $4815 |

---

(1)Balances represent financial assets that are fair valued in accordance with ASC 825 as well as financial assets that are fair valued as a result of consolidation of investment company VIE in accordance with ASC 946.

(2)Balance excludes $353 million of investments measured at estimated fair value using NAV as a practical expedient.

(3)Balance includes $31 million of assets, and corresponding liabilities, that are not subject to fair value hierarchy.

*Fair Value Information About Financial Instruments Not Recorded at Fair Value*

Information about fair value estimates for financial instruments not measured at fair value is discussed below:

**Mortgage Loans** — The fair value of mortgage loans is estimated using discounted cash flow analyses on a loan-by-loan basis by applying a discount rate to expected cash flows from future installment and balloon payments. The discount rate takes into account general market trends and specific credit risk trends for the individual loan. Factors used to arrive at the discount rate include inputs from spreads based on U.S. Treasury notes and the loan's credit quality, region, property-type, lien priority, payment type and current status.

**Private Loans** — The fair value of private loans is estimated using discounted cash flow analyses on a loan-by-loan basis by applying a discount rate to expected cash flows from future installment and balloon payments. The discount rate takes into account general market trends and specific credit risk trends for the individual loan.

------

**Policy Loans** — The carrying value of policy loans is the outstanding balance plus any accrued interest. Due to the collateralized nature of policy loans such that they cannot be separated from the policy contracts, the unpredictable timing of repayments and the fact that settlement is at outstanding value, the carrying value of policy loans approximates fair value.

**Other Invested Assets** — The common stock of Federal Home Loan Bank ("FHLB") is carried at cost which approximates fair value. The fair value of the company owned life insurance ("COLI") is equal to the cash surrender value of the policies.

**Long Term Borrowings** — Long term borrowings are carried at outstanding principal balance. The carrying value approximates fair value because the carrying value represents the amount owing and payable to the creditor at the reporting date. Fair values for subordinated debentures are estimated using discounted cash flow calculations principally on observable inputs including the Company's incremental borrowing rates, which reflect its credit rating, for similar types of borrowings with maturities consistent with those remaining for the debt being valued.

**Notes Payable** — Notes payable are carried at outstanding principal balance. For a majority of the notes, the carrying value of the notes payable approximates fair value because the underlying interest rates approximate market rates at the reporting date.

**Policyholders' Account Balances - investments contracts, excluding embedded derivative** — The fair values of the policyholder account balances' not involving significant mortality or morbidity risks are stated at the cost we would incur to extinguish the liability (i.e., the cash surrender value) as these contracts are generally issued without an annuitization date. For period-certain annuity benefit contracts, the fair value is determined by discounting the benefits at the interest rates currently in effect for newly issued immediate annuity contracts. All of the fair values presented within these categories fall within Level 3 of the fair value hierarchy as most of the inputs are unobservable market data.

The carrying amount and estimated fair value of financial instruments not recorded at fair value on a recurring basis are shown below. The table below excludes accrued investment income, which is recorded at amortized cost in the statements of financial position, as their carrying amounts approximate the fair values due to their short-term nature.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Carrying Amount** | **Fair Value** | **Fair Value Hierarchy Level** | **Fair Value Hierarchy Level** | **Fair Value Hierarchy Level** |
| | **Carrying Amount** | **Fair Value** | **Level 1** | **Level 2** | **Level 3** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **September 30, 2025** | | | | | |
| **Financial assets** | | | | | |
| &nbsp;&nbsp;&nbsp;Mortgage loans on real estate, net of allowance | $11090 | $11094 | $— | $— | $11094 |
| &nbsp;&nbsp;&nbsp;Private loans, net of allowance | 8387 | 8446 |  | 126 | 8320 |
| &nbsp;&nbsp;&nbsp;Policy loans | 253 | 253 |  |  | 253 |
| &nbsp;&nbsp;&nbsp;Other invested assets | 790 | 816 |  | 418 | 398 |
| Total financial assets | $20520 | $20609 |  |  |  |
| **Financial liabilities** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Policyholders' account balances – investment contracts, excluding embedded derivative | $80470 | $80452 | $— | $— | $80452 |
| &nbsp;&nbsp;&nbsp;Long term borrowings | 3449 | 3566 |  |  | 3566 |
| &nbsp;&nbsp;&nbsp;Notes payable | 204 | 206 |  |  | 206 |
| Total financial liabilities | $84123 | $84224 |  |  |  |
|  | **Carrying Amount** | **Fair Value** | **Fair Value Hierarchy Level** | **Fair Value Hierarchy Level** | **Fair Value Hierarchy Level** |
|  | **Carrying Amount** | **Fair Value** | **Level 1** | **Level 2** | **Level 3** |
|  | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **December 31, 2024** |  |  |  |  |  |
| **Financial assets** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Mortgage loans on real estate, net of allowance | $12117 | $11928 | $— | $— | $11928 |
| &nbsp;&nbsp;&nbsp;Private loans, net of allowance | 5732 | 5790 |  | 145 | 5645 |
| &nbsp;&nbsp;&nbsp;Policy loans | 274 | 274 |  |  | 274 |
| &nbsp;&nbsp;&nbsp;Other invested assets | 626 | 628 |  | 406 | 222 |
| Total financial assets | $18749 | $18619 |  |  |  |
| **Financial liabilities** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Policyholders' account balances – investment contracts, excluding embedded derivative | $79384 | $79384 | $— | $— | $79384 |
| &nbsp;&nbsp;&nbsp;Long term borrowings | 2957 | 2977 |  |  | 2977 |
| &nbsp;&nbsp;&nbsp;Notes payable | 189 | 189 |  |  | 189 |
| Total financial liabilities | $82530 | $82551 |  |  |  |

---

------

For financial assets and financial liabilities measured at fair value on a recurring basis using Level 3 inputs during the periods, reconciliations of the beginning and ending balances are shown below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
| | **Assets** | **Assets** | **Liabilities** | **Liabilities** |
| | **Invested<br>Assets (1)** | **Derivative Assets** | **Policyholders' Account Balances – Embedded Derivative** | **Funds Withheld for Reinsurance Liabilities - Embedded Derivative** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Balance, beginning of period | $7918 | $188 | $6257 | $63 |
| &nbsp;&nbsp;&nbsp;Fair value changes in net income | (22) | 58 | 30 | 20 |
| &nbsp;&nbsp;&nbsp;Fair value changes in other comprehensive income | 49 |  |  |  |
| &nbsp;&nbsp;&nbsp;Purchases | 402 | 34 |  |  |
| &nbsp;&nbsp;&nbsp;Sales | (327) |  |  |  |
| &nbsp;&nbsp;&nbsp;Settlements or maturities | (175) | (67) |  |  |
| &nbsp;&nbsp;&nbsp;Premiums less benefits |  |  | 54 |  |
| &nbsp;&nbsp;&nbsp;Transfers into Level 3 | 112 |  |  |  |
| &nbsp;&nbsp;&nbsp;Transfers out of Level 3 | (46) |  |  |  |
| Balance, end of period | $7911 | $213 | $6341 | $83 |
|  | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
|  | **Assets** | **Assets** | **Liabilities** | **Liabilities** |
|  | **Invested<br>Assets (1)** | **Derivative Assets** | **Policyholders' Account Balances – Embedded Derivative** | **Funds Withheld for Reinsurance Liabilities - Embedded Derivative** |
|  | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Balance, beginning of period | $9598 | $254 | $1196 | $79 |
| &nbsp;&nbsp;&nbsp;Fair value changes in net income | 177 | 41 | 533 | 199 |
| &nbsp;&nbsp;&nbsp;Fair value changes in other comprehensive income | (61) |  |  |  |
| &nbsp;&nbsp;&nbsp;Purchases | 1697 | 37 |  |  |
| &nbsp;&nbsp;&nbsp;Sales | (298) | (67) |  |  |
| &nbsp;&nbsp;&nbsp;Premiums less benefits |  |  | 42 |  |
| &nbsp;&nbsp;&nbsp;Transfers into Level 3 | 65 |  |  |  |
| &nbsp;&nbsp;&nbsp;Transfers out of Level 3 | (203) |  |  |  |
| Balance, end of period | $10975 | $265 | $1771 | $278 |
|  | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
|  | **Assets** | **Assets** | **Liabilities** | **Liabilities** |
|  | **Invested<br>Assets (1)** | **Derivative Assets** | **Policyholders' Account Balances – Embedded Derivative** | **Funds Withheld for Reinsurance Liabilities - Embedded Derivative** |
|  | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Balance, beginning of year | $8981 | $223 | $1123 | $37 |
| &nbsp;&nbsp;&nbsp;Fair value changes in net income | 83 | 86 | 4 | 46 |
| &nbsp;&nbsp;&nbsp;Fair value changes in other comprehensive income | 67 |  |  |  |
| &nbsp;&nbsp;&nbsp;Purchases | 1783 | 101 |  |  |
| &nbsp;&nbsp;&nbsp;Sales | (1909) |  |  |  |
| &nbsp;&nbsp;&nbsp;Settlements or maturities | (322) | (197) |  |  |
| &nbsp;&nbsp;&nbsp;Premiums less benefits |  |  | 148 |  |
| &nbsp;&nbsp;&nbsp;Transfers into Level 3 | 1042 |  | 5066 |  |
| &nbsp;&nbsp;&nbsp;Transfers out of Level 3 | (1814) |  |  |  |
| Balance, end of period | $7911 | $213 | $6341 | $83 |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| | **Assets** | **Assets** | **Liabilities** | **Liabilities** |
| | **Invested<br>Assets (1)** | **Derivative Assets** | **Policyholders' Account Balances – Embedded Derivative** | **Funds Withheld for Reinsurance Liabilities - Embedded Derivative** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Balance, beginning of year | $5585 | $227 | $872 | $— |
| &nbsp;&nbsp;&nbsp;Acquisitions from business combination | 4288 |  |  |  |
| &nbsp;&nbsp;&nbsp;Fair value changes in net income | 189 | 122 | 858 | 278 |
| &nbsp;&nbsp;&nbsp;Fair value changes in other comprehensive income | 121 |  |  |  |
| &nbsp;&nbsp;&nbsp;Purchases | 5042 | 111 |  |  |
| &nbsp;&nbsp;&nbsp;Sales | (4083) | (67) |  |  |
| &nbsp;&nbsp;&nbsp;Settlements or maturities | (2) | (128) | (30) |  |
| &nbsp;&nbsp;&nbsp;Premiums less benefits |  |  | 71 |  |
| &nbsp;&nbsp;&nbsp;Transfers into Level 3 | 177 |  |  |  |
| &nbsp;&nbsp;&nbsp;Transfers out of Level 3 | (342) |  |  |  |
| Balance, end of period | $10975 | $265 | $1771 | $278 |

---

(1)Balance includes separately managed accounts and certain consolidated variable interest entities.

Transfers into and out of Level 3 during the three and nine months ended September 30, 2025 were primarily the result of changes in observable pricing. The Company's valuation of financial instruments categorized as Level 3 in the fair value hierarchy are based on valuation techniques that use significant inputs that are unobservable or had a decline in market activity that obscured observability. The indicators considered in determining whether a significant decrease in the volume and level of activity for a specific asset has occurred include the level of new issuances in the primary market, trading volume in the secondary market, the level of credit spreads over historical levels, applicable bid-ask spreads, and price consensus among market participants and other pricing sources. Level 3 assets and liabilities include financial instruments whose values are determined using pricing models and discounted cash flow methodology based on spread/yield assumptions.

------

**12. Reinsurance&nbsp;&nbsp;&nbsp;&nbsp;**

The Company reinsures its business through a diversified group of reinsurers. The Company remains liable to the extent its reinsurers do not meet their obligations under the reinsurance agreements. The Company monitors trends in arbitration and any litigation outcomes with its reinsurers. Collectability of reinsurance balances is evaluated by monitoring ratings and the financial strength of its reinsurers. The effect of reinsurance on the applicable line items on our Condensed Consolidated Statements of Operations are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Premiums earned: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Gross amounts, including reinsurance assumed | $725 | $1253 | $2713 | $4124 |
| &nbsp;&nbsp;&nbsp;Reinsurance ceded | (159) | (365) | (506) | (1087) |
| &nbsp;&nbsp;&nbsp;Net amount | $566 | $888 | $2207 | $3037 |
| Other policy revenue: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Gross amounts, including reinsurance assumed | $263 | $212 | $743 | $527 |
| &nbsp;&nbsp;&nbsp;Reinsurance ceded | (82) | (4) | (241) | (23) |
| &nbsp;&nbsp;&nbsp;Net amount | $181 | $208 | $502 | $504 |
| Policyholder benefits and claims incurred: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Gross amounts, including reinsurance assumed | $715 | $1183 | $2873 | $3771 |
| &nbsp;&nbsp;&nbsp;Reinsurance ceded | (188) | (337) | (630) | (809) |
| &nbsp;&nbsp;&nbsp;Net amount | $527 | $846 | $2243 | $2962 |
| Change in fair value of market risk benefits: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Gross amounts, including reinsurance assumed | $328 | $110 | $694 | $296 |
| &nbsp;&nbsp;&nbsp;Reinsurance ceded | (18) | 24 | (70) | (4) |
| &nbsp;&nbsp;&nbsp;Net amount | $310 | $134 | $624 | $292 |
| Interest sensitive contract benefits: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Gross amounts, including reinsurance assumed | $585 | $629 | $1679 | $1394 |
| &nbsp;&nbsp;&nbsp;Reinsurance ceded | (62) | (106) | (159) | (326) |
| &nbsp;&nbsp;&nbsp;Net amount | $523 | $523 | $1520 | $1068 |

---

The following summarizes our significant life and annuity reinsurance treaties and related recoverable:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Reinsurance Recoverable** | **Reinsurance Recoverable** | **Agreement Type** | **Products Covered** |
| | **September 30, 2025** | **December 31, 2024** | | |
| | **(Dollars in millions)** | **(Dollars in millions)** | | |
| Principal Reinsurers: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;EquiTrust Life Insurance Company | $203 | $231 | Coinsurance | Certain Fixed Index and Fixed Rate Annuities |
| &nbsp;&nbsp;&nbsp;Athene Life Re Ltd. | 1473 | 1747 | Coinsurance Funds Withheld, Modified Coinsurance | Certain Fixed Annuities and Multi-Year Guaranteed Annuities |
| &nbsp;&nbsp;&nbsp;AeBe ISA LTD | 3924 | 4166 | Coinsurance Funds Withheld, Coinsurance | Certain Fixed Index and Fixed Rate Annuities |
| &nbsp;&nbsp;&nbsp;Reinsurance Group of America Inc. (RGA) | 3568 | 3420 | Coinsurance | Certain Term, Whole, Indexed Universal, Universal, and Universal with Secondary Guarantee Life Insurance Policies |
|  | $9168 | $9564 |  |  |

---

There were no significant changes to third party or intercompany reinsurance agreements for the three and nine months ended September 30, 2025.

------

**13. Separate Account Assets and Liabilities**

The following table presents the change of the Company's separate account assets and liabilities:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Balance, beginning of period | $1322 | $1266 | $1343 | $1189 |
| Additions (deductions): |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Policyholder deposits | 17 | 20 | 50 | 55 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income | 11 | 9 | 43 | 19 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized capital gains (losses) on investments | 49 | 44 | 84 | 156 |
| &nbsp;&nbsp;&nbsp;&nbsp;Policyholder benefits and withdrawals | (89) | (28) | (142) | (103) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net transfer from (to) general account | (112) | (6) | (172) | (4) |
| &nbsp;&nbsp;&nbsp;&nbsp;Policy charges | (3) | (3) | (11) | (10) |
| Total changes | (127) | 36 | (148) | 113 |
| Balance, end of period | $1195 | $1302 | $1195 | $1302 |
| Cash surrender value | $788 | $732 | $788 | $732 |

---

------

**14. Deferred Policy Acquisition Costs, Deferred Sales Inducements and Value of Business Acquired**

The following tables present a rollforward of deferred policy acquisition costs ("DAC"), deferred sales inducements ("DSI") and value of business acquired ("VOBA") for the periods indicated:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
| | **Annuities** | **Property<br>and Casualty** | **Life<br>Insurance** | **Total** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **DAC** | | | | |
| Balance, beginning of period | $1350 | $116 | $335 | $1801 |
| Additions | 324 | 75 | 45 | 444 |
| Amortization | (33) | (82) | (14) | (129) |
| Net change | 291 | (7) | 31 | 315 |
| Balance, end of period | 1641 | 109 | 366 | 2116 |
| **DSI** |  |  |  |  |
| Balance, beginning of period | 723 |  |  | 723 |
| Additions | 234 |  |  | 234 |
| Amortization | (14) |  |  | (14) |
| Net change | 220 |  |  | 220 |
| Balance, end of period | 943 |  |  | 943 |
| **VOBA** |  |  |  |  |
| Balance, beginning of period | 8457 | 7 | 63 | 8527 |
| Amortization | (200) | (1) | (1) | (202) |
| Net change | (200) | (1) | (1) | (202) |
| Balance, end of period | 8257 | 6 | 62 | 8325 |
| Total DAC, DSI, and VOBA Asset | $10841 | $115 | $428 | $11384 |
|  | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
|  | **Annuities** | **Property<br>and Casualty** | **Life<br>Insurance** | **Total** |
|  | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **DAC** |  |  |  |  |
| Balance, beginning of period | $406 | $140 | $271 | $817 |
| Additions | 242 | 106 | 26 | 374 |
| Amortization | (8) | (99) | (10) | (117) |
| Net change | 234 | 7 | 16 | 257 |
| Balance, end of period | 640 | 147 | 287 | 1074 |
| **DSI** |  |  |  |  |
| Balance, beginning of period | 103 |  |  | 103 |
| Additions | 141 |  |  | 141 |
| Amortization | (4) |  |  | (4) |
| Net change | 137 |  |  | 137 |
| Balance, end of period | 240 |  |  | 240 |
| **VOBA** |  |  |  |  |
| Balance, beginning of period | 7126 | 16 | 293 | 7435 |
| Acquisition from business combinations | 45 |  |  | 45 |
| Amortization | (162) | 3 | (9) | (168) |
| Other |  |  | (250) | (250) |
| Net change | (117) | 3 | (259) | (373) |
| Balance, end of period | 7009 | 19 | 34 | 7062 |
| Total DAC, DSI, and VOBA Asset | $7889 | $166 | $321 | $8376 |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| | **Annuities** | **Property<br>and Casualty** | **Life<br>Insurance** | **Total** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **DAC** | | | | |
| Balance, beginning of period | $887 | $132 | $306 | $1325 |
| Additions | 834 | 241 | 90 | 1165 |
| Amortization | (80) | (264) | (30) | (374) |
| Net change | 754 | (23) | 60 | 791 |
| Balance, end of period | 1641 | 109 | 366 | 2116 |
| **DSI** |  |  |  |  |
| Balance, beginning of period | 393 |  |  | 393 |
| Additions | 583 |  |  | 583 |
| Amortization | (33) |  |  | (33) |
| Net change | 550 |  |  | 550 |
| Balance, end of period | 943 |  |  | 943 |
| **VOBA** |  |  |  |  |
| Balance, beginning of period | 8838 | 10 | 65 | 8913 |
| Amortization | (581) | (4) | (3) | (588) |
| Net change | (581) | (4) | (3) | (588) |
| Balance, end of period | 8257 | 6 | 62 | 8325 |
| Total DAC, DSI, and VOBA Asset | $10841 | $115 | $428 | $11384 |
|  | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
|  | **Annuities** | **Property<br>and Casualty** | **Life<br>Insurance** | **Total** |
|  | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **DAC** |  |  |  |  |
| Balance, beginning of period | $190 | $158 | $224 | $572 |
| Additions | 472 | 302 | 83 | 857 |
| Amortization | (22) | (313) | (20) | (355) |
| Net change | 450 | (11) | 63 | 502 |
| Balance, end of period | 640 | 147 | 287 | 1074 |
| **DSI** |  |  |  |  |
| Balance, beginning of period | 8 |  |  | 8 |
| Additions | 235 |  |  | 235 |
| Amortization | (3) |  |  | (3) |
| Net change | 232 |  |  | 232 |
| Balance, end of period | 240 |  |  | 240 |
| **VOBA** |  |  |  |  |
| Balance, beginning of period | 39 | 20 | 305 | 364 |
| Acquisition from business combinations | 7239 |  |  | 7239 |
| Amortization | (269) | (1) | (21) | (291) |
| Other |  |  | (250) | (250) |
| Net change | 6970 | (1) | (271) | 6698 |
| Balance, end of period | 7009 | 19 | 34 | 7062 |
| Total DAC, DSI, and VOBA Asset | $7889 | $166 | $321 | $8376 |

---

------

The following table provides the projected VOBA asset amortization expenses for a five-year period and thereafter as of September 30, 2025:

---

| | |
|:---|:---|
| **Years** | **(Dollars in millions)** |
| 2025 (1) | $197 |
| 2026 | 748 |
| 2027 | 681 |
| 2028 | 624 |
| 2029 | 571 |
| Thereafter | 5504 |
| Total amortization expense | $8325 |

---

(1)Expected amortization for the remainder of 2025.

**15. Intangible Assets**

The components of definite-lived and indefinite-lived intangible assets are as follows. Refer to *Note 14 - Deferred Policy Acquisition Costs, Deferred Sales Inducements and Value of Business Acquired* for VOBA asset, which is an actuarial intangible asset arising from a business combination.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Gross Carrying Amount** | **Accumulated Amortization** | **Net Carrying Amount** | **Gross Carrying Amount** | **Accumulated Amortization** | **Net Carrying Amount** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Definite-lived intangible assets: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Distributor relationships | $1445 | $(83) | $1362 | $1445 | $(41) | $1404 |
| &nbsp;&nbsp;&nbsp;Trade name | 58 | (10) | 48 | 58 | (6) | 52 |
| &nbsp;&nbsp;&nbsp;Software and other | 119 | (34) | 85 | 52 | (9) | 43 |
| Total definite-lived intangible assets | 1622 | (127) | 1495 | 1555 | (56) | 1499 |
| Indefinite-lived intangible assets: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Insurance licenses | 46 |  | 46 | 46 |  | 46 |
| Total indefinite-lived intangible assets | 46 |  | 46 | 46 |  | 46 |
| Total intangible assets | $1668 | $(127) | $1541 | $1601 | $(56) | $1545 |

---

No impairment expenses of intangible assets were recognized for the three and nine months ended September 30, 2025 and 2024. The Company estimates that its intangible assets do not have any significant residual value in determining their amortization. Amortization expenses for definite-lived intangible assets were $21 million and $71 million for the three and nine months ended September 30, 2025, and $20 million and $33 million for the three and nine months ended September 30, 2024, respectively.

The following table outlines the estimated future amortization expense related to definite-lived intangible assets held as of September 30, 2025.

---

| | |
|:---|:---|
| **Years** | **(Dollars in millions)** |
| 2025 (1) | $23 |
| 2026 | 93 |
| 2027 | 83 |
| 2028 | 77 |
| 2029 | 70 |
| Thereafter | 1149 |
| Total amortization expense | $1495 |

---

(1)Expected amortization for the remainder of 2025.

------

**16. Acquisitions**

On May 2, 2024, in conjunction with the Merger, Brookfield Wealth Solutions indirectly acquired all of AEL's issued and outstanding common stock not already owned for a consideration of approximately $2.5 billion in cash and 28,803,599 shares of class A limited voting shares of BAM ("BAM Shares").

Following the Merger, on May 7, 2024, American National and AEL completed the Post-Effective Merger and subsequent Reincorporation. The Post-Effective Merger has been accounted for as a common control transaction as if the parent, American National, acquired the shares of its subsidiary, AEL, similar to that of a reverse acquisition without a change in basis for the assets acquired and liabilities assumed. American National is therefore regarded as the predecessor reporting entity from an accounting perspective even though AEL is the surviving legal entity.

The business operations of AEL, which are now part of ANGI, contributed revenues of $1.3 billion and a net loss of $250 million to the Company for the period from May 2, 2024 to September 30, 2024. Had the Merger occurred on January 1, 2024, the consolidated unaudited pro forma revenue and net profit would be (i) $6.5 billion and $0.5 billion, respectively, for the nine months ended September 30, 2024. The pro forma amounts have been calculated using the subsidiary's results and adjusting them for the revised depreciation and amortization that would have been charged assuming the fair value adjustments to investments, property and equipment and intangible assets had applied from January 1, 2024, together with the consequential tax effects.

As part of re-assessing the final valuation of certain assets, such as intangible assets and goodwill, and certain liabilities, the Company recognized measurement period adjustments to reflect new information obtained about facts and circumstances that existed as of the acquisition date. This resulted in a $45 million increase in both the VOBA asset and market risk benefits liability. In addition, discount rate and tax assumptions relating to intangible assets were updated, resulting in a $40 million decrease in intangible assets, $8 million increase to deferred tax asset and a $32 million increase in goodwill. Final valuation of the assets acquired and liabilities assumed and the completion of the purchase price allocation occurred in the second quarter of 2025.

Goodwill recognized is not deductible for income tax purposes. In conjunction with the Merger and Post-Effective Merger, Brookfield Wealth Solutions agreed to indemnify ANGI for certain liabilities that could arise as a result of merger-related activities, including tax liabilities.

------

The following summarizes the consideration transferred, fair value of assets acquired and liabilities assumed as of the acquisition date:

---

| | |
|:---|:---|
| | **(Dollars in millions)** |
| Fair value of consideration transferred: |  |
| &nbsp;&nbsp;&nbsp;Cash | $2525 |
| &nbsp;&nbsp;&nbsp;BAM Shares transferred by Brookfield Wealth Solutions | 1111 |
| Fair value of the Brookfield Wealth Solutions' pre-existing interest in AEL | 897 |
| Total consideration | $4533 |
| Assets acquired: |  |
| &nbsp;&nbsp;&nbsp;Investments | $42960 |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | 13367 |
| &nbsp;&nbsp;&nbsp;Accrued investment income | 414 |
| &nbsp;&nbsp;&nbsp;Value of business acquired | 7239 |
| &nbsp;&nbsp;&nbsp;Reinsurance recoverables and deposit assets | 14963 |
| &nbsp;&nbsp;&nbsp;Property and equipment | 42 |
| &nbsp;&nbsp;&nbsp;Intangible assets | 1540 |
| &nbsp;&nbsp;&nbsp;Other assets | 671 |
| Total assets acquired | $81196 |
| Liabilities assumed: |  |
| &nbsp;&nbsp;&nbsp;Future policy benefits | $311 |
| &nbsp;&nbsp;&nbsp;Policyholders' account balances | 61473 |
| &nbsp;&nbsp;&nbsp;Market risk benefits | 3023 |
| &nbsp;&nbsp;&nbsp;Notes payable | 768 |
| &nbsp;&nbsp;&nbsp;Subsidiary borrowings | 84 |
| &nbsp;&nbsp;&nbsp;Funds withheld for reinsurance liabilities | 8601 |
| &nbsp;&nbsp;&nbsp;Other liabilities | 2352 |
| Total liabilities assumed | 76612 |
| Less: Fair value of AEL preferred stock | 685 |
| Less: Non-controlling interest | 28 |
| Net assets acquired | 3871 |
| Goodwill | $662 |

---

Acquisition-related costs of $126 million incurred during the second quarter of 2024 were recorded as "Operating expenses" in the Condensed Consolidated Statements of Operations for that period.

**17. Future Policy Benefits**

The reconciliation of the balances described in the table below to the "Future policy benefits" in the Condensed Consolidated Statements of Financial Position is as follows.

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| Future policy benefits: |  |  |
| &nbsp;&nbsp;&nbsp;Annuities | $6563 | $5532 |
| &nbsp;&nbsp;&nbsp;Life Insurance | 1947 | 1816 |
| Deferred profit liability: |  |  |
| &nbsp;&nbsp;&nbsp;Annuities | 64 | 81 |
| &nbsp;&nbsp;&nbsp;Life Insurance | 105 | 76 |
| Other contracts and VOBA liability | 1666 | 1665 |
| Total future policy benefits | $10345 | $9170 |

---

------

*Future Policy Benefits*

The balances and changes in the liability for future policy benefits are as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
| | **Annuities** | **Life<br>Insurance** | **Total** | **Annuities** | **Life<br>Insurance** | **Total** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **Present Value of Expected Net Premiums:** |  |  |  |  |  |  |
| Balance, beginning of period | $— | $2353 | $2353 | $— | $3145 | $3145 |
| Beginning balance at original discount rate |  | 2507 | 2507 |  | 3254 | 3254 |
| &nbsp;&nbsp;&nbsp;Effect of changes in cash flow assumptions (1) |  | 68 | 68 |  | 195 | 195 |
| &nbsp;&nbsp;&nbsp;Effect of actual variances from expected experience | 1 | (56) | (55) | 11 | (325) | (314) |
| Adjusted beginning of period balance | 1 | 2519 | 2520 | 11 | 3124 | 3135 |
| &nbsp;&nbsp;&nbsp;Acquisition from business combination |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Issuances | 796 | 7 | 803 | 1287 | 38 | 1325 |
| &nbsp;&nbsp;&nbsp;Interest accrual | 7 | 71 | 78 | 10 | 87 | 97 |
| &nbsp;&nbsp;&nbsp;Net premiums collected | (807) | (219) | (1026) | (1306) | (244) | (1550) |
| &nbsp;&nbsp;&nbsp;Derecognitions (lapses and withdrawals) | 3 |  | 3 |  | 1 | 1 |
| Ending balance at original discount rate |  | 2378 | 2378 | 2 | 3006 | 3008 |
| &nbsp;&nbsp;&nbsp;Effect of changes in discount rate assumptions |  | (77) | (77) |  | (39) | (39) |
| Balance, end of period | $— | $2301 | $2301 | $2 | $2967 | $2969 |
| **Present Value of Expected Future Policy Benefits:** |  |  |  |  |  |  |
| Balance, beginning of period | $5532 | $4169 | $9701 | $2213 | $5040 | $7253 |
| Beginning balance at original discount rate | 5668 | 4601 | 10269 | 2217 | 5277 | 7494 |
| &nbsp;&nbsp;&nbsp;Effect of changes in cash flow assumptions (1) | 10 | 72 | 82 |  | (185) | (185) |
| &nbsp;&nbsp;&nbsp;Effect of actual variances from expected experience | (1) | (50) | (51) | 11 | (357) | (346) |
| Adjusted beginning of period balance | 5677 | 4623 | 10300 | 2228 | 4735 | 6963 |
| &nbsp;&nbsp;&nbsp;Acquisition of business combination |  |  |  | 311 |  | 311 |
| &nbsp;&nbsp;&nbsp;Issuances | 983 | 7 | 990 | 1300 | 44 | 1344 |
| &nbsp;&nbsp;&nbsp;Interest accrual | 212 | 132 | 344 | 105 | 145 | 250 |
| &nbsp;&nbsp;&nbsp;Benefit payments | (414) | (237) | (651) | (199) | (223) | (422) |
| &nbsp;&nbsp;&nbsp;Derecognitions (lapses and withdrawals) | 35 |  | 35 | 3 | 1 | 4 |
| &nbsp;&nbsp;&nbsp;Foreign currency translation | 78 |  | 78 | **—** |  |  |
| Ending balance at original discount rate | 6571 | 4525 | 11096 | 3748 | 4702 | 8450 |
| &nbsp;&nbsp;&nbsp;Effect of changes in discount rate assumptions | (8) | (277) | (285) | 83 | (168) | (85) |
| Balance, end of period | $6563 | $4248 | $10811 | $3831 | $4534 | $8365 |
| Liability for future policy benefits | $6563 | $1947 | $8510 | $3829 | $1567 | $5396 |
| Less: Reinsurance recoverables | (2) | (1270) | (1272) | (3) | (1288) | (1291) |
| Net liability for future policy benefits, after reinsurance recoverable | $6561 | $677 | $7238 | $3826 | $279 | $4105 |
| Weighted-average liability duration of future policy benefits (years) | 6 years | 14 years |  | 8 years | 15 years |  |
| Weighted average interest accretion rate | 5.29% | 4.70% |  | 5.12% | 4.63% |  |
| Weighted average current discount rate | 5.27% | 5.42% |  | 4.85% | 5.05% |  |

---

(1)For the nine months ended September 30, 2025, the Company recognized liability remeasurement impacts of $53 million from the net effect of the changes in cash flow assumptions, which were included in "Policyholder benefits and claims incurred" in the Condensed Consolidated Statements of Operations.

The Company performs its annual assumptions review during the third quarter of each year. In 2025, assumption updates resulted in a $31 million increase to future policy benefit liabilities. The notable changes to assumptions in the third quarter of 2025 resulted in (i) an increase in the liability for future policy benefits related to annuity products driven by unfavorable mortality. The change in mortality resulted in an offsetting decrease to the deferred profit liability and (ii) an increase in the liability for future policy benefits for universal life products primarily driven by unfavorable mortality, partially offset by a favorable update to premium persistency.

------

For the nine months ended September 30, 2024, the Company recognized liability remeasurement impacts of $15 million, which were included in "Policyholder benefits and claims incurred" in the Condensed Consolidated Statements of Operations. The notable changes to cash flow assumptions in the third quarter of 2024 resulted in (i) a decrease in the liability for future policy benefits related to annuity products driven by favorable mortality, which resulted in an offsetting increase to the deferred profit liability; (ii) a decrease in the liability for future policy benefits for term life products primarily driven by favorable mortality and favorable updates to policyholder lapse behavior assumptions; and (iii) an increase in the future policy benefits liability for universal life products driven by unfavorable updates in policyholder lapse assumptions and unfavorable mortality.

The amounts of undiscounted and discounted expected gross premiums and future benefit payments follow:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2024** | **September 30, 2024** |
| | **Undiscounted** | **Discounted** | **Undiscounted** | **Discounted** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **Annuities** | | | | |
| &nbsp;&nbsp;&nbsp;Expected future benefit payments | $11444 | $6563 | $6011 | $3831 |
| &nbsp;&nbsp;&nbsp;Expected future gross premiums |  |  |  |  |
| **Life Insurance** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Expected future benefit payments | 8585 | 4248 | 9051 | 4534 |
| &nbsp;&nbsp;&nbsp;Expected future gross premiums | 5381 | 3248 | 5858 | 3681 |
| **Total** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Expected future benefit payments | 20029 | 10811 | 15062 | 8365 |
| &nbsp;&nbsp;&nbsp;Expected future gross premiums | 5381 | 3248 | 5858 | 3681 |

---

The amount of revenue and interest recognized in the Condensed Consolidated Statements of Operations follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **Gross Premiums<br>or Assessments** | **Gross Premiums<br>or Assessments** | **Interest<br>Expense** | **Interest<br>Expense** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Annuity | $823 | $2903 | $204 | $176 |
| Life Insurance | 305 | 721 | 81 | 130 |

---

------

**18. Policyholders' Account Balances**

Policyholders' account balances relate to investment-type contracts and universal life-type policies. Investment-type contracts principally include traditional individual fixed rate annuities and fixed index annuities in the accumulation phase and non-variable group annuity contracts.

The balances and changes in policyholders' account balances follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2025** | **2024** | **2024** |
| | **Annuities** | **Life<br>Insurance** | **Annuities** | **Life<br>Insurance** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Balance, beginning of period | $80046 | $2107 | $14694 | $1975 |
| Issuances | 12851 | 35 | 8192 | 51 |
| Acquisition from business combination (1) |  |  | 61296 |  |
| Premiums received | 87 | 324 | 46 | 314 |
| Policy charges | (456) | (278) | (298) | (284) |
| Surrenders and withdrawals | (7916) | (81) | (6278) | (62) |
| Interest credited | 2236 | 71 | 1467 | 74 |
| Benefit payments | (817) |  | (386) |  |
| Other | 6 |  | 4 |  |
| Balance, end of period | $86037 | $2178 | $78737 | $2068 |
| Reconciling items: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Supplemental contracts | $516 | $— | $499 | $— |
| &nbsp;&nbsp;&nbsp;Variable universal life |  | 40 |  | 39 |
| &nbsp;&nbsp;&nbsp;Variable deferred annuity | 6 |  | 8 |  |
| &nbsp;&nbsp;&nbsp;Embedded derivative and other | 633 | 59 | 1004 | 58 |
| Total PAB balance, end of period | $87192 | $2277 | $80248 | $2165 |
| Weighted-average crediting rate | 3.60% | 5.18% | 3.89% | 4.88% |
| Net amount at risk (2) | $13168 | $40062 | $12495 | $38548 |
| Cash surrender value | $78463 | $1944 | $72719 | $1826 |

---

(1)Amount for the nine months ended September 30, 2024 excludes $177 million of liabilities relating to supplemental contracts at acquisition date.

(2)Net amount at risk is defined as the current guarantee amount in excess of the current account balance.

------

The balance of account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between rates being credited to policyholders and the respective guaranteed minimums follow.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Range of<br>Guaranteed Minimum<br>Crediting Rate** | **At Guaranteed Minimum** | **1 - 50 Basis Points Above** | **51 - 150 Basis Points Above** | **> 150 Basis Points Above** | **Other (1)** | **Total** |
| | | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Annuities | 0% - 1% | $3553 | $2611 | $4336 | $5155 | $— | $15655 |
|  | 1% - 2% | 1739 | 284 | 926 | 1239 |  | 4188 |
|  | 2% - 3% | 1933 | 415 | 241 | 13170 |  | 15759 |
|  | Greater than 3% | 265 | 5 | 7 | 10 |  | 287 |
| Products with either a fixed rate or no guaranteed minimum crediting rate | Products with either a fixed rate or no guaranteed minimum crediting rate |  |  |  |  | 50148 | 50148 |
|  | Total | $7490 | $3315 | $5510 | $19574 | $50148 | $86037 |
| Life Insurance | 0% - 1% | $— | $— | $— | $— | $— | $— |
|  | 1% - 2% | 38 | 2 | 67 | 820 |  | 927 |
|  | 2% to 3% | 381 |  | 220 |  |  | 601 |
|  | Greater than 3% | 650 |  |  |  |  | 650 |
| Products with either a fixed rate or no guaranteed minimum crediting rate | Products with either a fixed rate or no guaranteed minimum crediting rate |  |  |  |  |  |  |
|  | Total | $1069 | $2 | $287 | $820 | $— | $2178 |
|  | **September 30, 2024** | **September 30, 2024** | **September 30, 2024** | **September 30, 2024** | **September 30, 2024** | **September 30, 2024** | **September 30, 2024** |
|  | **Range of<br>Guaranteed Minimum<br>Crediting Rate** | **At Guaranteed Minimum** | **1 - 50 Basis Points Above** | **51 - 150 Basis Points Above** | **> 150 Basis Points Above** | **Other (1)** | **Total** |
|  |  | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Annuities | 0% - 1% | $4176 | $2882 | $3676 | $4763 | $— | $15497 |
|  | 1% - 2% | 1504 | 366 | 1411 | 1765 |  | 5046 |
|  | 2% - 3% | 1907 | 412 | 142 | 8354 |  | 10815 |
|  | Greater than 3% | 289 | 6 | 1 | 9 |  | 305 |
| Products with either a fixed rate or no guaranteed minimum crediting rate | Products with either a fixed rate or no guaranteed minimum crediting rate |  |  |  |  | 47074 | 47074 |
|  | Total | $7876 | $3666 | $5230 | $14891 | $47074 | $78737 |
| Life Insurance | 0% - 1% | $— | $— | $— | $— | $— | $— |
|  | 1% - 2% | 30 | 2 | 57 | 699 |  | 788 |
|  | 2% to 3% | 422 |  | 222 |  |  | 644 |
|  | Greater than 3% | 636 |  |  |  |  | 636 |
| Products with either a fixed rate or no guaranteed minimum crediting rate | Products with either a fixed rate or no guaranteed minimum crediting rate |  |  |  |  |  |  |
|  | Total | $1088 | $2 | $279 | $699 | $— | $2068 |

---

(1)Other includes products with either a fixed rate or no guaranteed minimum crediting rate or allocated to index strategies.

In the third quarter of 2025, the Company performed its annual assumption review related to investment-type contracts and universal life-type contracts, which resulted in $257 million net decrease primarily in the value of embedded derivatives related to fixed-index annuity products, which was included in "Change in fair value of insurance-related derivatives and embedded derivatives" in the Condensed Consolidated Statements of Operations. The notable changes made to cash flow assumptions from the annual assumption review were a net decrease in option budget primarily from a decrease in observed short-term option costs and an increase in our own credit spread through the update of the risk premium to reflect current market rates.

In the third quarter of 2024, the Company performed its annual assumption review related to investment-type contracts and universal life-type contracts, which resulted in $60 million net increase primarily in the value of embedded derivatives related to fixed-index annuity products, which was included in "Change in fair value of insurance-related derivatives and embedded derivatives" in the Condensed Consolidated Statements of Operations. The notable changes made to cash flow assumptions from the annual assumption review were a net increase in option budget primarily from an increase in investment portfolio rates and an increase in the utilization assumption for the lifetime income benefit riders partially offset by favorable updates to policyholder lapse behavior assumptions.

------

**19. Market Risk Benefits** 

The net balance of market risk benefit (MRB) assets and liabilities of, and changes in guaranteed minimum withdrawal benefits associated with, annuity contracts is as follows:

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| Balance, beginning of period | $2799 | $— |
| Balance, beginning of period, before effect of changes in the instrument-specific credit risk | 2549 | 1 |
| &nbsp;&nbsp;&nbsp;Acquisition from business combination (1) |  | 2420 |
| &nbsp;&nbsp;&nbsp;Issuances | (4) | 3 |
| &nbsp;&nbsp;&nbsp;Interest accrual | 110 | 61 |
| &nbsp;&nbsp;&nbsp;Attributed fees collected | 191 | 91 |
| &nbsp;&nbsp;&nbsp;Effect of changes in interest rates | 73 | 413 |
| &nbsp;&nbsp;&nbsp;Effect of changes in equity markets | 104 | (39) |
| &nbsp;&nbsp;&nbsp;Effect of changes in equity index volatility | (53) | (95) |
| &nbsp;&nbsp;&nbsp;Effect of changes in future expected policyholder behavior | 62 | (13) |
| &nbsp;&nbsp;&nbsp;Effect of changes in other future expected assumptions | 210 | 44 |
| &nbsp;&nbsp;&nbsp;Balance, end of period, before effect of changes in the instrument-specific credit | 3242 | 2886 |
| &nbsp;&nbsp;&nbsp;Effect of changes in the ending instrument-specific credit risk | 153 | 81 |
| Balance, end of period | 3395 | 2967 |
| &nbsp;&nbsp;&nbsp;Less: Reinsured MRB, end of period | (595) | (746) |
| Balance, end of period, net of reinsurance | $2800 | $2221 |
| Net amount at risk (2) | $12717 | $12078 |
| Weighted average attained age of contract holders (years) | 71 years | 71 years |

---

(1)Excludes the measurement period adjustment to market risk benefits liability recorded in the third quarter of 2024. See *Note 16 - Acquisitions* for the details.

(2)Net amount at risk is defined as the current guarantee amount in excess of the current account balance.

The reconciliation of market risk benefits by amounts in an asset position and in a liability position to the "Market risk benefits" amount in the Condensed Consolidated Statements of Financial Position follows.

---

| | | | |
|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Asset** | **Liability** | **Net Liability** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Market risk benefits | $1110 | $4505 | $3395 |
|  | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|  | **Asset** | **Liability** | **Net Liability** |
|  | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Market risk benefits | $856 | $3655 | $2799 |

---

In the third quarter of 2025, the Company performed its annual assumption review for annuity contracts, which resulted in a $202 million net increase in the market risk benefits liability, which was included in "Change in fair value of market risk benefits" in the Condensed Consolidated Statements of Operations. The notable changes to cash flow assumptions from the annual assumption review were a net increase in the utilization assumption for the lifetime income benefit riders, a decrease in option budget primarily from a decrease in observed short-term option costs partially offset by favorable updates to policyholder lapse behavior assumptions.

In the third quarter of 2024, the Company performed its annual assumption review for annuity contracts, which resulted in a $40 million net decrease in the market risk benefits liability, which was included in "Change in fair value of market risk benefits" in the Condensed Consolidated Statements of Operations. The notable changes to cash flow assumptions from the annual assumption review were a net increase in option budget primarily from an increase in investment portfolio rates and favorable updates to policyholder lapse behavior assumptions.

------

**20. Liability For Unpaid Claims and Claim Adjustment Expenses**

The liability for unpaid claims and claim adjustment expenses ("unpaid claims") for property and casualty insurance is included in "Policy and contract claims" in the Condensed Consolidated Statements of Financial Position and is the amount estimated for incurred but not reported ("IBNR") claims and claims that have been reported but not settled ("case reserves"), as well as associated claim adjustment expenses.

Information regarding the liability for unpaid claims is shown below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Policy and contract claims, beginning | $1910 | $1880 | $1867 | $1870 |
| Less: Unpaid claims balance, beginning – long-duration | 253 | 213 | 241 | 213 |
| Gross unpaid claims balance, beginning – short-duration | 1657 | 1667 | 1626 | 1657 |
| Less: Reinsurance recoverables, beginning | 303 | 271 | 288 | 302 |
| Net unpaid claims balance, beginning – short-duration | 1354 | 1396 | 1338 | 1355 |
| Acquisition from business combination, net of reinsurance |  |  |  | 1 |
| Add: incurred related to: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Current accident year | 242 | 354 | 837 | 1104 |
| &nbsp;&nbsp;&nbsp;Prior accident years | 18 | (7) | 35 | (39) |
| Total incurred claims | 260 | 347 | 872 | 1065 |
| Less: paid claims related to: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Current accident year | 166 | 232 | 407 | 541 |
| &nbsp;&nbsp;&nbsp;Prior accident years | 129 | 109 | 484 | 478 |
| Total paid claims | 295 | 341 | 891 | 1019 |
| Net unpaid claims balance, ending – short-duration | 1319 | 1402 | 1319 | 1402 |
| Add: Reinsurance recoverables, ending | 212 | 300 | 212 | 300 |
| Gross unpaid claims balance, ending – short-duration | 1531 | 1702 | 1531 | 1702 |
| Add: Unpaid claims balance, ending – long duration | 280 | 201 | 280 | 201 |
| Policy and contract claims, ending | $1811 | $1903 | $1811 | $1903 |

---

The estimates for ultimate incurred claims attributable to insured events of prior years increased by $18 million and increased by $35 million for the three and nine months ended September 30, 2025, respectively, and decreased by $7 million and decreased by $39 million for the three and nine months ended September 30, 2024, respectively. The unfavorable development in 2025 was a reflection of higher than anticipated losses arising from personal auto, personal other, and specialty market product lines. The favorable development in 2024 was a reflection of lower than anticipated losses arising from commercial other, business owners, workers' compensation, and homeowners lines of business.

For short-duration health insurance claims, the total of IBNR plus expected development on reported claims included in the liability for unpaid claims as of September 30, 2025 and December 31, 2024 were $7 million and $7 million, respectively.

------

**21. Long Term Borrowings**

The following is a summary of our long term borrowings:

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| Term Loan Credit Facility - due May 25, 2027 | $598 | $1297 |
| 5.000% Senior Notes - due June 15, 2027 | 489 | 485 |
| 5.750% Senior Notes - due October 1, 2029 | 596 | 595 |
| 6.144% Senior Notes - due June 13, 2032 | 497 | 496 |
| 6.000% Senior Notes - due July 15, 2035 | 692 |  |
| 5.000% American Equity Capital Trust II - due June 1, 2047 | 84 | 84 |
| 7.000% Fixed-Rate Reset Junior Subordinated Notes - due December 1, 2055 | 493 |  |
| Total | $3449 | $2957 |

---

*Term Loan Credit Facility* - On June 27, 2025, the Company repaid $700 million under this agreement using proceeds of the 2035 Senior Notes issued on June 27, 2025.

*6.000% Senior Notes* - On June 27, 2025, the Company issued $700 million aggregate principal amount of 6.000% Senior Notes due 2035 (the "2035 Senior Notes"). The 2035 Senior Notes bear interest at the rate of 6.000% per year, payable semi-annually on January 15 and July 15, beginning on January 15, 2026. The 2035 Senior Notes will mature on July 15, 2035; however the Company may, at its option, redeem some or all of the 2035 Senior Notes, at any time or from time to time prior to their maturity at the applicable redemption price, plus any accrued and unpaid interest thereon to, but excluding, the redemption date for the 2035 Senior Notes. We used the net proceeds from this offering to repay a portion of the outstanding indebtedness under our Term Loan Credit Facility.

*7.000% Fixed-Rate Reset Junior Subordinated Notes* - On August 22, 2025, the Company issued $500 million aggregate principal amount of 7.000% Fixed-Rate Reset Junior Subordinated Notes due 2055 (the "2055 Notes"). The 2055 Notes are unsecured and junior subordinated obligations of the Company that rank equally in right of payment with all of the Company's future equally-ranking junior subordinated indebtedness and that rank junior in right of payment to all of the Company's existing and future senior indebtedness. The 2055 Notes are effectively subordinated to all of the existing and future indebtedness and other liabilities of the Company's subsidiaries. The 2055 Notes bear interest (i) until, but excluding, December 1, 2030 (the "First Reset Date"), at the rate of 7.000% per annum and (ii) from, and including, December 1, 2030, at a rate per annum equal to the Five-year U.S. Treasury Rate (as defined in the applicable indenture) plus 3.183%, to be reset on each Reset Date (as defined in the applicable indenture), provided that such rate will not reset below 7.000%. The 2055 Notes will mature on December 1, 2055; however the Company may, at its option, redeem some or all of the 2055 Notes at any time or from time to time prior to their maturity (i) during the three-month period prior to, and including, the First Reset Date and (ii) after the First Reset Date, on any interest payment date, at the applicable redemption price, plus any accrued and unpaid interest thereon (including compounded interest, if any) to, but excluding, the date of redemption for the 2055 Notes.

The agreements above require the Company and its subsidiaries to maintain minimum net worth covenants. As of September 30, 2025 and December 31, 2024, the Company was in compliance with its financial covenants.

**22. Income Taxes**

For the three and nine months ended September 30, 2025, the effective tax rates on pre-tax income were 35.3% and 37.6%, respectively. For both periods, the effective tax rate is higher than the statutory rate of 21% due to a one-time adjustment related to the Bermuda corporate income tax. Excluding this one-time adjustment, our effective tax rate was not materially different from the statutory rate of 21%.

For the three and nine months ended September 30, 2024, the effective tax rates on pre-tax income were 18.8% and 109.4%, respectively. For the three month period, the Company's effective tax rate differed from the statutory rate of 21% primarily due to adjustments for noncontrolling interest. For the nine month period, the Company's effective tax rate differed from the statutory tax rate of 21% primarily due to an increase in our deferred tax asset related to the Bermuda corporate income tax.

*Pillar Two and Bermuda Corporate Income Tax Regime*

In December 2023, the Government of Bermuda enacted a corporate income tax ("CIT") regime, designed to align with the Organization for Economic Cooperation and Development's ("OECD's") global minimum tax rules. The Corporate Income Tax Act 2023 came into operation in its entirety on January 1, 2025. The regime applies a 15% CIT to Bermuda businesses that are part of Multinational Enterprise Groups with annual revenue of €750 million or more, which includes ANGI. As of September 30, 2025, we had a deferred tax asset of $303 million relating to this regime.

The Company continues to evaluate the impact of the global minimum tax requirements by monitoring the legislative changes and future developments in relation to Pillar Two across jurisdictions in which the Company operates and assessing their impact on our operations and financial statements.

------

*Other Tax Matters*

On July 4, 2025, the One Big Beautiful Bill Act (the "OBBBA") was enacted in the U.S. The OBBBA includes provisions that allow for the immediate expensing of domestic research and development expenses, immediate expensing of certain capital expenditures and other changes to the U.S. taxation of profits derived from foreign operations. The Company continues to evaluate the new legislation but it is not anticipated to have a material impact to our consolidated financial statements.

**23. Stockholders' Equity**

As a result of and following the Merger and the Reincorporation, the Company had 10,000 shares of common stock with a par value of $0.01 per share authorized and outstanding, all of which are held by Brookfield Wealth Solutions Ltd. and its affiliates. See *Note 1 - Organization and Description of the Company* for additional information.

As part of the acquisition of American Equity, the Company assumed the issuance of 16,000 shares of 5.95% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series A ("Series A") with a $1.00 par value per share and a liquidation preference of $25,000 per share, for aggregate net proceeds of $389 million. On February 24, 2025, the Company redeemed all of the 16,000 outstanding shares of Series A and the corresponding 16,000,000 depositary shares, each representing a 1/1,000th interest in one share of Series A with a total redemption payment of $408 million. As part of the redemption, the Company recognized a loss of $11 million and paid dividends totaling $8 million. For the three and nine months ended September 30, 2024, we paid dividends totaling $6 million and $12 million for Series A preferred stock, respectively.

As part of the acquisition of American Equity, the Company assumed the issuance of 12,000 shares of 6.625% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series B ("Series B") with a $1.00 par value per share and a liquidation preference of $25,000 per share, for aggregate net proceeds of $290 million.

Dividends on the Series B preferred stock are payable on a non-cumulative basis only when, as and if declared, quarterly in arrears on the first day of March, June, September and December of each year, commencing on December 1, 2020 for Series B. For the three and nine months ended September 30, 2025, we paid dividends totaling $5 million and $15 million for Series B preferred stock, respectively. For the three and nine months ended September 30, 2024, we paid dividends totaling $5 million and $10 million for Series B preferred stock, respectively. The Series B preferred stock are not subject to any mandatory redemption, sinking fund, retirement fund, purchase fund or similar provisions.

On January 10, 2025, the Company issued an aggregate of 12,000 shares of 7.375% Fixed-Rate Non-Cumulative Preferred Stock, Series D with a $1.00 par value per share and a liquidation preference of $25,000 per share, for aggregate net proceeds of $292 million. The Company used the net proceeds from this offering, together with cash on hand, to redeem in full the Series A preferred shares described above.

Dividends on the Series D preferred stock are payable on a non-cumulative basis only when, as and if declared, quarterly in arrears on the 15th day of January, April, July and October of each year, commencing on April 15, 2025. The Series D preferred stock are not subject to any mandatory redemption, sinking fund, retirement fund, purchase fund or similar provisions. During the nine months ended September 30, 2025, we paid dividends totaling $12 million and during the third quarter of 2025, we accrued for dividends totaling $6 million for the Series D preferred stock, respectively.

------

**24. Accumulated Other Comprehensive Income**

The components of and changes in the accumulated other comprehensive income ("AOCI"), and the related tax effects, are shown below:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Change in<br>Net Unrealized<br>Investment<br>Gains (Losses)** | **Change in<br>Discount Rate<br>for Future<br>Policy Benefits** | **Change in<br>Instrument-<br>Specific <br>Credit Risk<br>for Market<br>Risk Benefits** | **Defined<br>Benefit<br>Pension<br>Plan<br>Adjustment** | **Foreign<br>Currency<br>Translation /<br>Other** | **Total** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **Balance as of December 31, 2024** | $177 | $279 | $(196) | $103 | $(23) | $340 |
| &nbsp;&nbsp;&nbsp;Other comprehensive income (loss) before reclassifications | 355 | (35) | 68 | (4) | 42 | 426 |
| &nbsp;&nbsp;&nbsp;Amounts reclassified to (from) AOCI | (7) |  |  |  |  | (7) |
| &nbsp;&nbsp;&nbsp;Deferred income tax benefit (expense) | (75) | 12 | (19) | 1 | (8) | (89) |
| **Balance at March 31, 2025** | 450 | 256 | (147) | 100 | 11 | 670 |
| &nbsp;&nbsp;&nbsp;Other comprehensive income (loss) before reclassifications | 82 | (57) | (104) | (3) | 109 | 27 |
| &nbsp;&nbsp;&nbsp;Amounts reclassified to (from) AOCI | (34) |  |  |  |  | (34) |
| &nbsp;&nbsp;&nbsp;Deferred income tax benefit (expense) | (6) | 4 | 26 | 1 | (24) | 1 |
| **Balance at June 30, 2025** | 492 | 203 | (225) | 98 | 96 | 664 |
| &nbsp;&nbsp;Other comprehensive income (loss) before reclassifications | 623 | (56) | 125 | (30) | (94) | 568 |
| &nbsp;&nbsp;Amounts reclassified to (from) AOCI | 35 |  |  |  |  | 35 |
| &nbsp;&nbsp;Deferred income tax benefit (expense) | (141) | 15 | (26) | 6 | 11 | (135) |
| **Balance at September 30, 2025** | $1009 | $162 | $(126) | $74 | $13 | $1132 |
| **Balance as of December 31, 2023** | $(299) | $105 | $1 | $85 | $(1) | $(109) |
| &nbsp;&nbsp;&nbsp;Other comprehensive income (loss) before reclassifications | (56) | 128 | (11) | 5 | (3) | 63 |
| &nbsp;&nbsp;&nbsp;Amounts reclassified to (from) AOCI |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Deferred income tax benefit (expense) and other | 12 | (26) | 2 | (1) |  | (13) |
| **Balance at March 31, 2024** | (343) | 207 | (8) | 89 | (4) | (59) |
| &nbsp;&nbsp;&nbsp;Other comprehensive income (loss) before reclassifications | 489 | 101 | 18 | 19 | 10 | 637 |
| &nbsp;&nbsp;&nbsp;Amounts reclassified to (from) AOCI | 4 |  |  |  |  | 4 |
| &nbsp;&nbsp;&nbsp;Deferred income tax benefit (expense) | (106) | (21) | (4) | (4) | (2) | (137) |
| **Balance at June 30, 2024** | 44 | 287 | 6 | 104 | 4 | 445 |
| &nbsp;&nbsp;Other comprehensive income (loss) before reclassifications | 1689 | (290) | (90) | 4 | (2) | 1311 |
| &nbsp;&nbsp;Amounts reclassified to (from) AOCI | 2 |  |  |  |  | 2 |
| &nbsp;&nbsp;Deferred income tax benefit (expense) | (357) | 59 | 19 | (1) | 3 | (277) |
| **Balance at September 30, 2024** | $1378 | $56 | $(65) | $107 | $5 | $1481 |

---

**25. Related Party Transactions**

The Company has entered into recurring transactions and agreements with certain related parties. The impact on the Condensed Consolidated Financial Statements of significant related party transactions is discussed below.

*Investment Management*

For the three and nine months ended September 30, 2025 the Company's insurance subsidiaries paid investment management fees pursuant to investment management agreements with an affiliate of BAM of $56 million and $155 million, respectively. For the three and nine months ended September 30, 2024 the Company paid investment management fees of $40 million and $85 million, respectively.

------

*Reinsurance Agreements*

AEILIC had a coinsurance agreement with North End Re (Cayman) SPC, a wholly-owned subsidiary of Brookfield Wealth Solutions, to reinsure a portion of fixed indexed annuity product liabilities, 70% on a modified coinsurance ("Modco") basis and 30% on a coinsurance basis. AEILIC and North End Re entered into a recapture agreement which terminated this coinsurance agreement, effective December 1, 2024. Below is a table showing a summary of the impact of the reinsurance agreement prior to recapture:

---

| | | |
|:---|:---|:---|
| | | **September 30, 2024** |
| | | **(Dollars in millions)** |
| Total assets |  | $8020 |
| Total liabilities |  | 5660 |
|  | **Three Months Ended<br>September 30, 2024** | **Nine Months Ended<br>September 30, 2024** |
|  | **(Dollars in millions)** | **(Dollars in millions)** |
| Effect of reinsurance agreement on net income (loss)  | $(138) | $(216) |

---

AEILIC and Eagle have modified coinsurance agreements with Freestone, an affiliated Bermuda reinsurer wholly owned by the Company, to reinsure a quota share of in-force fixed rate, fixed indexed and payout annuities at 50% and ongoing flow fixed rate and fixed indexed annuities at 70%.

ANICO also has modified coinsurance agreements with Freestone. Pursuant to such agreements, ANICO has ceded to Freestone 80% of inforce and future flow PRT business, 70% of in-force and future flow single premium immediate annuity business, 100% of fixed deferred and equity-indexed annuity business issued up to December 31, 2021, and 70% of fixed deferred and equity-indexed annuity business in 2022 and later.

*Other Related Party Transactions*

For the nine months ended September 30, 2025 and 2024, the Company and its subsidiaries, in aggregate, purchased related party investments of $3.1 billion and $2.6 billion, respectively. Investment transactions with related parties are accounted for in the same manner as those with unrelated parties in the financial statements.

As of September 30, 2025 and December 31, 2024, we held investments in related parties of $11.3 billion and $9.6 billion, respectively.

American National and its subsidiaries entered into deposit agreements with BAMR US Holdings LLC, an indirect wholly-owned subsidiary of Brookfield Wealth Solutions. The balances at September 30, 2025 and December 31, 2024 were $646 million and $464 million, respectively. These deposits are considered a cash and cash equivalent in the Company's Condensed Consolidated Statements of Financial Position as of September 30, 2025 and December 31, 2024.

As of September 30, 2025 and December 31, 2024, Freestone had a deposit of $262 million and $254 million, respectively, with the Brookfield Treasury Management Inc., a subsidiary of Brookfield Corporation. This amount is included in cash and cash equivalents in the Company's Condensed Consolidated Statements of Financial Position. For the three and nine months ended September 30, 2025, the Company earned interest income of $3 million and $9 million, respectively, and $6 million and $8 million for the three and nine months ended September 30, 2024, respectively.

------

**26. Segment Reporting**

Management organizes the business into three reporting segments:

–Annuities - consists of fixed, fixed index, and variable annuity products as well as PRT contracts. Products are primarily sold through independent agents, brokers, and financial institutions, along with multiple-line and career agents.

–Property and Casualty ("P&C") - consists of personal, agricultural and targeted commercial coverages and credit-related property insurance. Products are primarily sold through multiple-line and independent agents or managing general agents. There are also small amounts of Health insurance, consisting of Medicare Supplement, stop-loss, other supplemental health products and credit disability insurance. Products are typically distributed through independent agents and managing general underwriters.

–Life Insurance - consists primarily of whole, term, universal, indexed and variable life insurance sold through career, multiple-line, and independent agents as well as direct marketing channels. American National ceased selling new life insurance policies through its multiple-line and independent agent distribution channels effective May 31, 2025. American National continues to sell certain life insurance products through its career agent distribution channel.

Corporate and other consists of net investment income from investments and certain expenses not allocated to the insurance segments and revenues and related expenses from non-insurance operations.

These segments are regularly reviewed by the Company's chief operating decision maker ("CODM") for the purpose of allocating resources to the segment and to assess its performance. The Company's CODM has been identified as the BWS Chief Executive Officer and the BWS Chief Financial Officer.

The key measure used by the CODM in assessing performance and in making resource allocation decisions is Distributable Operating Earnings ("DOE"). DOE provides the CODM with insights on capital allocation and investment strategies, as well as product mix and pricing of insurance products offered by the Annuities, P&C and Life Insurance segments.

DOE is calculated as net income after applicable taxes excluding the impact of depreciation and amortization, deferred income taxes related to basis and other changes, and breakage and transaction costs, as well as certain investment and insurance reserve gains and losses, including gains and losses related to asset and liability matching strategies, non-operating adjustments related to changes in cash flow assumptions for future policy benefits and change in market risk benefits, and is inclusive of returns on equity invested in certain variable interest entities and the Company's share of adjusted earnings from investments in certain associates. DOE allows the CODM to evaluate the Company's segments on the basis of return on invested capital generated by its operations and allows the Company to evaluate the performance of its segments.

The tables below provide each segment's results in the format that the CODM reviews its reporting segments to make decisions and assess performance.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
| | **Annuities** | **P&C** | **Life<br>Insurance** | **Total** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Net premiums and other policy related revenues | $308 | $364 | $96 |  |
| Net investment income, including reinsurance funds withheld | 1285 | 41 | 49 |  |
| Segment revenues (1)(2) | 1593 | 405 | 145 | $2143 |
| Policyholder benefits, net | 221 | 255 | 69 |  |
| Interest sensitive contract benefits, excluding index credits | 529 |  | 10 |  |
| Amortization of deferred policy acquisition costs, deferred sales inducements and value of business acquired | 247 | 83 | 15 |  |
| Other insurance and reinsurance expenses (3) | 100 |  |  |  |
| Operating expenses, excluding transactions costs | 107 | 29 | 14 |  |
| Segment DOE | $389 | $38 | $37 | $464 |
| Corporate and other DOE |  |  |  | (110) |
| Depreciation and amortization expenses |  |  |  | (35) |
| Deferred income tax recovery relating to basis and other changes |  |  |  | (25) |
| Transaction costs |  |  |  | 10 |
| Unrealized net investment gains (losses), including reinsurance funds withheld |  |  |  | (117) |
| Mark-to-market gains (losses) within insurance contracts and other net assets |  |  |  | 21 |
| Net income (loss) |  |  |  | $208 |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
| | **Annuities** | **P&C** | **Life<br>Insurance** | **Total** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Net premiums and other policy related revenues | $471 | $473 | $164 |  |
| Net investment income, including reinsurance funds withheld | 1034 | 43 | 80 |  |
| Segment revenues (1)(2) | 1505 | 516 | 244 | $2265 |
| Policyholder benefits, net | 443 | 329 | 117 |  |
| Interest sensitive contract benefits, excluding index credits | 402 |  | 8 |  |
| Amortization of deferred policy acquisition costs, deferred sales inducements and value of business acquired | 175 | 99 | 15 |  |
| Other insurance and reinsurance expenses (3) | 44 |  |  |  |
| Operating expenses, excluding transactions costs | 99 | 65 | 62 |  |
| Segment DOE | $342 | $23 | $42 | $407 |
| Corporate and other DOE |  |  |  | (47) |
| Depreciation and amortization expenses |  |  |  | (25) |
| Deferred income tax recovery relating to basis and other changes |  |  |  | 105 |
| Transaction costs |  |  |  | (32) |
| Unrealized net investment gains (losses), including reinsurance funds withheld |  |  |  | 128 |
| Mark-to-market gains (losses) within insurance contracts and other net assets |  |  |  | (835) |
| Net income (loss) |  |  |  | $(299) |
|  | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
|  | **Annuities** | **P&C** | **Life<br>Insurance** | **Total** |
|  | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Net premiums and other policy related revenues | $1281 | $1204 | $300 |  |
| Net investment income, including reinsurance funds withheld | 3761 | 123 | 156 |  |
| Segment revenues (1)(2) | 5042 | 1327 | 456 | $6825 |
| Policyholder benefits, net | 1031 | 861 | 232 |  |
| Interest sensitive contract benefits, excluding index credits | 1489 |  | 23 |  |
| Amortization of deferred policy acquisition costs, deferred sales inducements and value of business acquired | 692 | 272 | 31 |  |
| Other insurance and reinsurance expenses (3) | 313 |  |  |  |
| Operating expenses, excluding transactions costs | 349 | 96 | 61 |  |
| Segment DOE | $1168 | $98 | $109 | $1375 |
| Corporate and other DOE |  |  |  | (318) |
| Depreciation and amortization expenses |  |  |  | (125) |
| Deferred income tax recovery (expense) relating to basis and other changes |  |  |  | 147 |
| Transaction costs |  |  |  | (27) |
| Mark-to-market gains (losses) on investments, including reinsurance funds withheld |  |  |  | (342) |
| Mark-to-market gains (losses) on insurance contracts and other net assets |  |  |  | (597) |
| Net income (loss) |  |  |  | $113 |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| | **Annuities** | **P&C** | **Life<br>Insurance** | **Total** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Net premiums and other policy related revenues | $1586 | $1411 | $556 |  |
| Net investment income, including reinsurance funds withheld | 2056 | 131 | 304 |  |
| Segment revenues (1)(2) | 3642 | 1542 | 860 | $6044 |
| Policyholder benefits, net | 1521 | 1040 | 425 |  |
| Interest sensitive contract benefits, excluding index credits | 807 |  | 34 |  |
| Amortization of deferred policy acquisition costs, deferred sales inducements and value of business acquired | 294 | 314 | 41 |  |
| Other insurance and reinsurance expenses (3) | 71 |  |  |  |
| Operating expenses, excluding transactions costs | 186 | 141 | 186 |  |
| Income tax expense (recovery), net | 72 | (4) | 12 |  |
| Segment DOE | $691 | $51 | $162 | $904 |
| Corporate and other DOE |  |  |  | (92) |
| Depreciation and amortization expenses |  |  |  | (49) |
| Deferred income tax recovery (expense) relating to basis and other changes |  |  |  | 432 |
| Transaction costs |  |  |  | (163) |
| Mark-to-market gains (losses) on investments, including reinsurance funds withheld |  |  |  | 487 |
| Mark-to-market gains (losses) on insurance contracts and other net assets |  |  |  | (1461) |
| Net income (loss) |  |  |  | $58 |

---

(1)For the three and nine months ended September 30, 2025 and 2024, there were no material intersegment revenues.

(2)Our consolidated revenues in the Condensed Consolidated Statements of Operations principally represent the sum of "Segment revenues" and "Mark-to-market gains (losses) on investments, including reinsurance funds withheld" in the tables above.

(3)"Other insurance and reinsurance expenses" primarily represent "Change in fair value of market risk benefits" excluding the effect of changes in market risks (e.g., interest rates, equity markets and equity index volatility). See *Note 19 - Market Risk Benefits* for the details of market risk benefits.

The Company's Annuities segment offers annuity-based products to individuals and institutions. Total premium revenues recorded within Annuities segment for the three and nine months ended September 30, 2025 and 2024 were primarily from PRT transactions with institutions in the United States and United Kingdom. Premiums received from retail annuities are generally recorded as deposits and are not included in net premiums.

Our P&C segment provides a broad range of P&C products through American National, which include coverage for property, casualty, specialty and other. Total earned premiums within this segment for the three and nine months ended September 30, 2025 and 2024 were primarily from transactions with U.S.-based individuals and institutions.

The Company's Life Insurance business is principally provided by American National. Total premium revenues recorded within this segment for the three and nine months ended September 30, 2025 and 2024 were primarily from transactions with U.S. retail customers.

In addition to DOE, the CODM also monitors the assets, including investments accounted for using the equity method, liabilities and equity attributable to each segment.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Annuities** | **P&C** | **Life<br>Insurance** | **Total (1)** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **As of September 30, 2025** | | | | |
| Assets | $115143 | $4339 | $9670 | $129152 |
| Liabilities | 105507 | 2252 | 7469 | 115228 |
| Equity | 9636 | 2087 | 2201 | 13924 |
| **As of December 31, 2024** |  |  |  |  |
| Assets | $107208 | $4742 | $9232 | $121182 |
| Liabilities | 98851 | 2544 | 6396 | 107791 |
| Equity | 8357 | 2198 | 2836 | 13391 |

---

(1)Table excludes amounts related to Corporate and other which is not a reportable segment for ANGI.

------

A subsidiary of American National held $1.4 billion and $1.3 billion of assets pledged under a coinsurance reinsurance agreement with a customer domiciled in the United Kingdom as of September 30, 2025 and December 31, 2024, respectively. There were no other material assets held in jurisdictions outside of the United States as of September 30, 2025 and December 31, 2024. There was no material revenue generated in jurisdictions outside of the United States for the three and nine months ended September 30, 2025 and 2024.

**27. Financial Commitments and Contingencies**

*Commitments*

As of September 30, 2025, the Company and its subsidiaries, in aggregate, had outstanding unfunded commitments to purchase, expand or improve real estate and to fund mortgage loans, private loans and investment funds of $6.9 billion.

In addition, the subsidiaries of the Company had outstanding letters of credit in the amount of $6 million as of September 30, 2025.

The Company's subsidiaries lease office space, technological equipment and automobiles. The remaining long-term lease commitments as of September 30, 2025 were approximately $111 million and are included in the Company's Condensed Consolidated Statements of Financial Position within "Other liabilities".

*Federal Home Loan Bank ("FHLB") Agreements*

Certain of the Company's subsidiaries have access to the FHLB's financial services including advances that provide an attractive funding source for short-term borrowing and for access to other funding agreements. As of September 30, 2025, certain municipal bonds and collateralized mortgage obligations with a fair value of approximately $801 million and commercial mortgage loans of approximately $1.1 billion were on deposit with the FHLB as collateral for borrowing. As of September 30, 2025, the collateral provided borrowing capacity of approximately $1.5 billion. The deposited securities and commercial mortgage loans are included in the Condensed Consolidated Statements of Financial Position within "Available-for-sale fixed maturity securities" and "Mortgage loans on real estate", respectively.

*Litigation*

Certain of the Company's subsidiaries are defendants in various lawsuits concerning alleged breaches of contracts, various employment matters, allegedly deceptive insurance sales and marketing practices, and miscellaneous other causes of action arising in the ordinary course of operations. Certain lawsuits include claims for compensatory and punitive damages. The Company provides accruals for these items to the extent it deems the losses probable and reasonably estimable. After reviewing these matters with legal counsel, based upon information presently available, management is of the opinion that the ultimate resultant liability, if any, would not have a material adverse effect on the statements of financial position, liquidity or results of operations; however, assessing the eventual outcome of litigation necessarily involves forward-looking speculation as to judgments to be made by judges, juries and appellate courts in the future.

Such speculation warrants caution, as the frequency of large damage awards, which bear little or no relation to the economic damages incurred by plaintiffs in some jurisdictions, continues to create the potential for an unpredictable judgment in any given lawsuit. These lawsuits are in various stages of development, and future facts and circumstances could result in management changing its conclusions. It is possible that, if the defenses in these lawsuits are not successful, and the judgments are greater than management can anticipate, the resulting liability could have a material impact on the Company's financial position, liquidity, or results of operations. With respect to the existing litigation, management currently believes that the possibility of a material judgment adverse to the Company is remote. Accruals for losses are established whenever they are probable and reasonably estimable. If no one estimate within the range of possible losses is more probable than any other, an accrual is recorded based on the lowest amount of the range.

**28. Subsequent Events**

The Company evaluated all events and transactions through November 13, 2025, the date the accompanying condensed consolidated financial statements were issued.

On October 1, 2025, the Company completed the transfer of its property and casualty subsidiaries, American National Property And Casualty Company, United Farm Family Insurance Company and Farm Family Casualty Insurance Company (collectively, the "P&C Subsidiaries") to Argo Group International Holdings, Inc. ("Argo"). The Company received a capital contribution (the "Capital Contribution") of $400 million on October 27, 2025. The Company used the proceeds from the Capital Contribution together with additional funds to repay $500 million of the Term Loan Credit Facility on October 29, 2025 with the objective of keeping the transfer of the P&C Subsidiaries to Argo leverage neutral to the Company. Argo and the Company are both wholly-owned subsidiaries of Brookfield Wealth Solutions Ltd.

Effective October 1, 2025, ANICO entered into a coinsurance reinsurance agreement with a third-party insurer in Japan, Dai-ichi Frontier Life, whereby ANICO will reinsure certain policies on a flow basis.

On October 6, 2025, the Company redeemed all of the 12,000 outstanding shares of Series B and the corresponding 12,000,000 depositary shares, each representing a 1/1,000th interest in one share of Series B with a total redemption payment of $303 million. As part of the redemption, the Company paid dividends totaling $3 million. For the three months ended September 30, 2024, we paid dividends totaling $5 million for Series B preferred stock. The Company funded the redemption with the net proceeds from its previously announced sale of $500 million aggregate principal amount of the 2055 Notes. See *Note 21 - Long Term Borrowings* for additional details regarding the 2055 Notes.

------

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations**

Management's discussion and analysis reviews our unaudited condensed consolidated financial position at September 30, 2025 compared with December 31, 2024, and our unaudited condensed consolidated results of operations for the three and nine months ended September 30, 2025 and 2024, and where appropriate, factors that may affect future financial performance. This analysis should be read in conjunction with our unaudited condensed consolidated financial statements, notes thereto and selected condensed consolidated financial data appearing elsewhere in this Form 10-Q as well as the December 31, 2024 audited consolidated financial statements included in the Form 10-K, filed with the SEC on March 31, 2025. Interim operating results for the three and nine months ended September 30, 2025 are not necessarily indicative of the results expected for the entire year. Preparation of financial statements requires use of management estimates and assumptions.

**Cautionary Statement Regarding Forward-Looking Information**

All statements, trend analysis and other information contained in this report and elsewhere (such as in filings by us with the SEC, press releases, presentations by us or management or oral statements) may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, the Securities Act or the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking statements give expectations or forecasts of future events and do not relate strictly to historical or current facts. They may relate to markets for our products, trends in our operations or financial results, strategic alternatives, future operations, strategies, plans, partnerships, investments, share buybacks and other financial developments. They use words and terms such as anticipate, assume, believe, can, continue, could, enable, estimate, expect, foreseeable, goal, improve, intend, likely, may, model, objective, opportunity, outlook, plan, potential, project, remain, risk seek, should, strategy, target, will, would, and other words and terms of similar meaning or that are otherwise tied to future periods or future performance, in each case in all forms of speech and derivative forms, or similar words, as well as any projections of future events or results. Forward-looking statements, by their nature, are subject to a variety of assumptions, risks, and uncertainties that could cause actual results to differ materially from the results projected. Many of these risks and uncertainties cannot be controlled by the Company. Factors that may cause our actual decisions or results to differ materially from those contemplated by these forward-looking statements include, among other things:

&nbsp;&nbsp;&nbsp;&nbsp;• results differing from assumptions, estimates, and models.

&nbsp;&nbsp;&nbsp;&nbsp;• interest rate condition changes.

&nbsp;&nbsp;&nbsp;&nbsp;• investments losses or failures to grow as quickly as expected due to market, credit, liquidity, concentration, default, and other risks.

&nbsp;&nbsp;&nbsp;&nbsp;• option costs increases.

&nbsp;&nbsp;&nbsp;&nbsp;• counterparty credit risks.

&nbsp;&nbsp;&nbsp;&nbsp;• third parties service-provider failures to perform or to comply with legal or regulatory requirements.

&nbsp;&nbsp;&nbsp;&nbsp;• poor attraction and retention of customers or distributors due to competitors' greater resources, broader array of products, and higher ratings.

&nbsp;&nbsp;&nbsp;&nbsp;• information technology and communication systems failures or security breaches.

&nbsp;&nbsp;&nbsp;&nbsp;• credit or financial strength downgrades.

&nbsp;&nbsp;&nbsp;&nbsp;• inability to raise additional capital to support our business and sustain our growth on favorable terms.

&nbsp;&nbsp;&nbsp;&nbsp;• U.S. and global capital market and economic deterioration due to major public health issues, including political or social developments, or otherwise.

&nbsp;&nbsp;&nbsp;&nbsp;• failure to authorize and pay dividends on our preferred stock.

&nbsp;&nbsp;&nbsp;&nbsp;• subsidiaries' inability to pay dividends or make other payments to us.

&nbsp;&nbsp;&nbsp;&nbsp;• failure at reinsurance, investment management, or third-party capital arrangements.

&nbsp;&nbsp;&nbsp;&nbsp;• failure to prevent excessive risk-taking.

&nbsp;&nbsp;&nbsp;&nbsp;• failure of policies and procedures to protect from operational risks.

&nbsp;&nbsp;&nbsp;&nbsp;• increased litigation, regulatory examinations, and tax audits.

&nbsp;&nbsp;&nbsp;&nbsp;• changes to laws, regulations, accounting, and benchmarking standards.

&nbsp;&nbsp;&nbsp;&nbsp;• takeover or combination delays or deterrence by laws, corporate governance documents, or change-in-control agreements.

&nbsp;&nbsp;&nbsp;&nbsp;• effects of climate change, or responses to it.

&nbsp;&nbsp;&nbsp;&nbsp;• failure of efforts to meet environmental, social, and governance standards and to enhance sustainability.

For a detailed discussion of these and other factors that might affect our performance, see Item 1A of this report.

**Overview of our Business**

As a result of the Post-Effective Merger of American National into AEL, the condensed consolidated financial statements for the periods prior to the Post-Effective Merger represent the results of American National as the accounting acquirer. For periods subsequent to the Post-Effective Merger, the condensed consolidated financial statements represent the combined results of American National and AEL. See *Note 1 - Organization and Description of the Company* for additional discussion on the Post-Effective Merger. Throughout this report, unless otherwise specified or the context otherwise requires, all references to "ANGI", the "Company", "we", "our" and similar references are to American National Group Inc. and its consolidated subsidiaries.

Through our insurance subsidiaries, our Company is primarily focused on providing insurance solutions to individuals and institutions through a broad range of annuity and retirement products and services. Our business is presently conducted through our subsidiaries under three operating segments: Annuities, Property and Casualty ("P&C") and Life Insurance.

------

*Key Financial Data*

The following table presents key financial data of the Company:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Total assets | $130559 | $123659 | $130559 | $123659 |
| Net income (loss) attributable to American National Group Inc. common stockholder | 208 | (299) | 113 | 58 |
| Segment distributable operating earnings (1) | 464 | 407 | 1375 | 904 |

---

(1)Distributable Operating Earnings is a Non-GAAP measure. See "Reconciliation of Non-GAAP Measures".

**Results of Operations for the Three and Nine Months Ended September 30, 2025 and 2024** 

The results of operations discussed below comprise results for American National for the periods prior to the Post-Effective Merger and the combined results of American National and AEL for periods subsequent to the Post-Effective Merger.

*Net Premiums*

The breakdown of premiums by product, net of ceded premiums is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Annuities |  |  |  |  |
| &nbsp;&nbsp;Retail (1) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed Index | $— | $2 | $— | $3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed Rate |  | 1 | 2 | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Retail Annuities |  | 3 | 2 | 4 |
| &nbsp;&nbsp;Institutional |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Pension Risk Transfer (2) | 99 | 285 | 734 | 1228 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Institutional Annuities | 99 | 285 | 734 | 1228 |
| Total Annuities | 99 | 288 | 736 | 1232 |
| Life | 106 | 135 | 280 | 412 |
| Property Casualty |  |  |  |  |
| &nbsp;&nbsp;Property | 274 | 324 | 396 | 946 |
| &nbsp;&nbsp;Liability | 87 | 139 | 795 | 412 |
| &nbsp;&nbsp;Other |  | 2 |  | 35 |
| Total Property and Casualty | 361 | 465 | 1191 | 1393 |
| Total net premiums | $566 | $888 | $2207 | $3037 |

---

(1)Premiums received from retail annuities are generally recorded as deposits and are not included in net premiums on the Condensed Consolidated Statements of Operations.

(2)Premiums differ from gross annuity sales in Pension Risk Transfer (PRT), since premiums are recognized as revenue when due while they are included in sales upon deal close, which is confirmed by the counterparty.

*Comparison of Three Months Ended September 30, 2025 vs. 2024*

For the three months ended September 30, 2025, we reported total net premiums of $566 million, compared to net premiums of $888 million for the same period in 2024. The decrease of $322 million is primarily due to the phased withdrawal from non-core business in our P&C segment, reinsurance agreements executed on our Life Insurance segment, and a decline in our PRT related premiums due to overall decline in the market in 2025.

------

*Comparison of Nine Months Ended September 30, 2025 vs. 2024*

For the nine months ended September 30, 2025, we reported total net premiums of $2.2 billion, compared to net premiums of $3.0 billion for the same period in 2024. The decrease of $830 million is a result of the aforementioned phased withdrawal from non-core business in our P&C segment, reinsurance agreements executed on our Life Insurance segment, and a decline in our PRT related premiums due to overall decline in the market in 2025.

Gross annuity sales are comprised of directly written retail and institutional annuity deposits, which generally are not included in revenues on the Condensed Consolidated Statements of Operations.

The breakdown of gross annuity sales is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| &nbsp;&nbsp;Retail: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fixed Index | $2528 | $2027 | $6876 | $3677 |
| &nbsp;&nbsp;&nbsp;Fixed Rate | 2125 | 1799 | 4197 | 4016 |
| &nbsp;&nbsp;&nbsp;Variable (1) | 101 | 17 | 227 | 47 |
| &nbsp;&nbsp;&nbsp;Total Retail Annuities | 4754 | 3843 | 11300 | 7740 |
| &nbsp;&nbsp;Institutional: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Pension Risk Transfer (2) | 100 | 289 | 744 | 1233 |
| &nbsp;&nbsp;&nbsp;Funding Agreements |  |  | 900 |  |
| &nbsp;&nbsp;&nbsp;Total Institutional Annuities | 100 | 289 | 1644 | 1233 |
| Total gross annuity sales | $4854 | $4132 | $12944 | $8973 |

---

(1)Variable sales represent additional premiums on previously issued policies.

(2)Gross annuity sales differ from premiums in Pension Risk Transfer, since premiums are recognized as revenue when due while they are included in sales upon deal close, which is confirmed by the counterparty.

*Comparison of Three Months Ended September 30, 2025 vs. 2024*

For the three months ended September 30, 2025, we reported total gross annuity sales of $4.9 billion, compared to gross annuity sales of $4.1 billion for the same period in 2024. The increase of $722 million is primarily due to increased sales activity in our fixed index and fixed rate retail annuity products.

*Comparison of Nine Months Ended September 30, 2025 vs. 2024*

For the nine months ended September 30, 2025, we reported total gross annuity sales of $12.9 billion, compared to gross annuity sales of $9.0 billion in the prior year period. The increase of $4.0 billion is primarily due to our funding agreement backed notes ("FABN") issuances during the period coupled with increased sales in our fixed index annuity product primarily contributed from the inclusion of AEL for the full period in 2025.

------

The following table summarizes the financial results of our business for the three and nine months ended September 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Net premiums | $566 | $888 | $2207 | $3037 |
| Other policy revenue | 181 | 208 | 502 | 504 |
| Net investment income | 1285 | 1024 | 3720 | 2396 |
| Investment related gains (losses) | 2 | (128) | 71 | (160) |
| Other income | 24 | 12 | 83 | 12 |
| Total revenues | 2058 | 2004 | 6583 | 5789 |
| Policyholder benefits and claims incurred | 527 | 846 | 2243 | 2962 |
| Interest sensitive contract benefits | 523 | 523 | 1520 | 1068 |
| Amortization of deferred policy acquisition costs, deferred sales inducements and value of business acquired | 345 | 289 | 995 | 649 |
| Change in fair value of insurance-related derivatives and embedded derivatives | (187) | 344 | 143 | 346 |
| Change in fair value of market risk benefits | 310 | 134 | 624 | 292 |
| Operating expenses | 156 | 228 | 647 | 666 |
| Interest expense | 47 | 49 | 140 | 114 |
| Total benefits and expenses | 1721 | 2413 | 6312 | 6097 |
| Net income (loss) before income taxes | 337 | (409) | 271 | (308) |
| Income tax expense (benefit) | 119 | (77) | 102 | (337) |
| Net income (loss) | 218 | (332) | 169 | 29 |
| Less: Net income (loss) attributable to noncontrolling interests | (1) | (44) | 4 | (51) |
| Net income (loss) attributable to American National Group Inc. stockholders | 219 | (288) | 165 | 80 |
| Less: Preferred stock dividends and redemption | 11 | 11 | 52 | 22 |
| Net income (loss) attributable to American National Group Inc. common stockholder | $208 | $(299) | $113 | $58 |

---

*Comparison of Three Months Ended September 30, 2025 vs. 2024*

For the three months ended September 30, 2025, we reported net income of $219 million, compared to net loss of $(288) million for the same period in 2024. The increase of $507 million was primarily driven by a decrease in the change in fair value of insurance-related derivatives and embedded derivatives as a result of equity market and interest rate movements, a decrease in policyholder benefits and claims incurred, an increase in net investment income, and a decrease in operating expenses. Those impacts were partially offset by an increase in amortization of DAC, DSI, and VOBA which is a result of continued growth of the annuity business, a decrease in net premiums, and an increase in the change in fair value of market risk benefits.

Net premiums and other policy revenue were $747 million for the three months ended September 30, 2025, compared to $1.1 billion for the same period in 2024. The decrease of $349 million was primarily attributable to lower PRT sales in the quarter as compared to the prior year and the phased withdrawal from non-core businesses in our P&C segment.

Net investment income increased by $261 million for the three months ended September 30, 2025, compared to the same period in 2024. Net investment income comprise interest and dividends received on financial instruments, equity investments and other miscellaneous fee income. The increase in 2025 was driven by the increase in assets under management due to growth of the business as well as the continued rotation into higher yielding investment strategies.

We recorded $2 million of investment related gains for the three months ended September 30, 2025, an increase of $130 million compared to the same period in 2024. The increase was primarily driven by the non-recurrence of the realized losses on investments recognized during the third quarter of 2024 as a result of the transfer of assets pursuant to the RGA reinsurance transaction which was effective July 1, 2024.

Policyholder benefits and claims incurred were $527 million for the three months ended September 30, 2025, compared to $846 million for the same period in 2024. The decrease of $319 million was primarily due to a decrease in PRT sales which resulted in lower reserve changes coupled with a decrease in claims incurred due to the impact of business ceded to RGA subsequent to the effectuation of the life insurance reinsurance transaction.

Interest sensitive contract benefits represent interest credited to policyholders' account balances from our investment contracts with customers. During the three months ended September 30, 2025, interest sensitive contract benefits were equivalent compared to the same period in 2024, driven mainly by new business issued within our annuities segment and equity market movements, offset by surrender and withdrawal activities.

------

Amortization of deferred policy acquisition costs, deferred sales inducements and value of business acquired increased by $56 million compared to the same period in 2024, primarily due to the continued growth of the annuity business which increases the deferred acquisition cost and deferred sales inducements assets.

Change in fair value of insurance-related derivatives and embedded derivatives decreased by $531 million for the three months ended September 30, 2025 compared to the same period of 2024. The decrease was primarily due to the favorable impact of assumption updates as a result of our annual assumption review along with the impact of interest rates and equity market performance on the fair value of the embedded derivatives and equity-indexed options.

Change in fair value of market risk benefits represents the mark-to-market movements of our liability based on protection to the policyholder from capital market risk. The increase in the fair value of market risk benefits of $176 million for the three months ended September 30, 2025 compared to the same period of 2024 was primarily due to the impact of interest rates and equity markets on the valuation of these liabilities coupled with the impact of assumption updates as a result of our annual assumption review.

Operating expenses were $156 million for the three months ended September 30, 2025, compared to $228 million for the same period in 2024, a decrease of $72 million. The decrease was primarily driven by a non-recurring $27 million benefit realized from the termination of American National's pension plan, as well as ongoing cost optimization efforts.

The decrease of $2 million of interest expense on borrowings compared to the same period in 2024 was mainly due to the consolidation impact of certain investment variable interest entities.

*Comparison of Nine Months Ended September 30, 2025 vs. 2024*

The results of operations discussed below comprise results for American National for the periods prior to the Post-Effective Merger and the combined results of American National and AEL for periods subsequent to the Post-Effective Merger.

For the nine months ended September 30, 2025, we reported net income of $165 million, compared to a net income of $80 million for the same period in 2024. The increase is primarily driven by an increase in net investment income due to the inclusion of American Equity following the acquisition and an increase in investment related gains (losses) as a result of the non-recurrence of realized losses recognized in the prior year as a result of the transfer of assets pursuant to the RGA reinsurance transaction which was effective July 1, 2024, and a decrease in policyholder benefits and claims incurred. Those impacts were partially offset by an increase in the change in fair value of market risk benefits as a result of equity market and interest rate movements, an increase in interest sensitive contract benefits, an increase in amortization of DAC, DSI, and VOBA, and an increase in interest expense all of which are a result of continued growth of the annuity business and inclusion of American Equity following the acquisition.

Net premiums and other policy revenue of $2.7 billion decreased by $832 million for the nine months ended September 30, 2025, compared to the same period in 2024 primarily due to lower PRT sales as compared to the prior year period coupled with the phased withdrawal from non-core businesses in our P&C segment.

Net investment income increased by $1.3 billion for the nine months ended September 30, 2025, compared to the same period in 2024. The increase was primarily driven by the increase in assets under management following the acquisition of American Equity as well as the continued rotation into higher yielding investment strategies.

The Company realized investment related gains of $71 million for the nine months ended September 30, 2025, compared to losses of $160 million for the same period in 2024. The increase in investment gains of $231 million was primarily due to one-time realized losses recognized in the prior year as a result of the transfer of assets pursuant to the RGA reinsurance transaction which was effective July 1, 2024 as well as realized gains recognized during 2025 through the foreclosure and conversion of certain agricultural loans to real estate owned.

Policyholder benefits and claims incurred decreased by $719 million for the nine months ended September 30, 2025, compared to the same period in 2024. The decrease is primarily due to a reduction in PRT sales which resulted in lower reserve changes coupled with a decrease in claims incurred due to the impact of life insurance business ceded to RGA subsequent to the effectuation of the reinsurance transaction.

For the nine months ended September 30, 2025, interest sensitive contract benefits increased compared to the same period in 2024 by $452 million which was primarily driven by an increase in the in-force block of annuity business following the acquisition of American Equity.

Amortization of deferred policy acquisition costs, deferred sales inducements and value of business acquired increased by $346 million compared to the same period in 2024, primarily due to an increase in the amortization of VOBA due to the increase in the VOBA asset following the acquisition of American Equity as well as the continued growth of the annuity business which increases the deferred acquisition cost and deferred sales inducements assets.

Change in fair value of insurance-related derivatives and embedded derivatives decreased by $203 million for the nine months ended September 30, 2025 compared to the same period of 2024. The decrease was primarily due to the favorable impact of assumption updates as a result of our annual assumption review in the third quarter of 2025 along with the impact of interest rates and equity market performance on the fair value of the embedded derivatives and equity-indexed options.

------

The increase in the change in fair value of market risk benefit of $332 million for the nine months ended September 30, 2025 compared to the same period of 2024 was primarily due to the impact of interest rates and equity markets on the valuation of these liabilities, as well as impacts from assumption updates as a result of the annual assumption review. Additionally, the market risk benefit liabilities increased as a result of the acquisition of American Equity leading to increases in the change in the fair value of these liabilities.

Operating expenses decreased by $19 million for the nine months ended September 30, 2025 compared to the same period in 2024, primarily driven by non-recurring expenses from the acquisition of American Equity in 2024 as well as a one-time benefit realized from the termination of American National's pension plan during the third quarter of 2025.

Interest expense on borrowings increased by $26 million for the nine months ended September 30, 2025 compared to the same period in 2024 primarily as a result of increased borrowings with the new term loan entered into in May 2024, senior notes issued in June 2025, junior subordinated notes entered into in August 2025, as well as the acquisition of American Equity which included legacy senior notes and subordinated debt. These increases in interest expense were partially offset by recurring repayments of the term loan during 2025.

*Distributable Operating Earnings* 

We measure operating performance primarily using Distributable Operating Earnings ("DOE") which is a Non-GAAP metric which measures our ability to acquire net insurance assets at a positive margin, and invest these assets at a return that is greater than the cost of policyholder liabilities. See "Performance Measures Used by Management" for the reconciliation of GAAP consolidated net income to DOE.

The following table presents DOE of each of our reporting segments for the three and nine months ended September 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Annuities | $389 | $342 | $1168 | $691 |
| Life Insurance | 37 | 42 | 109 | 162 |
| Property and Casualty | 38 | 23 | 98 | 51 |
| Segment DOE | $464 | $407 | $1375 | $904 |

---

*Comparison of Three Months Ended September 30, 2025 vs. 2024*

Annuities – DOE within our annuities business represents contribution from both our retail and institutional platforms. DOE increased by $47 million for the three months ended September 30, 2025 compared to the same period in 2024. The increase is primarily attributable to increased investment income from our continued deployment into higher yielding investment strategies.

Life Insurance – DOE decreased by $5 million for the three months ended September 30, 2025 compared to the same period in 2024. The decrease is primarily driven by the favorable impact of assumption updates from the annual assumption review.

Property and Casualty – DOE increased by $15 million for the three months ended September 30, 2025 compared to the same period in 2024. The increase was driven by improvements in our loss experience arising from underwriting actions implemented over the past twelve months.

*Comparison of Nine Months Ended September 30, 2025 vs. 2024*

Annuities – DOE increased by $477 million for the nine months ended September 30, 2025 compared to the same period in 2024. The increase is primarily attributable to a full period of earnings contributed from AEL, coupled with new business wins and higher spread earnings.

Life Insurance – DOE decreased by $53 million for the nine months ended September 30, 2025 compared to the same period in 2024. The decrease was driven by the impact of the aforementioned RGA reinsurance treaty executed during the third quarter of 2024.

Property and Casualty – DOE increased by $47 million for the nine months ended September 30, 2025 compared to the same period in 2024. The increase was driven by improvements in loss experience arising from underwriting actions implemented since the prior year period.

------

**Financial Condition**

*Comparison as of September 30, 2025 and December 31, 2024*

The following table summarizes the financial position as of September 30, 2025 and December 31, 2024:

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| **Assets** | | |
| &nbsp;&nbsp;&nbsp;Investments | $89728 | $80755 |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | 11568 | 11330 |
| &nbsp;&nbsp;&nbsp;Accrued investment income | 786 | 761 |
| &nbsp;&nbsp;&nbsp;Deferred policy acquisition costs, deferred sales inducements and value of business acquired | 11384 | 10631 |
| &nbsp;&nbsp;&nbsp;Premiums due and other receivables | 499 | 437 |
| &nbsp;&nbsp;&nbsp;Ceded unearned premiums | 143 | 132 |
| &nbsp;&nbsp;&nbsp;Deferred tax asset | 303 | 529 |
| &nbsp;&nbsp;&nbsp;Reinsurance recoverables and deposit assets | 9531 | 10055 |
| &nbsp;&nbsp;&nbsp;Property and equipment | 170 | 175 |
| &nbsp;&nbsp;&nbsp;Intangible assets | 1541 | 1545 |
| &nbsp;&nbsp;&nbsp;Other assets | 2928 | 2745 |
| &nbsp;&nbsp;&nbsp;Goodwill | 783 | 783 |
| &nbsp;&nbsp;&nbsp;Separate account assets | 1195 | 1343 |
| Total assets | $130559 | $121221 |
| **Liabilities** |  |  |
| &nbsp;&nbsp;&nbsp;Future policy benefits | $10345 | $9170 |
| &nbsp;&nbsp;&nbsp;Policyholders' account balances | 89469 | 83079 |
| &nbsp;&nbsp;&nbsp;Policy and contract claims | 1811 | 1867 |
| &nbsp;&nbsp;&nbsp;Market risk benefits | 4505 | 3655 |
| &nbsp;&nbsp;&nbsp;Unearned premium reserve | 733 | 1044 |
| &nbsp;&nbsp;&nbsp;Due to related parties | 115 | 80 |
| &nbsp;&nbsp;&nbsp;Other policyholder funds | 353 | 347 |
| &nbsp;&nbsp;&nbsp;Notes payable | 204 | 189 |
| &nbsp;&nbsp;&nbsp;Long term borrowings | 3449 | 2957 |
| &nbsp;&nbsp;&nbsp;Funds withheld for reinsurance liabilities | 3131 | 3321 |
| &nbsp;&nbsp;&nbsp;Other liabilities | 4268 | 4141 |
| &nbsp;&nbsp;&nbsp;Separate account liabilities | 1195 | 1343 |
| Total liabilities | 119578 | 111193 |
| **Equity** |  |  |
| &nbsp;&nbsp;&nbsp;Preferred stock, Series A |  | 389 |
| &nbsp;&nbsp;&nbsp;Preferred stock, Series B | 296 | 296 |
| &nbsp;&nbsp;&nbsp;Preferred stock, Series D | 292 |  |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | 7558 | 7569 |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive income, net of taxes | 1132 | 340 |
| &nbsp;&nbsp;&nbsp;Retained earnings | 1480 | 1356 |
| &nbsp;&nbsp;&nbsp;Non-controlling interests | 223 | 78 |
| Total equity | 10981 | 10028 |
| Total liabilities and equity | $130559 | $121221 |

---

*September 30, 2025 vs. December 31, 2024*

Total assets increased by $9.3 billion during the period to $130.6 billion. The increase is primarily driven by net annuity inflows which results in increased cash and investment purchases, the issuance of the 2055 Notes, and favorable fair value movements on our equity securities portfolio.

Total investments increased by $9.0 billion from December 31, 2024 to September 30, 2025. The increase is primarily driven by the net annuity inflows and redeployment of cash and cash equivalents into fixed maturity investments resulting in increased investment purchases and favorable unrealized fair value movements on our equity securities portfolio.

------

Cash and cash equivalents increased by $238 million from December 31, 2024 to September 30, 2025. The increase is primarily driven by the issuance of the 2055 Notes during the third quarter of 2025 as well as annuity sales during the period not yet deployed into our investments. We continue to maintain a strong liquidity position across our segments. For further information, refer to "Liquidity and Capital Resources" section within this MD&A.

Deferred policy acquisition costs ("DAC"), deferred sales inducements ("DSI") and value of business acquired ("VOBA") are capitalized costs directly related to writing new policyholder contracts and include the VOBA intangible assets. During the year, the balance increased by $753 million primarily driven by deferrals associated with writing new business during the period.

Ceded unearned premiums represent a portion of unearned premiums ceded to reinsurers. The increase of $11 million from December 31, 2024 to September 30, 2025 is primarily driven by the recognition of earned premiums subject to reinsurance.

Deferred tax assets decreased by $226 million from December 31, 2024 to September 30, 2025. The decrease is primarily due to changes in the deferred tax asset related to Bermuda and changes in unrealized gains or losses in our investments offset by an increase in our net operating loss carryforwards.

Reinsurance recoverables and deposit assets are estimated amounts due to the Company from reinsurers and include reinsurance receivables and recoverables from reinsurers and deposit assets associated with reinsurance agreements. The amount decreased by $524 million primarily driven by a reduction in the associated insurance liabilities as well as the run off of certain blocks of business ceded to external reinsurers.

Intangible assets decreased by $4 million during the year, primarily due to the amortization of intangible assets during the period.

Other assets increased by $183 million during the year to $2.9 billion. The balance includes current tax asset, market risk benefit asset, as well as other miscellaneous receivables, and is primarily attributable to an increase in the market risk benefit asset as a result of assumption updates made during the annual assumption review.

Separate account assets and liabilities both decreased by $148 million during 2025, primarily due to policyholder benefits and withdrawals during the quarter as well as the release of $174 million of assets and the associated liabilities related to the lump sum payout of a portion of the qualified defined benefit pension plan during Q3 2025.

Future policy benefits and policyholders' account balances increased by $7.6 billion during 2025 primarily driven by annuity sales during the period as well as assumption updates as a result of the annual assumption review and the impact of changes in interest rates and equity markets on the valuation of the embedded derivatives during the period.

Market risk benefits increased by $850 million during 2025 primarily due to the impact of changes in interest rates and equity markets as well as assumption updates as a result of the annual assumption review on the valuation of market risk benefits.

Funds withheld for reinsurance liabilities decreased by $190 million during 2025 as a result of decrements on the existing ceded liabilities and the corresponding funds withheld payable as flow business is not being ceded to external reinsurers.

Other liabilities increased by $127 million during 2025. The balance includes the reinsured market risk benefits liability, accrued interest on debt and other miscellaneous payables. The increase during 2025 is primarily driven by an increase in miscellaneous payables.

**Liquidity and Capital Resources**

*Capital Resources*

We strive to maintain sufficient financial liquidity at all times so that we are able to participate in attractive opportunities as they arise, better withstand sudden adverse changes in economic circumstances within our operating subsidiaries and maintain payments to policyholders. Our principal sources of liquidity are cash flows from our operations and access to the Company's third-party credit facilities. We proactively manage our liquidity position to meet liquidity needs and continue to develop relationships with lenders who provide borrowing capacity at competitive rates, while looking to minimize adverse impacts on investment returns. We look to structure the ownership of our assets to enhance our ability to monetize them to provide additional liquidity, if needed. Our liquidity for the periods noted below consisted of the following:

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| Cash and cash equivalents | $11568 | $11330 |
| Liquid financial assets | 39017 | 32947 |
| Undrawn credit facilities | 1462 | 881 |
| Total liquidity (1) | $52047 | $45158 |

---

(1)Total Liquidity is a Non-GAAP measure. See "Performance Measures used by Management."

------

Today, we have significant liquidity within our insurance portfolios, giving us flexibility to secure attractive investment opportunities. In addition to a portfolio of highly liquid financial assets, our operating companies have additional access to liquidity from sources such as the Federal Home Loan Bank ("FHLB") and access to a sub-allocation under the Brookfield Wealth Solutions revolving credit facility. As of September 30, 2025, the Company had no drawings and a total of $1.5 billion undrawn commitment available related to this program, and access to $300 million of capacity under the revolving credit facility.

Liquidity within our insurance subsidiaries may be restricted from time to time due to regulatory constraints. As of September 30, 2025, the Company's total liquidity was $52.0 billion, which included $764 million of unrestricted cash and cash equivalents held outside of the regulated insurance companies.

*Comparison of the Nine Months Ended September 30, 2025 and 2024*

The following table presents a summary of our cash flows and ending cash balances for the nine months ended September 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** |
| Operating activities | $1636 | $2104 |
| Investing activities | (6485) | 6565 |
| Financing activities | 5087 | 2012 |
| Cash and cash equivalents: |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents, beginning of period | 11330 | 3192 |
| &nbsp;&nbsp;&nbsp;Net change during the period | 238 | 10681 |
| Cash and cash equivalents, end of period | $11568 | $13873 |

---

*Operating Activities*

For the nine months ended September 30, 2025, we generated $1.6 billion of cash from operating activities compared to $2.1 billion during 2024, primarily due to the change in the fair value of embedded derivatives for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024 as detailed above.

*Investing Activities*

For the nine months ended September 30, 2025, cash outflows arose as we deployed cash and cash equivalents held as of December 31, 2024 to short-term investments, private loans, and available-for-sale fixed maturity securities and continued to rotate our investment portfolio into higher yielding investment strategies. This resulted in net deployment of $6.5 billion of cash from investing activities, compared to net inflow of $6.6 billion in the prior year.

*Financing Activities*

For the nine months ended September 30, 2025, we recorded a net cash inflow of $5.1 billion from our financing activities, compared to net inflow of $2.0 billion recorded in 2024. The proceeds in the current year period were mainly as a result of $4.5 billion net payments received on policyholders' account deposits partially offset by withdrawals on such accounts.

*Financial Instruments*

To the extent that we believe it is economically prudent to do so, our strategy is to hedge a portion of our equity investments and/or cash flows exposed to foreign currencies by the Company. The following key principles form the basis of our foreign currency hedging strategy:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We leverage any natural hedges that may exist within our operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We utilize local currency debt financing to the extent possible; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may utilize derivative contracts to the extent that natural hedges are insufficient.

*Future Capital Obligations and Requirements*

As of September 30, 2025, the Company and its subsidiaries, in aggregate, had total unfunded investment commitments of $6.9 billion. The unfunded commitments are primarily recognized as mortgage loans, private loans, investment funds, investment real estate and other invested assets. For additional information, see *Note 27 - Financial Commitments and Contingencies* of the financial statements.

------

The following is the maturity by year on long term borrowings:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Payments Due by Year** | **Payments Due by Year** | **Payments Due by Year** | **Payments Due by Year** | **Payments Due by Year** | **Payments Due by Year** | **Payments Due by Year** | **Payments Due by Year** |
| | **Total** | **Unamortized<br>Discount and<br>Issuance Costs** | **Less Than<br>1 year** | **1-2 Years** | **2-3 Years** | **3-4 Years** | **4-5 Years** | **More Than<br>5 Years** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| **As of September 30, 2025** | | | | | | | | |
| Long term borrowings | $3449 | $(51) | $— | $1100 | $— | $— | $600 | $1800 |
| **As of December 31, 2024** |  |  |  |  |  |  |  |  |
| Long term borrowings | $2957 | $(43) | $— | $— | $1800 | $— | $600 | $600 |

---

For additional information, See *Note 21 - Long Term Borrowings* of the financial statements.

*Capital Management*

Capital management is the on-going process of determining and maintaining the quantity and quality of capital appropriate to take advantage of the Company's growth opportunities, to support the risks associated with the business and to optimize shareholder returns while fully complying with the regulatory capital requirements.

The Company and its subsidiaries take an integrated approach to risk management that involves the Company's risk appetite and capital requirements. The operating capital levels are determined by the Company's risk appetite and Own Risk and Solvency Assessment ("ORSA"). Furthermore, additional stress techniques are used to evaluate the Company's capital adequacy under sustained adverse scenarios.

American National and AEL are required to follow Risk Based Capital ("RBC") requirements based on guidelines of the National Association of Insurance Commissioners ("NAIC"). RBC is a method of measuring the level of capital appropriate for an insurance company to support its overall business operations, in light of its size and risk profile. It provides a means of assessing capital adequacy, where the degree of risk taken by the insurer is the primary determinant.

The Company has determined that it is in compliance with all capital requirements as of September 30, 2025 and December 31, 2024.

**Performance Measures Used by Management**

To measure performance, we focus on net income and total assets, as well as certain Non-GAAP measures, including DOE and Total Liquidity, which we believe are useful to investors to provide additional insights into assets within the business available for redeployment. Refer to the "Results of Operations", "Financial Condition," and "Liquidity and Capital Resources" sections of this MD&A for further discussion on our performance and Non-GAAP measures for the three and nine months ended September 30, 2025 and 2024.

*Non-GAAP Measures*

We regularly monitor certain Non-GAAP measures that are used to evaluate our performance and analyze underlying business performance and trends. We use these measures to establish budgets and operational goals, manage our business and evaluate our performance. We also believe that these measures help investors compare our operating performance with our results in prior years. These Non-GAAP financial measures are provided as supplemental information to the financial measures presented in this MD&A that are calculated and presented in accordance with GAAP. These Non-GAAP measures are not comparable to GAAP and may not be comparable to similarly described Non-GAAP measures reported by other companies, including those within our industry.

Consequently, our Non-GAAP measures should not be evaluated in isolation, but rather, should be considered together with the most directly comparable GAAP measure in our condensed consolidated financial statements for the years presented. The Non-GAAP financial measures we present in this MD&A should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP.

*Distributable Operating Earnings*

We use DOE to assess operating results and the performance of our businesses. We define DOE as net income after applicable taxes, excluding the impact of depreciation and amortization, deferred income taxes related to basis and other changes, and breakage and transaction costs, as well as certain investment and insurance reserve gains and losses, including gains and losses related to asset and liability matching strategies, non-operating adjustments related to changes in cash flow assumptions for future policy benefits and change in market risk benefits, and is inclusive of returns on equity invested in certain variable interest entities and our share of adjusted earnings from our investments in certain associates.

DOE is a measure of operating performance that is not calculated in accordance with, and does not have any standardized meaning prescribed by GAAP. DOE is, therefore, unlikely to be comparable to similar measures presented by other issuers.

------

We believe our presentation of DOE is useful to investors because it supplements investors' understanding of our operating performance by providing information regarding our ongoing performance that excludes items we believe do not directly affect our core operations. Our presentation of DOE also provides investors enhanced comparability of our ongoing performance across years.

*Total Liquidity*

Total Liquidity is a measure of our liquidity position and includes cash and cash equivalents, undrawn revolving credit facilities and liquid financial assets held by our regulated insurance entities.

The following table contains further details regarding our use of our Non-GAAP measures, as well as a reconciliation of GAAP consolidated net income to DOE:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** | **(Dollars in millions)** |
| Net income (loss) attributable to American National Group Inc. common stockholder | $208 | $(299) | $113 | $58 |
| Mark-to-market losses (gains) on insurance contracts and other net assets (2)(3) | (21) | 835 | 597 | 1461 |
| Mark-to-market losses (gains) on investments, including reinsurance funds withheld (1) | 117 | (128) | 342 | (487) |
| Transaction costs | (10) | 32 | 27 | 163 |
| Deferred income tax expense (recovery) relating to basis and other changes | 25 | (105) | (147) | (432) |
| Depreciation and amortization expenses | 35 | 25 | 125 | 49 |
| Corporate and other DOE | 110 | 47 | 318 | 92 |
| Segment DOE | $464 | $407 | $1375 | $904 |

---

(1)"Mark-to-market losses (gains) on investments, including reinsurance funds withheld" primarily represent mark-to-market gains or losses on our investments. Mark-to-market gains or losses on our invested assets are presented as "Investment related gains (losses)" on the Condensed Consolidated Statements of Operations. See *Note 10 - Net Investment Income and Investment Related Gains (Losses)* in the notes to the condensed consolidated financial statements for additional details.

(2)"Mark-to-market losses (gains) on insurance contracts and other net assets" principally represents the mark-to-market effect on insurance-related liabilities, net of reinsurance, due to changes in market risks (e.g., interest rates, equity markets and equity index volatility). These mark-to-market effects are primarily included in "Interest sensitive contract benefits", "Change in fair value of insurance-related derivatives and embedded derivatives" and "Change in fair value of market risk benefits" on the Condensed Consolidated Statements of Operations. See the following notes to the condensed consolidated financial statements for additional information: (i) *Note 9 - Derivative Instruments*; (ii) *Note 18 - Policyholders' Account Balances*; and (iii) *Note 19 - Market Risk Benefits*.

(3)Included in "Mark-to-market losses (gains) on insurance contracts and other net assets" are "returns on equity invested in certain variable interest entities" and "our share of adjusted earnings from our investments in certain associates" as stated in the definition of DOE. "Returns on equity invested in certain variable interest entities" primarily represent equity-accounted income from our investments in real estate partnerships and investment funds and are included in "Net investment income" on the Condensed Consolidated Statements of Operations.

**New Accounting Pronouncements**

See *Note 2 - Summary of Significant Accounting Policies* to our unaudited condensed consolidated financial statements in this Form 10-Q, which is incorporated by reference in this Item 2.

**Item 3. Quantitative and Qualitative Disclosures About Market Risk**

*Market Risk*

Our Condensed Consolidated Statements of Financial Position within our financial statements include substantial amounts of assets and liabilities whose fair values are subject to market risks. Our significant market risks are primarily associated with interest rates, foreign currency exchange rates and credit risk. The fair values of our investment portfolios remain subject to considerable volatility. The following sections address the significant market risks associated with our business activities.

------

*Foreign Exchange Rate Risk*

The Company's obligations under its insurance contracts are predominantly denominated in U.S. dollars, but a portion of the assets supporting these liabilities are denominated in non-U.S. dollars. We manage foreign exchange risk primarily using foreign exchange forwards and cross currency swaps. Our investment policy sets out the foreign currency exposure limits and types of derivatives permitted for hedging purposes. Our net assets are subject to financial statement translation into U.S. dollars. All of our financial statement translation-related impact from changes in foreign currency rates is recorded in other comprehensive income. Gains and losses from foreign currency transactions of the Company's invested assets are reported in "Investment related gains (losses)" in the Condensed Consolidated Statements of Operations. The impact on net income resulting from a hypothetical 10% decrease in foreign currencies against the U.S. Dollar, net of the impact of foreign exchange hedging strategies, would not be expected to be material.

*Interest Rate Risk*

Substantial and sustained increases or decreases in interest rates may cause certain market dislocations that could negatively impact our financial performance.

We manage interest rate risk through our asset liability management, which we refer to as ALM, the framework whereby the effective and key rate durations of the investment portfolio are closely matched to those of the insurance reserves. Within the context of the ALM framework, we use derivatives including interest rate swaps, options and futures to reduce market risk. For the annuities business, where the timing and amount of the benefit payment obligations can be readily determined, the matching of asset and liability cash flows is effectively controlled through this comprehensive duration management process.

*Other Price Risk*

Other price risk is the risk of variability in fair value due to movements in equity prices or other market prices such as commodity prices and credit spreads.

The Company's exposure to the equity markets is managed by sector and individual security, and the Company mitigates the equity risk by diversification of the investment portfolio.

The Company also has equity risk associated with the equity-indexed life and annuity products the Company issues and assumes. The Company has entered into derivative transactions, primarily over-the-counter equity call options, to hedge the exposure to equity-index changes.

*Credit Risk*

Credit risk is the risk of loss from amounts owed by counterparties and arises any time funds are extended, committed, owed or invested through actual or implied contractual arrangements, including reinsurance. The Company is primarily exposed to credit risk through its fixed income investments, which include debt securities and private loans.

We manage exposure to credit risk by establishing concentration limits by counterparty, credit rating and asset class. To further minimize credit risk, the financial condition of the counterparties is monitored on a regular basis. These requirements are outlined in our investment policy.

*Insurance Risk*

The Company makes assumptions and estimates when assessing insurance and reinsurance risks, and significant deviations, particularly with regards to mortality, morbidity, longevity and policyholder behavior, could adversely affect our business, financial condition, results of operations, liquidity and cash flows. All transaction terms are likely to be determined by qualitative and quantitative factors, including our estimates.

We manage insurance risk through choosing whether to purchase reinsurance for certain amounts of risk underwritten in our Annuities, P&C and Life Insurance segments.

*Legal Risk*

In the future, we may be parties in actions that routinely arise out of the normal course of business, including legal actions seeking to establish liability directly through insurance contracts. Plaintiffs occasionally seek punitive or exemplary damages. We do not believe that such normal and routine litigation will have a material effect on our financial condition or results of operations. We are also involved from time to time in other kinds of legal actions, some of which assert or may assert claims or seek to impose fines and penalties. We believe that any liability that may arise as a result of other pending legal actions will not have a material effect on our financial statements.

------

*Operational Risk*

Operational risk is the potential for loss resulting from inadequate or failed internal processes, people and systems, or from external events. The Company's internal control processes are supported by the maintenance of a risk register and independent internal audit review. The risk of fraud is managed through a number of processes including background checks on staff on hire, annual code of conduct confirmations, anti-bribery training and segregation of duties.

We have material outsourcing arrangements. These arrangements are subject to agreements with formal service levels, operate within agreed authority limits and are subject to regular review by senior management. Material outsourcing arrangements are approved and monitored by the Board of Directors.

Disaster recovery and business continuity plans have also been established to manage the Company's ability to operate under adverse conditions.

**Item 4. Controls and Procedures**

<u>Evaluation of Disclosure Controls and Procedures</u>

In accordance with Exchange Act Rules 13a-15(e) and 15d-15(e), our management, under the supervision of our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report on Form 10-Q. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded the design and operation of our disclosure controls and procedures were effective as of September 30, 2025 in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by us in the reports that we file or submit under the Exchange Act.

There were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

**PART II. OTHER INFORMATION** 

**Item 1. Legal Proceedings**

See *Note 27 - Financial Commitments and Contingencies* to the unaudited condensed consolidated financial statements in this Form 10-Q, which is incorporated by reference in this Item 1, for any required disclosure.

**Item 1A. Risk Factors**

We describe certain factors that may affect our business or operations under "Risk Factors" in Part I, Item 1A, of our 2024 Annual Report on Form 10-K.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds**

None.

**Item 3. Defaults Upon Senior Securities**

None.

**Item 4. Mine Safety Disclosures** 

None.

**Item 5. Other Information**

During the three months ended September 30, 2025, none of the Company's directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated any contract, instruction, or written plan for the purchase or sale of the Company's securities intended to satisfy the conditions of the affirmative defense provided by Rule 10b5-1(c) or any "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.

------

**Item 6. Exhibits**

Note Regarding Reliance on Statements in Our Contracts and Other Exhibits: We include agreements and other exhibits to this report to provide information regarding their terms and not to provide any other factual or disclosure information about us, our subsidiaries or affiliates, or the other parties to the agreements, or for any other purpose. The agreements and other exhibits may contain representations and warranties by each of the parties to the applicable agreement. These representations and warranties have been made solely for the benefit of the other parties to the applicable agreement or other arrangement and (i) should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate; (ii) have in many cases been qualified by disclosures that were made to the other party in connection with the negotiation of the applicable agreement, which disclosures are not necessarily reflected in the agreement; (iii) may apply standards of materiality in a way that is different from what may be viewed as material to investors; and (iv) were made only as of the date of the applicable agreement or other exhibit, or such other date or dates as may be specified in the document and are subject to more recent developments. Accordingly, these representations and warranties may not describe the actual state of affairs as of the date they were made or at any other time.

---

| | |
|:---|:---|
| **Exhibit Number** | **Description** |
| 3.1 | <u>[Certificate of Incorporation of American National Group Inc. (Incorporated by reference to Exhibit 3.2 to Form 8-K filed on May 8, 2024)](https://www.sec.gov/Archives/edgar/data/1039828/000110465924058469/tm2413694d1_ex3-2.htm)</u> |
| 3.2 | <u>[Certificate of Amendment to the Certificate of Incorporation of American National Group Inc. (including the Certificate of Designations with respect to the Series D Preferred Stock of the Company) (Incorporated by reference to Exhibit 3.1 to Form 8-K filed on January 10, 2025)](https://www.sec.gov/Archives/edgar/data/1039828/000110465925002579/tm2430912d7_ex3-1.htm)</u> |
| 3.3 | <u>[Bylaws of American National Group Inc. (Incorporated by reference to Exhibit 3.3 to Form 8-K filed on May 8, 2024)](https://www.sec.gov/Archives/edgar/data/1039828/000110465924058469/tm2413694d1_ex3-3.htm)</u> |
| 4.1 | <u>[Indenture, dated as of October 2, 2024, between American National Group Inc., as issuer, and Wilmington Trust, National Association, as trustee (Incorporated by reference to Exhibit 4.1 to Form 8-K filed on October 2, 2024)](https://www.sec.gov/Archives/edgar/data/1039828/000110465924105456/tm2425384d1_ex4-1.htm)</u> |
| 4.2 | <u>[T](https://www.sec.gov/Archives/edgar/data/1039828/000110465925081897/tm2523654d6_ex4-1.htm)[hird](https://www.sec.gov/Archives/edgar/data/1039828/000110465925081897/tm2523654d6_ex4-1.htm)[Supplemental Indenture, dated as of](https://www.sec.gov/Archives/edgar/data/1039828/000110465925081897/tm2523654d6_ex4-1.htm)[August](https://www.sec.gov/Archives/edgar/data/1039828/000110465925081897/tm2523654d6_ex4-1.htm)[2](https://www.sec.gov/Archives/edgar/data/1039828/000110465925081897/tm2523654d6_ex4-1.htm)[2](https://www.sec.gov/Archives/edgar/data/1039828/000110465925081897/tm2523654d6_ex4-1.htm)[, 2025, between American National Group Inc., as issuer, and Wilmington Trust, National Association, as trustee (Incorporated by reference to Exhibit 4.1 to Form 8-K filed on](https://www.sec.gov/Archives/edgar/data/1039828/000110465925081897/tm2523654d6_ex4-1.htm)[August](https://www.sec.gov/Archives/edgar/data/1039828/000110465925081897/tm2523654d6_ex4-1.htm)[2](https://www.sec.gov/Archives/edgar/data/1039828/000110465925081897/tm2523654d6_ex4-1.htm)[2](https://www.sec.gov/Archives/edgar/data/1039828/000110465925081897/tm2523654d6_ex4-1.htm)[, 2025)](https://www.sec.gov/Archives/edgar/data/1039828/000110465925081897/tm2523654d6_ex4-1.htm)</u> |
| 4.3 | <u>[Form of](https://www.sec.gov/Archives/edgar/data/1039828/000110465925081897/tm2523654d6_ex4-1.htm)[7](https://www.sec.gov/Archives/edgar/data/1039828/000110465925081897/tm2523654d6_ex4-1.htm)[.000%](https://www.sec.gov/Archives/edgar/data/1039828/000110465925081897/tm2523654d6_ex4-1.htm)[Fixed-Rate Reset](https://www.sec.gov/Archives/edgar/data/1039828/000110465925081897/tm2523654d6_ex4-1.htm)[Junio](https://www.sec.gov/Archives/edgar/data/1039828/000110465925081897/tm2523654d6_ex4-1.htm)[r Subordinated](https://www.sec.gov/Archives/edgar/data/1039828/000110465925081897/tm2523654d6_ex4-1.htm)[Notes due 20](https://www.sec.gov/Archives/edgar/data/1039828/000110465925081897/tm2523654d6_ex4-1.htm)[5](https://www.sec.gov/Archives/edgar/data/1039828/000110465925081897/tm2523654d6_ex4-1.htm)[5 (included in Exhibit 4.2)](https://www.sec.gov/Archives/edgar/data/1039828/000110465925081897/tm2523654d6_ex4-1.htm)</u> |
| 31.1 | <u>[Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](a2025-09x30ex311.htm)</u> |
| 31.2 | <u>[Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](a2025-09x30ex312.htm)</u> |
| 32.1 | <u>[Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](a2025-09x30ex321.htm)</u> |
| 32.2 | <u>[Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](a2025-09x30ex322.htm)</u> |
| 101 | The following materials from American National Group Inc.'s Quarterly Report on Form 10-Q for the period ended September 30, 2025 formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Statements of Financial Position, (ii) the Condensed Consolidated Statements of Operations, (iii) the Condensed Consolidated Statements of Comprehensive Income, (iv) the Condensed Consolidated Statements of Changes in Stockholders' Equity, (v) the Condensed Consolidated Statements of Cash Flows and (vi) the Notes to Condensed Unaudited Consolidated Financial Statements. |
| 104 | The cover page from American National Group Inc.'s Quarterly Report on Form 10-Q for the period ended September 30, 2025 formatted in iXBRL and contained in Exhibit 101. |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| Date: | November 13, 2025 | AMERICAN NATIONAL GROUP INC. | AMERICAN NATIONAL GROUP INC. |
|  |  | By: | /s/ Reza Syed |
|  |  |  | Reza Syed |
|  |  |  | Chief Financial Officer & Executive Vice President |

---

## Exhibit 31.1

**Exhibit 31.1** 

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002** 

I, Timothy A. Walsh, certify that:

1. I have reviewed this quarterly report on Form 10-Q of American National Group Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | | |
|:---|:---|:---|:---|
| Date: | November 13, 2025 | By: | /s/ Timothy A. Walsh |
|  |  |  | Timothy A. Walsh |
|  |  |  | Chief Executive Officer and President |
|  |  |  | *(Principal Executive Officer)* |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002** 

I, Reza Syed, certify that:

1. I have reviewed this quarterly report on Form 10-Q of American National Group Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | | |
|:---|:---|:---|:---|
| Date: | November 13, 2025 | By: | /s/ Reza Syed |
|  |  |  | Reza Syed |
|  |  |  | Chief Financial Officer and Executive Vice President |
|  |  |  | *(Principal Financial Officer)* |

---

## Exhibit 32.1

**Exhibit 32.1** 

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002** 

In connection with the Quarterly Report of American National Group Inc. (the "Company") on Form 10-Q for the period ended September 30, 2025 as filed with the Securities and Exchange Commission on or about the date hereof (the "Report"), I, Timothy A. Walsh, Chief Executive Officer and President of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934;

and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | | |
|:---|:---|:---|:---|
| Date: | November 13, 2025 | By: | /s/ Timothy A. Walsh |
|  |  |  | Timothy A. Walsh |
|  |  |  | Chief Executive Officer and President |
|  |  |  | *(Principal Executive Officer)* |

---

## Exhibit 32.2

**Exhibit 32.2** 

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002** 

In connection with the Quarterly Report of American National Group Inc. (the "Company") on Form 10-Q for the period ended September 30, 2025 as filed with the Securities and Exchange Commission on or about the date hereof (the "Report"), I, Reza Syed, Chief Financial Officer and Executive Vice President of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934;

and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | | |
|:---|:---|:---|:---|
| Date: | November 13, 2025 | By: | /s/ Reza Syed |
|  |  |  | Reza Syed |
|  |  |  | Chief Financial Officer and Executive Vice President |
|  |  |  | *(Principal Financial Officer)* |

---

<br>